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Abstract 
Hair differs from other human materials used for toxicological analysis, such as blood 
or urine, because of its substantially longer window of detection (months to years) 
enabling retrospective investigations of drug consumption. Due to its solid and durable 
nature, hair may be analysed centuries after growth with little degradation. Other 
advantages of hair analysis include the non-invasiveness of its collection, which is of 
particular importance in infant/child investigations and the ease of sample storage.  
Although hair analysis offers the potential to reveal information which is not possible 
with other biological matrices, it also suffers from some unique limitations that can 
make interpretation of findings challenging. These are largely due to exposure of hair 
to the environment before analysis can take place. 
Current analytical techniques allow detection and quantification of cannabinoids in 
hair samples. Frequently used techniques include gas chromatography mass 
spectrometry and liquid chromatography mass spectrometry. The majority of studies 
exclusively analyse the natural products Δ9-tetrahydrocannabinol (THC), Cannabinol 
(CBN), cannabidiol (CBD) or the metabolite 11-nor-9-carboxy-tetrahydrocannabinol 
(THC-COOH).  
In this thesis THC, CBD, CBN, THC-COOH and the additional metabolite 11-Hydroxy-
delta-9-tetrahydrocannabinol (11-OH-THC) have been simultaneously detected and 
quantified in authentic hair samples using a novel atmospheric pressure chemical 
ionisation method coupled to gas chromatography mass spectrometry. The results of 
these findings are compared to self-report data and are largely found to be in 
concordance, with some anomalies. In addition, several strategies to overcome the 
complication of external contamination of hair samples were trialled and compared to 
self-report data.    
In this thesis there is also an investigation presented to demonstrate the in-situ 
derivatisation of cannabinoids using matrix-assisted laser desorption ionisation 
(MALDI).  This is the first time a hair has been analysed for cannabinoids using MALDI 
and the first example of in situ derivatisation for hair samples. 
The addition of an N-methylpyridium group results in improved ionisation efficiency, 
permitting both detection and mapping of Δ9-tetrahydrocannabinol (THC), Cannabinol 
(CBN), cannabidiol (CBD) and the metabolites 11-nor-9-carboxy-tetrahydrocannabinol 
(THC-COOH), 11-Hydroxy-delta-9-tetrahydrocannabinol (11-OH-THC) and 11-nor-
delta(9)-carboxy-tetrahydrocannabinol glucuronide (THC-COO-gluc) in single hair 
samples.  
Additionally, for the first time an in-source re-arrangement of THC is reported and 
characterised in this thesis, thus contributing new knowledge in the analysis of this 
drug by MALDI mass spectrometry.  
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ECS   endocannabinoid System 
EI   electron impact ionisation  
ESI   electrospray ionisation  
FMPTS  2-Fluoro-1-methylpyridinium-p-toluene-sulfonate 
GC  gas chromatography 
GC-MS  gas chromatography mass spectrometry  
GC-MS/MS  gas chromatography tandem mass spectrometry  
ICR   incorporation rate  
LC  liquid chromatography  
LC-MS   liquid chromatography-mass spectrometry  
LiTFA   lithium trifluoroacetate 
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LLE  Liquid-liquid extraction  
LOD   limit of detection  
LOQ   limit of quantitation  
m/z   mass to charge ratio  
MALDI-MSP  matrix assisted laser desorption ionisation-mass spectrometry profiling 
MALDI-MSI  matrix assisted laser desorption ionisation- mass spectrometry imaging  
MDMA  3,4-Methylenedioxymethamphetamine 
MIPSE  molecularly imprinted solid phase extraction  
MS/MS tandem mass spectrometry 
MTBSTFA  N-Methyl-N-tert-butyldimethylsilyltrifluoroacetamide 
ND   not detected  
NICE   national institute for heal and care excellence  
PFOH   2,2,3,3,3-pentafluoropropanol 
PFPA    Pentafluoropropionic anhydride 
Q  quadrupole 
QqQ   triple quadrupole  
Q-ToF  quadrupole time-of-flight 
QUALY  quality adjusted life years  
RT   retention time  
SAMHSA  substance abuse and mental health services administrator  
SoHT   society of hair testing  
SCRA  synthetic cannabinoid receptor agonists  
SPE  solid phase extraction 
TFA   trifluoroacetic acid 
TFAA   trifluoracetic acid anhydride  
THC   Δ⁹-tetrahydrocannabinol 
THCA-A  Δ9-Tetrahydrocannabinolic Acid A 
THC-COO-glu   Δ9-Tetrahydrocannabinolic acid-glucuronide  
THC-COOH  11-Nor-9-carboxy-Δ⁹-tetrahydrocannabinol 
TMS   trimethylsilyl  
TOF   time of flight  
UPLC-MS/MS  ultra-performance liquid chromatography tandem mass spectrometry 
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Matrix (Disambiguation) 
 
In relation to matrix assisted laser desorption ionisation the term matrix refers to a 
solvent containing one or more small organic molecules which is fundamental to the 
ionisation process. 
In toxicology (in this thesis in relation to the use of gas chromatography-mass 
spectrometry) the term matrix refers to hair extracts. 
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Chapter 1. General introduction 
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The field of forensic toxicology encompasses analysis of biological specimens for 
substances such as alcohol, drugs and poisons, which are related to a medico-legal 
investigation.  
Recent Home Office data indicates that, in England and Wales, cannabis remains the 
most commonly encountered illicit drug, where it accounted for 72% of the 138,955 
drug samples seized by police in the financial year ending March 2017 [1]. As in 
previous years, cannabis was the most commonly used drug in 2016/17, with an 
estimated 6.6% of adults aged 16 to 59 having used it in the last year (around 2.2 
million people) [2]. Due to its widespread use and popularity, the detection of cannabis 
use is important in the field of forensic toxicology.  
 
In this introductory chapter, cannabis, including its mechanism of action and 
interpretational issues will be discussed in detail. In addition, the use of hair as an 
alternative biological matrix with advantages and pitfalls will also be discussed. Finally, 
current analytical techniques used to detect cannabis use in hair samples will be 
described.  
 
1.1 Cannabis 
 
Cannabis is a highly variable plant species in terms of botany, genetics, and chemical 
constituents. The precise number of species in the Cannabis genus has long been 
disputed [3]. Some reports proposed Cannabis as a polytypic genus, however, based 
on morphological, anatomical, phytochemical, and genetic studies, it is generally 
accepted as having a single, highly polymorphic species known as Cannabis sativa 
Linnaeus [4].  
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Cannabis has been used for recreational and medicinal purposes for centuries. For the 
purpose of this research, the term cannabis refers to the dried flower tops of the 
female plant. This product is also commonly known as marijuana or marihuana. The 
most common way to administer cannabis is by smoking, although it can also be 
ingested [5].  
 
1.1.1 Chemical components of cannabis 
 
The cannabis sativa L. plant contains more than 500 chemicals of which 61 are 
cannabinoids, a further 1500 compounds are produced by pyrolysis during smoking of 
cannabis [6]. Of the naturally occurring compounds delta-9-tetrahydrocannabinol 
(THC) is considered to be the main psychoactive component.  
The THC content in cannabis plant material is extremely variable. In America the mean 
concentration of THC in plant material seized by the Drug Enforcement Agency (DEA) 
has increased year-on-year from 4 to 12% in the years 1995 to 2014, although 
concentration ranges are not reported [7].  
In 2005 a study of 247 cannabis samples collected from street level users in the UK 
revealed a wide concentration range of 1.16-23% with a median level of 14% [8]. In a 
more recent UK study conducted in 2016, the concentration range was highly variable, 
from 1.9% to 22.5%, with a median value of 14.2% for the 400 samples tested [9].  
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1.1.2 Tetrahydrocannabinol formation and metabolism  
 
In the growing Cannabis sativa plant, most cannabinoids are initially formed as 
carboxylic acids (e.g., Δ9-THCA and CBDA) that are decarboxylated to their 
corresponding neutral forms as a consequence of drying, heating, combustion, or aging 
[10] (Figure 1-1). CBN is often analysed in hair samples. It is not formed 
biosynthetically but is an oxidative degradant of Δ9-THC [11]. 
 
Figure 1-1. The biosynthetic pathway for the production of cannabinoids and breakdown products of THC. 
Compounds highlighted with a red box are target analytes in this research project.  
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When ingested or inhaled, THC undergoes complex hepatic metabolism based on 
oxidation and subsequent glucuronidation [6]. Since this is an enzymatic pathway only 
present in vivo, metabolite detection has been suggested as a solution to external 
contamination difficulties associated with solely analysing THC, CBD and CBN content 
in hair samples (see Section 1.3.7). The main oxidative metabolites of THC are 11-
hydroxy-delta-9-tetrahydrocannabinol (11-OH-THC) and 11-nor-9-carboxy-delta-9-
tetrahydrocannbinol (THC-COOH) which are shown in Figure 1-2. THC-COOH 
subsequently undergoes glucuronidation to form 11-nor-delta(9)-carboxy-
tetrahydrocannabinol glucuronide (THC-COO-gluc). 
 
Figure 1-2. The in vivo metabolic pathway of THC. 
 
1.1.3 Mechanism of action  
 
The effects of THC are triggered by the compound binding to receptors in the 
endogenous cannabinoid system.  
The endocannabinoid system (ECS) is a widespread neuromodulatory system that plays 
important roles in central nervous system development, synaptic plasticity, and the 
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response to endogenous and external stimuli [12]. The ECS comprises of cannabinoid 
receptors, endogenous cannabinoids, and the enzymes responsible for the synthesis 
and degradation of the endocannabinoids.   
Two cannabinoid receptors have been identified in humans (CB1 and CB2) [13]. CB1 
receptors are found mainly on neurons in the brain and are present in high densities in 
other areas of the central nervous system (CNS). CB1 is activated by the endogenous 
cannabinoids anandamide and 2-arachidonylglycerol (shown in Figure 1-3), among 
others. The pre-synaptic CB1 receptor inhibits the release of both excitatory and 
inhibitory neurotransmitters in the CNS and peripheral nervous system. Activation of 
the CB1 receptor produces a sensation of euphoria, along with other effects such as 
antiemetic and analgesic [14] which will be discussed further in Section 1.1.4.  
T 
Figure 1-3. Structures of cannabinoid receptor agonists. a) plant cannabinoid THC, b) plant cannabinoid CBD, c) 
endocannabinoid anandamide, d) endocannabinoid 2-arachidonylglycerol e) synthetic cannabinoid JWH-018  f) 
synthetic cannabinoid CP47,497 
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The CB2 receptor is predominantly expressed in the immune system, for example in 
the tonsils and spleen. CB2 receptors appear to be involved in inflammatory processes 
[15], and so targeting this receptor may be a new approach to treat inflammatory 
diseases. Whilst activation of the CB1 receptor produces psychotropic effects, the 
activation of the CB2 receptor does not [16]. THC has approximately equal affinity for 
the CB1 and CB2 receptor whilst CBD has a very low affinity for both cannabinoid 
receptors. Interestingly, CBD antagonizes cannabinoid receptor agonists [16].  
Recently there has been a rapid growth in the detection of synthetic cannabinoid 
receptor agonists (SCRAs). These are becoming increasingly chemically diverse, with 
169 detected from 2008 to 2016. In 2015, just over 22 000 seizures of synthetic 
cannabinoids were reported across Europe [17]. These seizures amounted to more 
than 2.5 tonnes of the substances.  
SCRAs were originally developed to research the CB1 and CB2 receptors. SCRAs include 
compounds such as JWH-018 and CP47,497 (shown in Figure 1-3) which are now sold 
under the brand names such as “spice”,” K2”, and “black mamba” for recreational use. 
Many SCRAs have a higher CB1 binding affinity than THC, and so have been known to 
cause severe adverse effects  [18].  
A more detailed review on downstream cellular responses to CB1 and CB2 activation 
can be found by Ibsen et al.[19].  
 
 
 
 
23 
 
1.1.4 Desired effects and therapeutic uses of cannabis 
 
It is widely accepted that cannabis can have many therapeutic properties including as a 
treatment for chronic pain [20–22], muscle spasticity in multiple sclerosis patients 
[23,24] and as an anti-sickness (antiemetic) treatment for patients undertaking 
chemotherapy [25,26]. There is also some evidence to suggest cannabis can be used as 
a treatment for Tourette’s syndrome [27]. In light of these findings, the use of medical 
marijuana has been legalised in several American states, and in September 2018 the 
law in the UK was changed to allow its use in some specific treatments [28]. 
 
In 2010, GW Pharmaceuticals released a cannabis-derived medicine in the form of an 
oromucosal spray marketed under the brand name of Sativex. It is used to treat muscle 
stiffness/spasm due to multiple sclerosis. The formulation contains a 1:1 ratio of THC 
and CBD as active ingredients and can be prescribed in the UK [29]. However, NICE 
(National Institute for Health and Care Excellence) recommend that Sativex should not 
be prescribed as it is not cost effective [30].   
 
In 2018, Epidiolex was approved as a prescription medicine by the FDA. Epidiolex is 
used to treat severe forms of epilepsy and is also produced by GW Pharmaceuticals. In 
contrast to Sativex, the active ingredient of Epidiolex is solely CBD [31].  
1.1.5 Adverse effects of cannabis use 
 
The recreational use of cannabis is illegal in most countries (including the UK). This is 
due to the adverse effects associated with cannabis usage including anxiety, 
depression, panic reactions and psychotic symptoms including an increased risk of 
developing schizophrenia [32]. However, despite some recent sensationalist media 
coverage, it is important to highlight the fact that cannabis consumption alone is not 
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enough to cause mental health problems, but in combination with other compounding 
factors such as a family history of mental health issues, the age of exposure to 
cannabis, and genetic factors cannabis can increase the risk of developing mental 
health problems. A detailed review of the link between cannabis use and mental 
health problems can be found by Radhakrishnan et al. [33]. Some studies suggest that 
CBD intake may mitigate adverse effects of THC usage including 
hallucinations/delusions and social withdrawal (introvertive anhedonia) [34]. 
 
In addition to possible adverse effects on mental health, a link between cannabis 
consumption and reaction time impairment has been established and it is thought that 
people who drive under the influence of cannabis are around twice as likely to be 
involved in a serious car accident [35–38]. Other negative traits associated with 
cannabis use include risk taking, antisocial behaviour, and poor academic performance 
[39]. 
 
1.2 Biological matrices for the detection of cannabis use 
 
The biological matrices blood, urine, hair, oral fluid and sweat have been proposed for 
the detection of cannabis use. Each matrix has its own advantages and limitations 
associated with it, as summarised in Table 1-1. A detailed review of biological matrices 
used for determining cannabis use can be found by Musshoff and Madea [40].  
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Biological 
sample 
Advantages Limitations 
Blood  Preferred for the interpretation of 
acute effects after cannabis abuse. 
Able to distinguish between 
occasional and regular users [41]. 
Invasive. Sample collection needs to 
be performed by a trained medical 
professional. Shortest window of 
detection compared to other 
biological samples. Blood samples 
should be stored at -20°C [42].  
Urine Non-invasive. Commonly used in 
workplace testing, well-established 
technique.  
Procedure is limited to samples 
obtained within a few days after the 
last consumption [40] (up to months 
if sample is taken from a chronic 
user). Concerns around privacy 
during collection. Samples must be 
stored at -20°C[43]. 
Sweat Non-invasive. Usually collected 
weekly over several weeks, giving a 
long detection window and insights 
into drug use patterns [44].  
 
 
 
Possibility of time-dependent drug 
loss from the patch by drug 
degradation on the patch or skin, 
reabsorption into the skin and 
volatile losses through the covering 
membrane of the patch [44]. 
Hair Non-invasive, long window of 
detection (depending on hair 
length) stored at room 
temperature. 
Possibility of external contamination. 
Low incorporation rates of 
metabolites [45] .  
Oral fluid Non-invasive. Fast, simple sample 
collection. Compatible with point-
of-collection-testing making rapid 
analysis possible at the roadside 
[46].  
Only able to detect recent cannabis 
use unless sample is provided by a 
chronic cannabis smoker [47]. THC 
can reduce salivation, leading to 
reduced sample volume. 
Confirmatory testing still needed 
after a roadside positive test.  
 
Table 1-1. Advantages and limitations of several biological matrices used for the detection of recent or ongoing 
cannabis use.  
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1.3 Hair testing for the analysis of cannabis use  
1.3.1 Hair  
 
Hair is a feature common to all mammals. Its main biological function is to facilitate 
thermoregulation, but additional functions include camouflage and increasing sensory 
perception. The main function of human hair is for protection (eyelashes stop things 
entering and irritating the eyes whilst scalp hair prevents physical damage from 
sunlight to the head and neck) [48].  
As described in Table 1-1, hair differs from other human materials used for 
toxicological analysis such as blood or urine because of its substantially longer 
detection window (months to years) enabling retrospective investigation of chronic 
and past consumption. Because of its solid and durable nature, hair analysis can be 
performed even centuries after growth [49]. Other advantages of hair analysis include 
the non-invasiveness of its collection; eradicating the need for special restroom 
facilities and same-sex collectors (as with urinalysis) or medically trained sample 
collectors (as with blood analysis). Finally, the ease of sample storage is an additional 
benefit of hair analysis as samples can be stored at room temperature and take up 
relatively little storage space.  
 
1.3.2 Applications of hair testing  
 
Despite the analytical pitfalls of hair testing with regards to external contamination, 
there are many applications which call for retrospective intake analysis which is not 
possible with other testing methods such as blood, urine or saliva analysis. 
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The first report of this type of retrospective analysis came in 1858 when arsenic was 
detected in the hair of a corpse exhumed 11 years after burial [50]. Perhaps one of the 
most famous uses of elemental analysis in hair was arsenic found in the hair of 
Emperor Napoleon Bonaparte over 100 years after his death [51]. Whilst elemental 
analysis of hair is still an important tool in forensic science today, modern hair analysis 
has much wider applications since the advent of chromatographic techniques allow for 
the detection of a wide variety of compounds.  
Applications of modern hair testing include workplace drug testing programmes [52], 
drug facilitated crime investigations [53,54], post-mortem investigations [55–59], 
driving licence renewals [60]  and even the detection of chemical warfare agents [61].  
One of the most common reasons for undertaking hair testing in the UK is for evidence 
in family courts as to whether a parent has abstained from drugs and/or alcohol. The 
Times newspaper claimed that in 2010 over 10,000 hair tests had been conducted for 
UK family courts over the course of a year [62].  
Clinical applications of hair testing have become more prevalent in recent years. This 
includes investigating patient compliance to prescribed medications. To date, research 
has primarily focused on the detection of drugs used to treat HIV [63–67]. The testing 
of neonatal hair to determine in-utero exposure has also been studied for both alcohol 
[68–70], nicotine [71] and illicit drugs [71–81].  Another possible clinical application of 
hair testing is to determine the suitability of a patient to receive an organ 
transplantation by determining drug and alcohol use or abstinence [82,83]. It has also 
been suggested that hair cortisol levels can be used as a biomarker for chronic stress, 
and a recent review article by Steudte-Schmiedgen concluded that hair cortisol 
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analysis is a promising addition to trauma and posttraumatic stress disorder (PTSD) 
related research [84]. 
1.3.3 Anatomy of hair 
 
To understand the incorporation of xenobiotics into hair, an understanding of the 
anatomy of hair is also needed. Initially hair can be divided into two main sub groups, 
the hair shaft which is seen externally as flexible tubes of dead, fully keratinized 
epithelial cells and the living hair follicle which is located 3-5 mm below the surface of 
the skin. 
 Anatomy of the hair shaft 
 
The hair shaft has three structural areas; the innermost of these is the medulla as can 
be seen in Figure 1-4. It may be continuous across the hair shaft, discontinuous or even 
completely absent. The cortex represents the majority of the hair fibre composition 
and plays an important role in the physical and mechanical properties of hair [85].  The 
outermost region of the hair shaft is the cuticle; it covers the hair from the root to the 
tip of the epidermis and is formed of 5-10 layers of flat overlapping cells. The cuticle 
can become damaged due to hair treatments, such as bleaching, dying, perming and 
the use of styling techniques such as straightening and curling which exposes the hair 
to intense heat.  
 
29 
 
 
Figure 1-4. The anatomy of the hair shaft showing the three distinct areas. Reproduced from [86]. 
 
 Anatomy of the hair follicle  
 
The structure of the hair follicle can be seen in Figure 1-5. At the base of the hair bulb 
is the dermal papilla which contains the blood supply to the follicle. This is the main 
source for transport and supply of metabolic fuel and hence of drug molecules. The 
cell membranes of the matrix cells (that are localized in a cone-shaped region around 
the papilla) and the cell membranes of the melanocytes (that are situated at the apex 
of the papilla) are exposed to the circulating blood, lymph and extracellular fluids [87]. 
As the hair grows from the bulb it dehydrates and keratinisation takes place.  
 
30 
 
 
Figure 1-5. The structure of the hair follice. Reproduced from [88]. 
 
1.3.4 Hair growth rates and hair growth cycle 
 
Other important factors in the interpretation of hair analysis results include the hair 
growth rate and the hair growth cycle. Hair grows in a cycle composed of the anagen 
(active growing), catagen (transition) and telogen (resting) stages. At any one time, 
approximately 85% of adult scalp hair is in the growing phase (anagen) with the 
remaining 15% in the resting phase (telogen). In the telogen phase the dermal papilla 
contains no capillaries [89]. The rate of hair growth can vary between individuals, with 
studies showing a five-fold difference in head hair growth rate from 0.6 to 3.36 cm per 
month [89]. However, as can be seen in Table 1-2 reproduced from the review article 
by LeBau et al., the average growth rate is approximately 1 cm per month [90]. Despite 
the wide range in growth rates between individuals the Society of Hair Testing (SoHT) 
recommends using the 1 cm per month average when interpreting results for head 
hair [91]. This can cause assessments of a timeline of usage/abstinence to be 
inaccurate. For example, for an individual with a hair growth rate of 0.65 cm per 
 
31 
 
month a 1 cm section would equate to approximately 47 days of usage. However, for 
an individual with a hair growth rate of 2.2 cm per month a 1 cm section would equate 
to approximately 14 days of usage.  
Year of 
publication 
Growth rate (cm/month) 
 Minimum Maximum Average Reference 
1951 0.84 1.15 0.98 [92] 
1964 0.76 0.96 0.86 [93] 
1992 0.84 1.37 1.12 [94] 
1993 0.6 3.36 Not reported [89] 
1996 0.65 2.2 1.4 [95] 
2004 0.95 1.12 1.04 [96] 
2007 0.73 1.48 1.11 [97] 
Table 1-2. Published growth rates of human head hair, adapted from a review article by LeBeau et al. [98]. 
It is worth noting that other hair types such as chest, pubic, axillary, beard, arm and leg 
can be used in testing however head hair is preferred because it has the fastest growth 
rate with the highest percentage of follicles in the anagen phase [99]. 
1.3.5 Mechanisms of drug incorporation into hair 
 
There are several possible mechanisms of incorporation of drug compounds into hair. 
Whilst for interpretational purposes it would be advantageous for compounds only to 
be incorporated from the blood stream, there are several other possible mechanisms. 
These include sweat, sebum, smoke, contaminated hands and secondary transfer 
(Figure 1-6). In this section each model will be discussed, including an evaluation of 
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how each possible route of incorporation can affect the interpretation of hair testing 
results. 
 
Figure 1-6. Possible methods of cannabinoid incorporation into hair samples, in addition to incorporation via the 
bloodstream. Adapted from [100].  
 
 Incorporation from blood 
 
Incorporation models typically assume that drugs or chemicals enter hair by passive 
diffusion from blood capillaries into growing cells within the hair bulb and then 
becomes “trapped” in the keratinised cells as the hair dehydrates [101]. 
For a drug molecule to permeate a cell it must cross the plasma membrane. Therefore, 
the physicochemical properties of both the cell membrane and drug molecule largely 
dictate the amount of drug which is incorporated into the hair from the bloodstream. 
Nakahara et al. studied the effects of melanin affinity and lipophilicity on the 
incorporation rate (ICR) of twenty drugs of abuse using a rat model. They concluded 
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that both melanin affinity and lipophilicity were positively correlated with the ICR, 
except for in the case of 11-nor-9-carboxy-THC (THC-COOH) where the ICR was low 
despite having high lipophilicity [45].  
The pKa of the drug molecule is also important in the passage of the drug from the 
plasma into the melanocytes of the hair bulb as the molecule must be non-ionised to 
cross the cell membrane. There is a pH gradient from plasma (pH 7.3) to the 
melanocytes of the hair bulb (pH 3-5) [99] this in turn means that basic compounds 
incorporate preferentially to acidic compounds. This is described in more detail in  
Figure 1-7 reproduced from Pragst et al. [99]. 
It should be noted that it is only possible for drugs to be incorporated into the hair 
bulb when the hair is in the anagen phase of the growth cycle (see Section 1.3.3).  
 
Figure 1-7. Influnce of acidic/basic properties of drugs on the incorporation of xenobiotics from the bloodstream 
into the cells of the hair bulb reproduced from [99]. 
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Ideally, the passage from blood to the hair follicle would be the only incorporation 
route of xenobiotics into hair, allowing for a clear dose-response correlation; however, 
this is not the case, and interpretational issues arising from this are summarised in 
Section 1.3.6.1   
    
 Incorporation from sebum and sweat 
 
As sebum is secreted directly on to the hair surface this is thought to play a role in the 
detection of drugs in hair samples [99]. Stout and Ruth found that sebum had a 
nominal effect on incorporation in their study of cocaine, nicotine and flunitrazepam in 
mouse hair [102], however there is a lack of literature of the effect of sebum on 
incorporation of cannabinoids. 
It is well known that drugs and their metabolites are excreted in sweat. In fact, sweat-
testing is becoming a popular alternative sampling technique [103] (see Section 1.2). 
Sweat bathes scalp and other hair and this presents interpretational difficulties in the 
context of hair analysis, as it is difficult to determine whether drugs came from 
incorporation via the blood stream or via sweat. Whilst this may not seem 
problematic; as drugs present in sweat are a direct consequence of intake, it could lead 
to elevated levels detected in hair (possibly taking samples beyond a cut-off). In 
addition, it will skew the results of segmental analysis, as shown by Henderson et al., 
where deuterated cocaine was detected in multiple hair segments suggesting multiple 
intakes of the drug however only a single dose of the drug was administered [104]. 
This was found in 74% of the 23 individuals tested, despite washing the hair prior to 
analysis.   
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 Incorporation from external sources 
 
In addition to incorporation from the bloodstream and sweat, external sources of 
contamination must also be considered when analysing hair since the hair shaft is 
exposed to the environment.  
Likely sources of external contamination include powders from drugs such as cocaine 
and smoke contamination from drugs such as crack cocaine, heroin and cannabis. It is 
possible that contamination can also occur from touching drugs and then touching hair 
directly after [100,105].  In fact, in 2009 the FBI ceased all hair testing for cocaine citing 
the likelihood of external contamination as the reason [106]. Testing was then re-
instated in 2014 due to new guidelines which included extensive wash protocols and 
the detection of metabolites [107].  
Washing procedures have been used to help eliminate externally bound drugs, along 
with monitoring of metabolites. These can be useful in reducing false positives, 
however may not prevent them entirely.  This is discussed further in Section 1.3.8.  
1.3.6 Analysis of hair to detect cannabis use  
 
Several cannabinoids, including THC and its metabolites can be detected in hair 
samples using standard analytical techniques such GC-MS and LC-MS. Between the 
year 2000 and 2014 there was just one publication on the detection of cannabinoids 
using LC-MS and 15 publications using GC-MS. These and their findings are 
summarised Table 1-3. 
There are a wide range of concentrations of each cannabinoid detected in the hair of 
cannabis users. Differences in amounts and frequency of usage and in individual 
smoking style (depth of inhalation, puff duration, and breathhold) will be a factor. 
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Analytical reasons for variations could also include differing sample preparation, 
analytical technique, and differing concentration of cannabinoids in the original plant 
material.  
In most studies summarised in Table 1-3 the concentration of THC is greater than other 
cannabinoids. This is not always the case, as some studies found CBD to be at higher 
concentration than THC [108,109]. In the study conducted by Salomone et al. 29% of 
individuals had CBD concentrations higher than THC [110]. 
In all cases where both THC and THC-COOH are analysed in the same sample, the 
concentration of THC is much higher. This could be explained by the fact that peak 
plasma concentrations are approximately three times higher for THC than for THC-
COOH after cannabis is smoked, as shown in Figure 1-8. However THC-COOH was 
detected for on average 11 times longer in blood than THC in a study conducted by 
Heustis et al. [111]. 
Some studies found that samples had low THC concentrations but high CBN 
concentrations [108,112,113]. This may be explained by the pyrolytic degradation of 
THC to CBN when cannabis is smoked [112,114].  
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Figure 1-8. Mean plasma levels of THC, 11-OH-THC and THC-COOH during and after smoking a single 3.55% THC 
marijuana cigarette reproduced from [111].  
 
 
THC 
(ng/mg) 
CBD 
(ng/mg) 
CBN 
(ng/mg) 
THC-COOH 
(pg/mg) 
No. of 
samples  
Mass of sample 
used (mg)  
Instrumentation LOD/LOQ 
THC (ng/mg) 
LOD/LOQ  
CBD (ng/mg) 
 LOD/LOQ 
CBN (ng/mg) 
LOD/LOQ  
THC-COOH (pg/mg) 
Ref 
<LOQ-
0.070 
0.013-0.02 0.031-0.300 N/A 10 10 GC–EI-MS/MS 0.031, 0.062 0.007, 0.012 0.011, 0.030 N/A [115] 
0.02-0.232 <LOQ-0.018 0.009-0.107 N/A 23 10 GC-EI-MS/MS 0.015, 0.20 0.0005, 0.001 0.0005, 0.001 N/A [113] 
<LOQ-4.2 <LOQ-12.1 <LOQ-0.85 N/A 77 50 GC-EI-MS 0.012, 0.037 0.013, 0.038 0.016, 0.048 N/A [116] 
0.09-0.72 ND-0.57 <LOQ-0.34 N/A 12 50 GC-EI-MS Not reported Not reported Not reported N/A [117] 
0.06-0.27 <LOQ-0.05 0.05-1.38 N/A 22  50 GC-EI-MS 0.006, 0.05 0.005, 0.05 0.002, 0.05 N/A [118] 
<LOQ-0.73 0.81-19.02 0.12-1.48 N/A 20 10 GC-EI-MS 0.05, 0.27 0.08, 0.27 0.14, 0.51 N/A [109] 
0.29-2.2 0.53-18.36 0.55-4.54 N/A 25 10 GC-EI-MS 0.05, 0.27 0.08, 0.27 0.14, 0.51 N/A [108] 
0.13-7.25 0.23-2.79 0.05-2.27 N/A 9 Not reported GC-MS 0.001 
Not reported 
0.02 
Not reported 
0.02 
Not reported 
N/A [119] 
0.054-
0.553 
0.018-1.862 0.031-0.205 N/A 14 50 UHPLC-MS/MS 0.0012, 
0.0039 
0.0054, 0.018  0.0016, 
0.0053  
N/A [110] 
0.003-
0.438 
N/A N/A 0.03 -1.53 93 70-100 strands GC-NCI-MS/MS Not reported  N/A N/A not reported  [120] 
ND-0.11 N/A N/A ND-7.3 53 20 GC-NCI-MS/MS 0.001 N/A N/A 0.1 [121] 
N/A N/A N/A ND-9.01 18 20 GC-NCI-MS/MS N/A N/A N/A 0.025, 0.05 [122] 
N/A N/A N/A 0.05-9.38 224 25 GC-NCI-MS/MS N/A N/A N/A 0.015, 0.05 [123] 
N/A N/A N/A 0.6-1.39 4 20 GC-NCI-MS N/A N/A N/A 0.3, 0.4 [124] 
N/A N/A N/A 0.09-1.94 12 20 GC-GC-ECCI-MS N/A N/A N/A Not reported 
0.05 
[125] 
N/A N/A N/A 0.06-14.23 23 20 GC-NCI-MS/MS N/A N/A N/A 0.025, 0.5 [126] 
   Table 1-3. Summarised results from publications investigating cannabinoid detection in user hair samples, including reported Limits of Detection (LOD), limits of quantification (LOQ) and  
concentration ranges of various cannabinoids(N/A= cannabinoid not included in the study ND= not detected). 
 
 
 
 Dose/concentration correlation studies  
 
Often in the context of medical or legal settings, toxicologists are asked to determine 
how much, or how often, a drug was used. To give an accurate answer to this question 
there must be a strong dose-concentration correlation for the biological sample being 
analysed.  
In a study conducted by Huestis et al. it was found that 36% of confirmed cannabis 
users by urinalysis and self-report (n=38) had no detectable levels of THC or THC-COOH 
in their hair samples (LOQ 1.0 and 0.1 pg/mg of hair respectively). They also discovered 
that the median concentrations of THC and THC-COOH were not statistically different 
between daily and non-daily cannabis users [121]. Whilst a link between dose and 
concentration of cannabinoids in hair was not found, it should be noted that it was 
more likely for THC and THC-COOH to be detected in daily user’s hair than in non-daily 
users.  
Similarly, in 157 cases where cannabinoids were detected in hair samples as part of a 
study conducted by Sachs and Dressler [127] they concluded that: "a dose-
concentration relationship does not exist either for THC or THC-COOH, or even both".  
Despite Sachs and Dressler publishing these findings in the year 2000, the 
interpretation issue of a lack of dose/concentration correlation is still heavily debated 
today. For example, in the 2016 SoHT annual meeting one attendee asked the 
following question: "What actually is the merit of quantification? Why do we strive to 
quantify we cannot compare inter-person, we cannot compare inter-lab? We cannot say the 
higher dose will give a higher result." 
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The President of the SoHT, Markus Baumgartner replied: "I think we should apply what 
the SoHT suggested many many years ago and that is low, medium or high range, not to say 
anything about the doses but to compare low medium or high. I think this is very helpful from 
my viewpoint." 
Without further investigation it is difficult to know if low, medium or high 
concentrations can be reliably reported. For this type of reporting to be effective there 
would need to be a uniform approach to sample preparation and analysis techniques. 
In addition, a shared database of results from all laboratories undertaking hair analysis 
would need to be available to overcome the problem of small or non-representative 
databases, which is not yet the case.  
1.3.7 External contamination studies  
 
As one of the main methods of drugs becoming incorporated into the hair is through 
external contamination, it is important to have an evidence base to aid in 
interpretation of analytical results. There are few studies that have been conducted in 
this area of research, as summarized below.  
 Contamination due to cannabis smoke 
 
Since THC is present in the smoke produced when the plant material is combusted, the 
presence of THC in body fluids can be due to passive exposure to smoke, and not 
necessarily direct or intentional usage. As a result of this passive exposure to cannabis 
smoke has successfully been used as a defence in UK courts [128].  
 Several studies have been conducted into the passive exposure of cannabis smoke in 
relation to cannabinoid levels in blood [129–133] , urine [129–138] and oral fluid [139–
142]. Early studies suggested that passive exposure to cannabis smoke could give 
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positive results, however these studies were heavily criticised due to the extreme, 
unrealistic conditions used [143]. This included the simultaneous burning of multiple 
marijuana cigarettes and the use of very small, unventilated rooms. In some studies 
participants even had to wear goggles to prevent eye irritation [133,136].  
One recent study conducted by Röhrich et al. focused on investigating more realistic 
conditions of passive exposure on blood and urine samples [132]. The study was 
carried out in a Netherlands coffee shop where cannabis was legally being smoked. 
Eight non-smoking participants stayed in the coffee shop for three hours. The results 
showed that none of the urine samples produced immunoassay results higher than the 
cut-off concentration of 25 ng/mL, therefore none of the participants would be 
accused of cannabis use in a routine drug screen. GC-MS analysis revealed trace 
amounts of THC and THC-COOH in both urine and plasma. However, the highest 
concentration of THC-COOH found in urine was less than half of the cut-off 
concentration recommended by the Substance Abuse and Mental Health Services 
Administration (SAMHSA) guidelines for federal workplace drug testing programmes of 
15 ng/mL, and so again, none of the eight participants would be reported positive for 
cannabis consumption. 
Whilst it has been widely reported that marijuana smoke elevates the THC levels found 
in hair samples, investigations into the level of incorporation and/or factors effecting 
this incorporation are extremely limited as discussed below:  
The first in vitro study was performed by Strano-Rossi and Chiarotti where hair 
samples were exposed to marijuana smoke to evaluate decontamination procedures 
[112]. Further to this Thorspecken et al. adapted a desiccator to contaminate hair 
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samples with marijuana smoke to investigate the effect of moistening the hair and hair 
treatments on the level of THC detected. The authors concluded that moistening the 
hair before exposure raised the concentration of THC and CBN, whilst bleaching and 
perming the hair lowered the concentration of THC and CBN. This study was limited by 
that fact that only one, pooled sample of dark blonde hair of Caucasian origin was 
used, and similarly only one time point was used (sixty minutes of exposure).  
The first and as yet only in vivo marijuana smoke contamination study was conducted 
in 2014 by Moosmann et al. In this study three participants were exposed to the 
smoke of one marijuana cigarette whilst breathing through SCUBA regulators [144]. 
The exposure was repeated every weekday over a three-week period in a relatively 
small room (2.5 m2).  
The authors stated that the degree of contamination differed with length of hair, with 
shorter hair being less affected by contamination than medium and longer hair. 
However, it should be noted that the sample size was small (n=1 for each hair length) 
and differences could also be due to personal washing technique of the hair as neither 
this nor the brand of shampoo used was standardised in the study.  
The authors also cast doubt over the Society of Hair Testing recommended sampling 
site of the posterior vertex region [145] , claiming that this sampling site suffers from 
the highest degree of contamination. However, again it must be noted that only one 
participant was used for this part of the study, and personal hair washing procedure of 
this individual could contribute to the finding. 
Interestingly, THC was detected in all three of the participant’s hair samples after the 
exposure period with a concentration range of 140-1700 pg/mg of hair. This is well 
 
43 
 
above the SoHT cut-off of 50 pg/mg. Two out of the three participants had levels of 
THC above the cut-off four weeks after exposure and one participant even had levels 
above the cut off seven weeks after exposure, despite daily washing of the hair with 
shampoo and a decontamination procedure prior to analysis.   
 
 Contamination due to handling of cannabis plant material  
 
Since THC is present in plant material, it is reasonable to assume that contamination of 
hair samples could be due to touching plant material or contaminated surfaces. 
Moosmann et al. showed that THC could be detected in the hair samples of non-
cannabis users after the handling of plant material, even after extensive washing for 
four weeks post exposure [146].  
Contamination of synthetic cannabinoids was further investigated by Moosmann et al.. 
Hair samples of laboratory analysts who had been in contact with synthetic 
cannabinoid herb mixtures were tested. All of the hair samples were positive for at 
least one synthetic cannabinoid, despite the implementation of a decontamination 
wash procedure and gloves and laboratory coats being worn throughout the handling 
period [147].  
Concentrations of synthetic cannabinoids in hair samples ranged from trace amounts 
up to a maximum of 170 pg/mg. It was also shown that subjects without direct contact 
with the synthetic cannabinoids, but who were co-habiting with the analysts also had 
cannabinoids detected in their hair. One of the analysts had a concentration less than 
0.5 pg/mg in his hair, his girlfriend who did not have direct contact with the synthetic 
cannabinoids had a concentration of 11 pg/mg in her hair.  This could be partially 
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explained by previous findings showing that longer hair is more susceptible to external 
contamination [144], however, much more research into the secondary transfer of 
cannabis plant/synthetic cannabinoid herb material needs to be conducted to fully 
understand the implications when interpreting results. One other possible explanation 
for the result is usage of the drug, as participants were not screened for drug use prior 
to the study.  
Interestingly, it was also shown in this study that hair samples from other parts of the 
body (leg, chest and pubic region) tested positive for the synthetic cannabinoids, 
despite being completely covered up during the handling experiment. It should be 
noted that not all the participants gave a positive result for the same sampling site. A 
limitation is that and only three individuals took part in this part of the study. Further 
studies are clearly needed for a better understanding of this type of contamination for 
both synthetic and non-synthetic cannabinoids.  
 
1.3.8 Strategies to overcome the issue of external contamination of 
cannabinoids 
 
As mentioned previously in Section 1.3.7, external contamination is one of the main 
causes of interpretational issues in relation to hair analysis. In this section a review of 
literature citing a variety of published strategies to overcome this issue is presented. 
   
 Identification of metabolites 
 
One strategy to reduce the number of false positives test results is to also identify THC 
metabolites, since these are only produced in vivo, as discussed in Section 1.1.2).  
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THC-COOH is by far the most frequently targeted metabolite of THC in hair samples. 
The Society of Hair Testing  recommend that this is the metabolite detected to confirm 
cannabis usage [145]. In many cases THC-COOH is the only metabolite that is targeted 
for detection [121,148–151]. Recently there has been some debate as to the suitability 
of THC-COOH to identify THC usage in hair samples since Moosmann et al. reported 
that THC-COOH could be detected in segments correlating to a period 2-3 months 
before THC was orally ingested (n=2) [100]. The authors attributed this to 
contamination from sweat/sebum as sweat patches remained positive for THC-COOH 
for up to 25 days after oral intake of THC. However, Gambelunghe et al. did not detect 
THC-COOH in the sweat patches of cannabis users [152] which was also the finding of 
Kintz et al. [153].  
Moosmann et al. postulated that since THC-COOH is present in sweat, it could be 
transferred from the hair of a user to the hair of another person, through touch 
contamination or from sleeping on the same pillow[100]. Hill et al. recently tested this 
theory [154] and concluded: 
"Our experiments attempting to transfer THC-COOH in the presence of moisture from 
THC-COOH positive hair to either fabric or negative hair have shown that such transfer 
does not occur easily and, if it should occur, is readily removed by an extended aqueous 
washing procedure". 
 
THC-COOH is not the only metabolite to be detected in hair; 11-OH-THC was first 
reported to be detected by Wicks and Tsanaclis [155]. In a large study (n=1272), 11-
OH-THC was detected in 77 samples (6%) where the metabolite THC-COOH was not. 
THC-COOH was detected in a total of 543 samples.  
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In a further study of 6838 samples by Tsanaclis and Wicks, 11-OH-THC was again 
detected in a large number of hair samples (n=2016). In this study, THC-COOH was 
detected in more samples (n=2303) and at a higher median concentration (0.003 
ng/mg) than 11-OH-THC (0.002 ng/mg) [156].  
Pinchini et al. have recently reported a method to detect THC-COO-gluc in cannabis 
user hair samples (n=20) using UPLC-MS-MS [157]. Interestingly, this metabolite was 
found to be at least three times more concentrated than THC-COOH and was detected 
in four cases where THC-COOH was not. Whilst the authors warn that this data is 
"absolutely preliminary" the use of THC-COO-gluc as a biomarker for cannabis use in 
hair samples seems promising.  
 Limitations of metabolite analysis  
 
The main limitation with metabolite analysis is that metabolites are not always 
detected, even when cannabis consumption is confirmed [158,159]. This has been 
attributed to poor incorporation rates of the metabolites into the hair [45]. Conversely, 
there are several examples where hair samples are considered to be positive for THC 
metabolites, yet negative for the parent drug [120,160]. The likelihood of the presence 
of THC metabolites in hair after passive exposure to cannabis smoke has yet to be fully 
understood since studies to date have either been conducted in vitro or such that 
participants were not able to inhale the second-hand smoke produced [144], which is 
unrealistic. 
 Decontamination/ Wash analysis 
 
Washing hair samples before analysis is suggested by the SoHT to be a mandatory 
process. Ideally, this step should remove any trace of drugs present on the exterior of 
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the hair shaft but not remove any drug compounds that are incorporated into the 
cortex of the hair.  
A comprehensive review into the many different washing procedures was recently 
conducted by Vogliardi et al. They concluded that the washing procedures most 
frequently used are those which utilise one or two washes with non-protic solvents, 
such as dichloromethane or a single short wash with a protic solvent such as methanol.  
However, some laboratories reverse the washing procedure, using a sequence of non-
protic solvent followed by a protic one [161]. Additional solvents routinely used for the 
decontamination of hair samples for the analysis of cannabinoids include isopropanol, 
water, ether and acetone [161].  There is no universally recognised procedure for the 
decontamination of hair samples, nor is there any indication of which procedure is 
most or least optimal for removing external contamination whilst keeping internally 
bound cannabinoids in place.   
Tsanaclis and Wicks proposed analysing the wash residue obtained from the 
decontamination procedure as a strategy to differentiate between external 
contamination cannabis use when metabolites are not detected [162]. The 
concentration of THC in the wash residue was compared to the concentration of THC 
in the hair after the completion of washing procedures. The authors suggest that wash: 
hair ratios of zero (i.e. no drug found in the wash procedure) suggested drug use was 
likely, while ratios greater than 0.1 and less than 0.5 indicated drug use was 'possible' 
and ratios greater than 0.5 meant that drug use was 'questionable'.  
In a larger study conducted by Tsanaclis et al. 46 samples from the medico-legal sector 
were analysed for cannabis consumption [163]. In 21 of these samples (45.7%) THC 
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and THC-COOH were detected above the cut-off level and so consumption was 
confirmed. Wash ratio analysis was then performed on the samples where THC was 
detected but THC-COOH was not. Of these 21.7% were in the category of drug use 
'likely', 17.4% were in the category drug use 'possible' and 15.7% were in the category 
of drug use 'questionable'.   
 Limitations with the assessment of wash residue  
 
The Society of Hair Testing recognise that there is no standard washing procedure and 
accept that "different washing procedures will affect the remaining amount of drug in 
the hair" [145]. This will almost certainly affect the THC wash to hair ratio. In addition, 
the fact that metabolites of THC were found in wash residues in this study (see Section 
4.4.2) could suggest that the wash procedure used by Tsanaclis and co-workers caused 
leaching of the metabolites that are incorporated into the hair into the wash residue. If 
this is also the case for THC, the wash residue concentration could be greater simply 
due to greater amounts being removed from the hair cortex. In addition, the authors 
recognise that the bands 0-0.1, 0.1-0.5 and greater than 0.5 are arbitrary numbers, 
which are not based on studies conducted to determine which ratio correlates to 
which usage conclusions. 
Results from hair wash analysis can still only be put into three categories; 'likely', 
'possible' and ‘questionable'. Arguably this is no better than reporting an ‘inconclusive’ 
result.  However, this approach could prove useful in cases where a ruling is made on 
the ‘balance of probability’ (i.e. a civil case) rather than ‘beyond reasonable doubt’ (i.e. 
a criminal case). The validity of the wash analysis approach would also depend on case 
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circumstances and other evidence available, for example urine analysis would also 
need to be taken into consideration.  
Others have also suggested wash values have limited validity. Thorspecken et al. stated 
that a positive cannabinoid finding in the last wash step of the solution did not imply a 
positive cannabinoid finding in hair. In contrast a negative result in the last wash 
solution did not always entail a negative result in the hair. Therefore the criterion that 
a negative wash solution assures a complete removal of external contamination does 
not seem universally valid [164].  
Moosmann et al. studied the hair/wash ratio for synthetic cannabinoids after 
participants had handled herbal mixtures [147]. The results showed that whilst some 
samples had a high ratio (correctly suggesting external contamination) others had a 
negative wash result and a positive hair result (wrongfully suggesting drug use). This 
study shows that the notion of a wash to hair ratio may be too simplistic. The authors 
advise the concurrent analysis of additional body fluids to prove drug usage in cases 
where metabolites are not detected in hair.  
 
 THCA-A as an indication of "touch" contamination   
 
The biogenetic precursor of THC, Δ9-tetrahydrocannabinolic acid A (THCA-A) has been 
identified as a possible marker of contamination due to the touching of marijuana 
plant material. This is because THCA-A is not incorporated significantly into hair 
through the bloodstream after oral intake of THCA-A [165], and it is only detected in 
negligible amounts in cannabis smoke [144]. As a consequence of this Moosmann et al. 
postulated that the presence of high THCA-A concentrations in the hair samples of 
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known cannabis users could be linked to handling plant material or touching 
contaminated surfaces, and then touching head hair [146]. 
This hypothesis was tested in a recent study where ten volunteers rolled one cannabis 
cigarette each day for five consecutive days whilst refraining from smoking or being in 
contact with cannabis for the rest of the study period.  At the end of the exposure 
period all hair samples tested positive for THC and THCA-A. 
Four weeks after the first exposure period nine out of ten hair samples were still 
positive for THCA-A and five out of ten were still positive for THC [146]. One limitation 
with this study however is that the participants self-reported not to have used or been 
exposed to cannabis smoke within the last six months. Unfortunately, the usage of 
cannabis cannot be ruled out as body fluid analysis was not carried out prior to the 
study being conducted, nor was it carried out during the study period.  
In a previous study conducted by Moosmann et al. hair samples from children and 
their cannabis consuming parents were analysed [159]. The authors found that there 
was no significant difference in the concentration ratio THCA-A/THC between the two 
separate groups of adults and children if the specific relationship between child and 
caregiver was not considered. However, comparison of the THCA-A/THC concentration 
ratio within families showed that in 9 out of the 10 cases studied there was a 
significant statistical difference with the ratio being greater for the children than the 
adults. The authors concluded that the higher the THCA-A /THC ratio in relation to 
their caregivers, the more likely that THC is present due to external contamination. 
This could be possibly from adults touching plant material and then touching the 
child's hair. 
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It was suggested that this method could not only be useful in the case of child 
exposure, but also in law enforcement handling or in the case of cannabis growers. 
However, the main limitation of this method is the varying amounts of THCA-A and 
THC found within the plant material itself [159] and so unfortunately one general cut-
off value to differentiate between this type of contamination and usage in terms of a 
THCA-A/THC ratio is not yet feasible.  
1.4 Instrumentation for drug testing in hair  
 
In this section the current methodology in hair analysis of chromatographic separation 
followed by detection using a mass spectrometer will be discussed. A review of 
methods previously used was shown in Table 1-3.  
1.4.1 Chromatographic separation  
 
Since hair samples are complex matrices (containing many compounds in addition to 
analytes of interest), they generally require the separation of their components by 
liquid chromatography (LC) or gas chromatography (GC) prior to their introduction to 
the ion source.  
In chromatography, separation is based on different affinities to a mobile and 
stationary phase.  
 Gas Chromatography  
 
In gas chromatography (GC) the process of separation is based on a two-step 
sequence. First, the components of a mixture are adsorbed onto a coating that lines 
the inner wall of a column located in an oven. Next, the oven is progressively heated, 
and the adsorbed components are sequentially transferred into a gaseous mobile 
phase before moving into the mass spectrometer (Figure 1-9). The temperature at 
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which a compound elutes from the column is a function of the vapour pressure of the 
compound. The higher the vapour pressure of the compound the more rapidly it will 
transverse the column, carried by the mobile phase.  
 
Figure 1-9. Separation process on a capillary GC column adapted from [166]. The orange path represents a 
compound of high volatility. The purple path represents a compound of relatively low volatility,  
 
 Liquid Chromatography  
 
Liquid chromatography (LC) was first developed to expand the range of compounds 
that could be analysed as its predecessor, GC, is not suitable for involatile, polar and 
high molecular mass analytes.   
The principle of separation in LC is that organic compounds in an aqueous mobile 
phase will adsorb preferentially onto an organic stationary phase. Compounds are then 
eluted sequentially using a gradient of the composition of the mobile phase from 
aqueous to organic (e.g. from water to acetonitrile). The order of elution of the 
components is a function of the preference of the particular compound to be 
associated with either the stationary or the mobile phase as the composition of the 
mobile phase changes during the gradient [166].  
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The column used in liquid chromatography is different to that used in GC as it contains 
porous particles coated with an organic stationary phase. The mobile phase carries 
analytes around and through the particles. The order of elution is determined by the 
length of time individual analytes remain adsorbed on the stationary phase.  
 
1.4.2 Mass Spectrometry (MS)  
 
Mass spectrometry is an analytical technique which has far reaching applications. Ions 
are produced in the gas phase which can then be analysed in term of a mass to charge 
(m/z) ratio. This mass to charge ratio along with additional information such as 
fragmentation pattern can then be used to identify the analyte. Many different mass 
spectrometry instruments are used for the analysis of elements, isotopes, small 
molecules (such as drug compounds) and macromolecules (such as proteins). In this 
section the theory behind the different mass spectrometry techniques used in this 
thesis will be discussed.  
A basic diagram of a mass spectrometer is depicted in Figure 1-10. MS instruments 
generally have at least four main features; a) an inlet (sample introduction) b) an 
ionisation source (production of ions from an analyte) c) one or multiple mass 
analysers (for separation of ions based on a mass-to-charge ratio) and d) a mass 
detector (for conversion of separated ions into electrical signals that can be 
represented in the form of a mass spectrum [167].  
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Figure 1-10. The general layout and main components of any mass spectrometer, including; (a) sample inlet, (b) 
an ionisation source, (c) one or more mass analysers, (d) a mass detector along with a data system displaying the 
mass spectrum.  Adapted from  [166]. 
 
 Ionisation  
 
For analytes to be detected they must first be ionised. Ions can be formed using a 
variety of methods, the choice of technique varies depending on the target analyte 
and application (see Figure 1-11). In this section the ionisation techniques used in this 
thesis will be discussed. Namely Electron Ionisation (EI), Matrix-Assisted Laser 
Desorption Ionisation (MALDI), Atmospheric Pressure Chemical ionisation (APCI) and 
Electrospray Ionisation (ESI).  
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Figure 1-11. Mass spectrometric techniques for different needs arranged by main fields of application and 
estimated relative hardness or softness reproduced from [168]. Techniques used in this PhD project have been 
circled. 
 
  Electron Ionisation  
 
Electron ionisation (EI), sometimes referred to as electron impact, was first developed 
by A.J Dempster in 1918 [169]. EI was the first commercially available ionisation 
method and is still widely used today, often in the analysis of small organic molecules. 
It is known as a “hard” ionisation technique, high energy impacts mean more 
fragmentation of the analyte. This means that molecular ion peaks are not always 
observed in mass spectra. This makes the technique unfavourable in the analysis of 
large molecules or trace levels.  
In EI, molecules in the gas phase are bombarded with energetic electrons obtained 
from a heated filament located inside the vacuum. The bombardment removes an 
electron from the sample molecules, thus ionising them. The initial product is a 
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positively charged molecular ion, a radical cation [M]+·. The more common annotation 
is [M]+ and will be used hereafter to denote a positively charged molecular ion. Excess 
energy imparted during the ionisation process is distributed along the bonds of the 
ions formed and often leads to fragmentation of the parent molecule [167]. 
Fragmentation is generally predictable and provides information on the structure of 
the analyte. A major disadvantage of EI is that it is limited to molecules with molecular 
masses of <1kDa.  
Ion Formation            M+ e-→  M+· + 2e- 
Fragmentation           M+· → m1+ +n· or m1+· + n 
 Electrospray ionisation  
 
Electrospray ionisation (ESI) was first introduced by Dole and co-workers in 1968 [170] 
and was later coupled to a quadrupole mass analyser in 1984 by Yamashita and Fenn 
[171]. 
ESI is accomplished by passing a solution of analyte through a needle held at high 
electrical potential into a chamber at atmospheric pressure. The high electrical 
potential in the range of 2-5kV is applied between the capillary and cone and causes an 
accumulation of positively charged ions at the tip of the capillary, to form what is 
known as a Taylor cone [167]. When the imposed electric field is high enough the cone 
elongates which then breaks and forms a spray of charged droplets. The solvent 
component of the droplet begins to evaporate with the aid of a stream of nitrogen gas 
and the diameter of the droplets is reduced, until eventually only charged analyte 
molecules remain.  A schematic of an ESI source is shown in Figure 1-12.  
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Figure 1-12. Schematic representation of an electrospray ionisation source reproduced with permission from 
[166]. 
 
 Atmospheric Pressure Chemical Ionisation  
 
Atmospheric Pressure Chemical Ionisation (APCI) was developed in the 1970s by the 
Horning group [172]. APCI is an ionisation technique which utilises gas-phase ion-
molecule reactions at atmospheric pressure. In APCI, primary ions are produced by a 
corona discharge.  
When using nitrogen, nitrogen plasma is created by the corona discharge needle. N2+. 
and N4+. ions react directly with analyte molecules [173] (Figure 1-13). Each ionisation 
event liberates a further electron and can thereby initiate a chain of ionisation events, 
sustaining the corona discharge.  
 
Figure 1-13. Ion formation when using nitrogen in an APCI source. Reproduced from Portoles et al. [174].  
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The same sequence of reactions, although initiated by different sources of primary 
ionisation, is observed not only in APCI but also in atmospheric pressure photonisation 
(APPI) and direct analysis in real time (DART)[175].   
 
  Matrix-Assisted Laser Desorption Ionisation   
 
Matrix-Assisted Laser Desorption ionisation (MALDI) was first introduced in the late 
1980s [176,177]. The main purpose of the work at that time was to develop a mass 
spectrometric technique that employed “soft” ionisation, decreasing the 
fragmentation of analytes and increasing the range of masses to be successfully 
analysed.  
MALDI makes use of the absorption of laser light by a solid sample layer. The energy 
uptake upon laser irradiation then causes desorption and ionisation of the sample in a 
two-step process (Figure 1-14). Although lasers of both ultraviolet (UV) and infrared 
(IR) wavelengths are available, UV lasers are most commonly used. Of these nitrogen 
lasers and frequency tripled or quadrupled Nd:Yag lasers serve the majority of 
applications [178].  
In MALDI-MS profiling (MALDI-MSP) analysis, the analyte is first co-crystallised with an 
excess of matrix that has a constituent aromatic component able to absorb photons 
from a UV laser beam (a more detailed discussion of matrix compounds can be found 
in Chapter 2).  When dried the analyte-matrix mixture is exposed to a sudden input of 
energy from a laser pulse, the matrix evaporates carrying with it the analyte molecules 
which then enter the mass analyser. A schematic of this process can be found in Figure 
1-14.  
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Figure 1-14. A schematic diagram of the process of MALDI-MS showing laser irradiation, desorption and 
subsequent ionisation of matrix and analyte molecules. Reproduced with permission from [166]. 
 
MALDI MSP experiments generate mass spectra in discrete areas of a sample. MALDI-
MSP can be performed on sample solutions which are co-crystallised with matrix on a 
MALDI target as shown in Figure 1-15 A and directly on biological tissues which are co-
crystallised with matrix as shown in Figure 1-15 B.  
 
Figure 1-15. The principle of MALDI MS profiling from A) dried sample spots on a target plate and B) dried sample 
spots deposited directly onto a biological sample. Arrows represent laser shots. Reproduced with permission 
from [179]. 
The ionisation mechanisms in MALDI are not fully understood, with several proposed 
theories of ionisation [180–183]. Originally, it was thought that positively charged ions 
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were produced solely by a proton transfer reaction since most ions generated in 
MALDI are singly charged. However, it is now thought to be a complex process 
involving several stages 
 A two-step framework is generally accepted as useful model for many MALDI 
experiments. The steps are primary ionisation during or shortly after the laser pulse, 
followed by secondary reactions in the expanding plume of desorbed material [184]. 
Molecules generate a dense gas plume as they desorb from the surface. Collisions in 
the gas plume may result in additional reactions.  
Charge transfer takes place from the protonated matrix to any compound with a 
higher proton affinity yielding protonated molecules, [M+H]+. The reactions likely to 
occur in the gas phase are ion generation and ion-ion recombination. Ion 
recombination leads to a proposed “lucky survivor” model [182]. Most ions resulting 
from excitation by the laser are re-neutralised as cationic and anionic components re-
combine. Therefore, singly charged ions are the lucky survivors of the re-neutralisation 
conflict. Neutralization probability strongly increases with the charge state and so 
singly charged ions have the greatest chance of “surviving”. The model developed by 
Karas et al. offers an explanation to the phenomenon of almost exclusively M+H peak in 
MALDI spectra. A more detailed review of alternative MALDI ionisation theories can be 
found by Lu et al. [183]. 
 MALDI imaging (MALDI MSI) 
 
MALDI-MSI was first reported in 1997 by the Caprioli group [185]. This technique 
utilises the sensitivity and selectivity of MS to provide information on chemical 
composition.  
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Unlike with traditional techniques such as GC-MS and LC-MS (the most commonly used 
mass spectrometry method in the analysis of hair samples), MSI can give spatial 
information on the compounds observed in the mass spectrum as homogenisation of 
the hair sample is not required. This feature has made MSI an unique tool for clinical, 
pharmacological, and forensic science research. 
The MALDI-MS images presented within this thesis were acquired in raster mode 
which was developed by AB Sciex. This method of data acquisition is achieved by 
continuously firing the laser in rows across a sample.  The sample preparation is similar 
to MALDI-MSP; however, the matrix is sprayed rather than spotted on top of the 
sample. A schematic of MALDI-imaging workflow can be seen in Figure 1-16.  
 
 
Figure 1-16. The MALDI MSI workflow showing a) matrix application b) laser irradiation c) the reconstruction of 
molecular image maps from specific ions. 
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 Mass analysers 
 
Following ionisation, ions are then separated based on their mass to charge ratio (m/z) 
by one or more mass analysers. The principles of the mass analysers used in this PhD 
project (quadrupole and time-of-flight) as well as their hybrid and tandem couplings 
(quadrupole time-of-flight and triple quadrupole) will be detailed in this section.   
 Quadrupole  
 
Quadrupole (Q) analysers consist of a set of four rods. The rods, which are metal or 
metal-coated ceramic are placed parallel to each other with opposite pairs connected 
electrically (Figure 1-17). The voltage placed on one pair of rods is comprised of a 
positive direct current (dc) combined with a superimposed radio frequency (rf) voltage. 
The other pair of rods carries a negative dc voltage with an rf component that is 180˚ 
out of phase with that of the first pair. Whilst for simplicity Figure 1-17 represents the 
rods as either positive or negative, the rods in fact constantly oscillate between 
positive and negative polarities.  
Mass separation is based on the fact that ions begin to oscillate upon entering the field 
produced by the superimposed rf and dc voltages. For any field derived from the 
combination of voltages, only ions with one specific m/z value have a stable trajectory 
along the axis of the quadrupole to the detector. All other ions with different m/z 
values develop unstable oscillation patterns perpendicular to the flight path and are 
lost by collision with, and discharge onto, the rods. Changing the dc and rf voltages 
progressively while keeping their ratio constant, enables the scanning of a mass range 
yielding spectra comprised of different m/z values.  
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Figure 1-17. Schematic representation of quadrupole mass analyser; ions pass through four parallel rods, those 
with a stable trajectory (red line) pass through to the detector whereas ion with an unstable trajectory (purple 
line) collide with the rods.  Reproduced with permission from [166]. 
 
 Triple quadrupole 
 
The triple quadrupole (QqQ) consists of two quadrupole analysers (Q1 and Q3), and a 
central section between Q1 and Q3 that is an Rf-only component (designated with a 
lower-case q) as shown in Figure 1-18. The rf field in q2 acts to constrain the ions, 
enabling their transfer between the two analytical quadrupoles. The central cell is the 
location where the collision gas is introduced to effect collision-induced dissociation 
(CID). The products of the CID process are analysed in Q3 by scanning to collect full 
spectra or by recording the intensity of a specific ion.  
 
Figure 1-18. Schematic of a triple quadrupole mass analyser. Reproduced with permission from [166]. 
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QqQ instruments are versatile because the Q1 and Q3 analysers can be used in 
conjunction with each other in either scanning or static (selected ion monitoring 
mode). The various scan modes are shown in Figure 1-19. 
 
Figure 1-19. Representation of the different scan modes available for a triple quadrupole mass analyser 
reproduced from [167]. 
 
 Quadrupole-Time of flight  
 
In this PhD project, when a time-of-flight (ToF) mass analyser in reflectron mode was 
used it was solely used coupled to a quadrupole mass analyser. Therefore, the 
description that follows is written with this application in mind. A schematic of the Q-
ToF analyser is shown in Figure 1-20. 
The basic principle of a linear time-of-flight mass analyser is that ions formed in the 
MALDI source are accelerated towards a flight tube by a potential applied between the 
sample plate and the extraction grid. This imparts a constant kinetic energy on the ions 
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as they enter the field-free flight tube. The ions will then separate according to their 
velocities which will depend on their respective mass before reaching the detector 
[167]. Briefly, ions will a lower mass will have a shorter flight time than ions with a 
higher mass. The relationship between velocity (v), mass (m) and kinetic energy (Ek) is 
shown below: 
ܧ௄ =
1
2
݉ݒଶ 
In reflectron mode, an ion mirror corrects for the small variations in kinetic energy 
imparted to individual ions and helps to re-focus the ions before they reach the 
detector. 
For conventional ToF-MS analysis all three quadrupoles are operated in RF-only mode 
and act as ion guides allowing the passage of ions with a pre-selected range of m/z 
values. The ions are then focused into the orthogonal time-of-flight mass spectrometer 
for detection [167].  
For ToF-MS/MS analysis the quadrupoles are used as described in the previous section 
before the resulting product ions are focused into the orthogonal time-of-flight mass 
spectrometer and detected [186]. 
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Figure 1-20. Schematic of a hybrid Quadrupole Time-of-flight hybrid mass analyser. The red line represents the 
path of ions through the quadrupoles and time-of-flight mass analyser. Reproduced from [187]. 
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1.5 Aims of this project 
 
Despite cannabis being the most commonly used illicit drug, at commencement of this 
study there were no methods published for detection of cannabinoids using MALDI, in 
hair or in other biological matrices. Since MALDI-MSI can provide unique information 
regarding the spatial distribution of cannabinoids within a sample, it is important that 
a method is established. 
There was also a lack of consistency in the traditional GC-MS/MS methods available for 
cannabinoid detection in hair samples, with some methods describing detection of 
parent compounds only, and others detecting only a single metabolite. Often it was 
reported that metabolites could not be detected due to poor incorporation into the 
hair matrix, and so trace analysis with low detection limits is needed.  
In addition, there was no consensus in the interpretation of cannabinoid findings in 
hair samples, with several different methods of determining whether a sample 
contained cannabinoids due to cannabis use or due to external contamination. Since 
the implications of false positive and false negative samples can be life changing, this 
inconsistent area of practice needs to be addressed. 
This project sought to investigate the above issues by:  
1. developing a method to detect cannabinoids in intact hair samples using both 
MALDI profiling and MALDI imaging techniques  
2. applying the developed methods to hair exposed to cannabis smoke 
contamination  
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3. developing a GC-MS/MS method to simultaneously detect and quantify THC, 
CBN, CBD, THC-COOH and the rarely studied 11-OH-THC metabolite 
simultaneously in hair samples  
4. applying this method to cannabis user and non-user hair samples to study the 
correlation between the results of mass spectrometric analysis and self-report 
data with a variety of methods of interpretation  
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Chapter 2. Development of Matrix-Assisted laser 
desorption ionisation Mass Spectrometry to 
detect cannabinoids in hair samples  
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2.1 Introduction 
 
Matrix Assisted Laser Desorption Ionisation-Mass Spectrometry (MALDI-MS) has been 
highlighted as a potential hair analysis method due several advantages over current 
techniques including improved chronological information [188], simpler sample 
preparation and less sample needed compared to traditional GC-MS and LC-MS 
methods of analysis. Several drugs have already been analysed in hair samples using 
MALDI imaging techniques including methamphetamine [189], cocaine [190], ketamine 
[191], zolpidem, [192] and nicotine[193].  
For analytes to be ionised and detected using MALDI-MS, a matrix (a solvent 
containing small organic molecules) must be applied. The matrix must have two main 
properties: it must have the ability to absorb at the wavelength of the laser used and 
have the ability to transfer protons during the ionisation process [194]. Selection of the 
correct matrix for MALDI-MS detection is of utmost importance as using the optimal 
matrix can improve the sensitivity of a method, whilst using an unsuitable matrix can 
lead to the inability to detect an analyte which is present, even in high concentration. 
The selection of the correct matrix is of particular importance in this study due to the 
extremely low concentration of cannabinoids and metabolites found in hair samples.  
In a recent review into MALDI approaches for the analysis of low molecular weight 
compounds Bergman et al. concluded that there is no easy way to determine which 
matrices or methods will work and without a set president of the analysis of similar 
molecules, a "trial and error" approach is often needed [195].   
In this study several different approaches including matrix selection, the use of 
additives (see Section 2.4.1) and derivatisation (see Section 2.5) were investigated to 
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develop a suitable method to detect cannabinoids in hair samples using MALDI-MS. In 
addition to this an in-source re-arrangement of the THC is reported for the first time, 
confirmed with the use of LC-MS.   
In addition, the developed method was applied to cannabis smoke contaminated hair. 
Since THC is present in the smoke produced when the plant material is combusted, the 
presence of THC in hair can be due to exposure to cannabis smoke, and not necessarily 
direct or intentional usage. The exact mechanism of smoke contamination is not yet 
understood as discussed in detail in Section 1.3.7.1.  
 
2.2 Methods and Materials 
 
2.2.1 Chemicals and reagents 
 
Matrices. α-Cyano-4-hydroxycinnamic acid (CHCA), 2,5-Dihydroxybenzoic acid (DHB), 
6-Aza-2-thiothymine (ATT), 3-Hydroxycoumarin (3-HC) and were purchased from 
Sigma-Aldrich (Poole, UK). 
Additives. trifluoroacetic acid (TFA), Lithium chloride (LiCl), lithium trifluoroacetate 
(LiTFA),  Hexadecyltrimethylamnium bromide (CTAB) and aniline were purchased from 
Sigma-Aldrich (Poole, UK). 
Derivatisation reagents. 2-Fluoro-1-methylpyridinium-p-toluene-sulfonate (FMPTS) 
and triethylamine (TEA) were both purchased from Sigma-Aldrich (Poole, UK). 
Drug Standards. Cannabinol (CBN), cannabidiol (CBD) Δ9-tetrahydrocannabinol (THC), 
11-nor-9-carboxy-tetrahydrocannabinol (THC-COOH) 11-Hydroxy-delta-9-
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tetrahydrocannabinol (11-OH-THC) and 11-nor-delta(9)-carboxy-tetrahydrocannabinol 
glucuronide (THC-COO-gluc) were purchased as analytical references from Cerilliant 
(Sigma-Aldrich, Zwijndrecht, The Netherlands).  
Solvents. Acetonitrile (ACN) and Methanol were purchased from Fisher Scientific. 
2.2.2 Sample Preparation  
 
 Matrix Preparations 
 
CHCA was prepared at either 10 mg/mL or 5mg/mL concentrations with the solvent 
composition being  ACN:0.2% aqueous TFA (70:30).  
DHB was prepared at 10 mg/mL dissolved in acetonitrile and 0.2% aqueous TFA (1:1). 
3-HC was prepared at 10 mg/mL in 50% ACN with 0.2% aqueous TFA. ATT was 
prepared at 10 mg/mL in 50% ACN with 0.2% aqueous TFA.  
The 3-HC ATT binary matrix was prepared according to Shanta et al. with 10 mg/mL of 
both ATT and 3-HC matrices dissolved in 50% acetonitrile (ACN) with 0.2% TFA [196]. 
Cannabinoid standards (100 µg/mL unless otherwise stated) were mixed 1:1 with 
matrix solutions and deposited in triplicate on the MALDI target. The spots were left to 
dry at ambient temperature before analysis.   
 
 Addition of Additives to the matrix  
 
Aniline was added in equimolar amounts to CHCA. Two different matrix compositions 
with added aniline were prepared; ACN:0.5% TFA (70:30) as suggested by Groeneveld 
et al.[197] and  ACN:0.5% TFA (75:25) as proposed by Kuyawama et al.[198].  
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CTAB was added to the CHCA matrix mixture in a ratio of 1:1000 in a water-acetonitrile 
solution (50/50, v/v) as described by Su et al.[199]  
Lithium salts were added as described by Cerruti et al.[200]. Briefly, CHCA was 
prepared at 10 mg/mL in acetonitrile/ water/trifluoroacetic acid (70/30/0.1, ν/ν/ν) and 
Lithium solutions at 25, 50 and 100 mM were mixed with the matrix solution for each 
lithium salt. 
2.2.3  Derivatisation 
 
Derivatisation was carried out according to Thieme et al.[201]. Briefly, 40 µl of 10 
mg/mL 2-Fluoro-1-methylpyridinium-p-toluene-sulfonate (FMPTS) and 10 µl of 
trimethylamine was mixed using a vortex. This caused the colourless solution to turn 
"canary yellow" as previously observed by Thieme et al. THC standard (20 µL, 0.1 
µg/µL) was added to the mixture and left at room temperature for five minutes before 
spotting (1 µL) onto a target plate. 
 
2.2.4 Microscopy of hair samples  
 
Hair samples were placed on glass slide using double-sided Sellotape® Super Clear 
tape before imaging with an Olympus BX60 microscope.   
 
2.2.5 Spiking of hair 
 
Hair samples from an individual who reported not to have used any illicit drugs were 
collected by cutting and washed with methanol and water by vortexing.  The samples 
were then cut into 5 cm sections and placed into the bottom of a well in a 24-well cell 
culture plate to keep the spiking solution volume to a minimum whilst still submerging 
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the hairs. Spiked samples were prepared by soaking in cannabinoid standard solutions 
(300 µL, 0.5 µg/mL). Blank hair samples were prepared by soaking in methanol (300 
µL). The plate was sealed with tape to avoid evaporation of the standards.  All hairs 
were soaked for two hours, removed and allowed to dry for one hour at room 
temperature.  
 
2.2.6 In situ derivatisation of cannabinoids  
 
The hair was placed on glass slide using double-sided Sellotape® Super Clear tape. 
Derivatisation reagent (2.5 mL) was then sprayed using a neo for Iwata® air-brush at a 
pressure of 30 psi onto an area of 9 cm2 with the sample in the centre of the area. This 
step was carried out in a fume hood due to hazards associated with the use of the 
triethylamine catalyst.  
 
2.2.7 Deposition of matrix for imaging 
 
The hairs were coated in CHCA (5 mg/mL) with the solvent composition ACN:0.2% 
Aqueous TFA (70:30) using the SunCollect autospraying system (SunChrom GmbH, 
Friedrichsdorf, Germany). Fifteen layers were sprayed at a flow rate of 2 µL/min.  
 
2.3 Instrumentation  
 
2.3.1 MALDI Instrumentation and analytical conditions  
 
All data was acquired in positive ion mode on an Applied Biosystems/MDS Sciex hybrid 
quadrupole time-of-flight mass spectrometer (Q-Star Pulsar-i) with an orthogonal 
MALDI ion source (Applied Biosystems, Foster City, CA, USA) and a Neodymium-doped 
yttrium aluminium garnet (Nd: YAG) laser (355 nm, 1 KHz). The laser power was 30 % 
(1000 Hz, 3.2 µJ), which had an elliptical spot size of 100 × 150 µm [202]. Image 
acquisition was performed using the “raster image” mode [203]. The MALDI-MS/MS 
images were obtained using argon as the collision gas; the collision energy and the 
collision gas pressure were set at 20 and 5 arbitrary units, respectively. 
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Images were acquired using ‘oMALDI Server 5.1’ software supplied by MDS Sciex 
(Concord, Ontario, Canada) and processed using Biomap 3.7.5 software (www.maldi-
msi.org) to generate black and white images for each m/z ratio of interest. Further 
Image analysis and processing was performed using the public domain software ImageJ 
(http://rsb.info.nih.gov/ij); where the previous black and white images were assigned 
different colours and overlaid to create one final image.  
 
2.3.2 LC-MS/MS Instrumentation and analytical conditions 
 
All experiments were performed on a Thermo Finnigan LCQ™ ‘classic’ quadrupole ion 
trap liquid chromatography mass spectrometer with electrospray ionisation (ESI) 
interfaced to a liquid chromatography system. The system used also consisted of an 
auto sampler and auto injector. The column used was a Phemonex Lunar® C18 (150 
mm x 1 mm, 5 μm) with a corresponding guard column. LC-MS/MS Chromatographic 
separation was realised using gradient elution according to a previously published 
method by  Roth et al. [204]. Briefly, 0.1% HCOOH in water was used as mobile phase A 
and ACN+ 0.1% HCOOH was used as mobile phase B. Mobile phase A was gradually 
reduced over time whilst mobile phase B was increased from 20 to 95%. The total run 
time was 15 minutes with the THC molecule eluting at 4 minutes.  
All experiments were performed on a Thermo Finnigan LCQ™ ‘classic’ quadrupole ion 
trap liquid chromatography mass spectrometer equipped with an electrospray 
ionisation (ESI) source, interfaced to a liquid chromatography system. The system used 
also consisted of an auto sampler and auto injector.  
2.4 Profiling of THC with multiple matrices  
 
The use of α-Cyano-4-hydroxycinnamic acid (CHCA) resulted in the greatest intensity 
response as shown in Figure 2-1. However, upon inspection of the mass spectra it is 
evident that a peak associated with the matrix is unresolved with the peak associated 
with THC (m/z 315). This could explain why using 10 mg/mL CHCA decreased the THC 
intensity observed as with larger concentrations of the matrix present, a greater 
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suppressant effect from the matrix peak will be observed. This finding is in agreement 
with Zhang et al. who also observed a suppressant effect and much stronger matrix 
clusters at concentrations higher than 5 mg/mL when analysing peptides [205]. 
 
Figure 2-1. Absolute intensity of THC peak (m/z 315.2) with a range of different matrices.  
The binary matrix of 6-aza-2-thiothymine (ATT) and 3-hydroxycoumarin (3-HC) 
proposed by Shanta et al. as a new combination matrix for the analysis of small 
molecules [196] gave the lowest intensity response. 2,5-Dihydroxybenzoic acid (DHB) 
did not crystallise uniformly and this is reflected in the large standard deviation of 
intensities observed. Crystal inhomogeneity is a well-documented problem with using 
the DHB matrix  [206].  
2.4.1 The use of matrix additives 
 
Matrices can cause signal interference, or suppression of the analyte signal in the 
region below 1,000 Da [207]. This is due to the most frequently used matrices, e.g., 
CHCA and DHB, being small organic molecules themselves. When ionized, the matrix 
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usually forms clusters at low masses, which can interfere with the detection of low 
molecular weight analytes [195]. In MALDI, an additive is any compound which is 
added to the matrix/solvent composition. Additives have been proposed to eliminate 
or reduce ion suppression effects [208], and thereby improve the signal-to-background 
ratio. Some examples of additives include sugars [209], acids [210], surfactants, 
[211,212] and weak bases [213].  
 Addition of CTAB 
 
The addition of the surfactant cetrimonium bromide (CTAB) to the CHCA matrix has 
previously been reported to supress CHCA-related ion signals in the low mass 
region[211]. However, in this study it was found that the relative intensity of the THC 
peak decreased with the addition of CTAB as can be seen in Figure 2-2, the absolute 
intensity also decreased with the addition of CTAB. One explanation for the fact that 
the CHCA-CTAB matrix performed poorly with the THC is that it does not contain an 
amine group, this method has been successfully used to analyse compounds found in 
clandestine tablets, however all compounds reported contained amine groups such as 
MDMA[199]. Guo et al. also reported that non-amine containing drugs such as benzoin 
and warfarin gave weaker peak intensities than drugs containing amine groups using 
the CHCA-CTAB matrix [211]. 
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Figure 2-2. a) Relative intensity of THC peak (m/z 315) with CHCA used as the matrix. b) Relative intensity of THC 
peak with CHCA-CTAB used as the matrix. THC peak intensities were normalised with the [CHCA+H]+ peak of m/z 
190.05.  
 
2.4.2 Addition of aniline and matrix composition  
 
As shown in Figure 2-3, the relative intensity of the peak corresponding to THC (m/z 
315.2) was greater when using 5 mg/mL CHCA rather than 10 mg/mL CHCA.  
At both CHCA concentrations the addition of the ionic liquid aniline improved the 
relative intensity of the THC peak. This was not entirely unexpected as improved signal 
intensity using CHCA-Aniline has previously been reported for a range of compounds 
including proteins, peptides and amino acids [206,214]. However, this is the first time 
this matrix additive has been reported for the use of cannabinoid detection.  
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Figure 2-3. Effect of matrix composition and the addition of aniline on the relative intensity of the THC peak 
normalised to the CHCA dimer of m/z 379. 
 
2.4.3 Addition of Lithium Salts  
 
The addition of lithium salts to CHCA in order generate lithium-analyte adducts to 
improve the detection of lipids both in profiling and imaging experiments is well 
documented [200,214,215]. In this study two common lithium salts, LiCl and LiTFA 
were added to CHCA and analysed with THC. As shown in Figure 2-4, the addition of 
either salt decreased the THC signal intensity greatly. Figure 2-4a shows that an 
increase in lithium chloride concentration had little effect on the intensity of the THC 
signal. Figure 2-4b shows that an increase in lithium trifluoroacetate concentration 
caused the THC signal intensity to decrease. However, the expected peak of the 
Lithium adduct [M+Li]+ (m/z 321) was not observed with either lithium salt, suggesting 
that the adduct had not formed. This was also the case when CHCA without the 
addition of aniline was used as the matrix (data not shown).   
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This could be explained by the lack of a phosphate group in THC molecule, as it is 
thought that the lithium ion exhibits a high affinity to phospholipids due to the 
presence of an exchangeable hydrogen on the phosphate group forming strong ion-
dipole interactions with a strong covalent character [200]. This result suggests that the 
lithium ion does not have a high affinity for the hydroxyl group of the THC molecule, 
but that the addition of lithium salts supresses the THC signal.  
 
Figure 2-4. Intensity of THC peak (m/z 315.2) after the addition of lithium chloride (a) lithium trifluoacetate (b) to 
CHCA matrix in a range of different concentrations. 
 
2.4.4 The laser-induced rearrangement of THC 
 
Whilst investigating the optimum matrix compositions it was noted that there was not 
a singular peak associated with THC at m/z 315 as expected, but rather a "cluster" of 
peaks as shown in Figure 2-5A. Whilst peaks at m/z 316 and 317 can be partially 
explained by the presence of 13C isotopes within the molecule, the origin of the peaks 
observed at m/z 311-314 are not apparent. The lack of these peaks in the matrix 
blanks and the similar spectrum obtained with DHB matrix shown in figure 2-5B 
supports the theory that the peaks are associated with the THC molecule.  
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To investigate this phenomenon further, LC-MS/MS analysis of the THC standard was 
carried out.  
A single peak in the chromatogram confirmed the purity of the THC standard. The 
mass spectrum of the peak can be seen in Figure 2-6, showing the M+H at m/z 315. 
Interestingly, the peak previously seen at m/z 314 is no longer present. In addition to 
this the peak at m/z 313 has now reduced to 3% of the intensity of the m/z 315 peak 
(previously seen at 50-110% of the 315 peak depending on matrix used, see Figure 2-
5B and 5C). Since this LC-MS system uses a softer ionisation source it is reasonable to 
Figure 2-5. A- m/z region 310-318 of THC with CHCA matrix. B- m/z region 310-318 THC with DHB matrix. 
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assume that the cause of the THC "cluster" is the MALDI ionisation process, in 
particular the use of laser energy. To further investigate the influence of laser power 
on the molecule an experiment was carried out with increasing laser power. It can be 
seen in Figure 2-7 that increasing laser power causes the ratio of m/z 313 to 315 signal 
intensity to increase, showing increasing m/z 313 formation. 
 
Figure 2-6. LC-MS mass spectrum of THC standard.  
 
Figure 2-7. Ratio of signal intensity of m/z 313.2 to 315.2 at increasing laser energies (n=3 per point). 
 
One possible explanation for this observation is a laser induced re-arrangement of the 
THC molecule as depicted in Figure 2-8. The loss of hydrogens as free radicals would 
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increase the conjugation of the THC molecule, making the molecule more stable and 
the reaction favourable. MS/MS spectra obtained by direct infusion shown in Figure 2-
9 also support this theory.  
 
Figure 2-8. Re-arrangement of THC molecule. 
 
The MS/MS spectra of the parent ion at m/z 315.1 is shown in Figure 2-9A and the 
MS/MS spectra of the re-arranged parent ion at m/z 313.1 is t is shown in Figure 2-9B. 
The spectra are very similar with many fragments forming from common mass losses 
(peaks labelled with a star). These peaks have a mass shift of -2 from spectrum A to 
spectrum B, reaffirming the loss of two hydrogens from the THC molecule. One 
notable difference between the spectra is a shift of -2 from m/z 259.1 in spectrum 2-
9A to m/z 257.1 in spectrum 2-9B. The suggested structures of these fragments can be 
seen the insert of Figures 2-9A and 2-9B, the latter of which was first proposed by 
Bijlsma et al. based on MSE accurate mass data[216]. These structures agree with the 
proposed re-arrangement shown in Figure 2-8. In addition to this both mass spectra 
have a common fragment ion at m/z 193, the structure of which is shown in Figure 2-9-
B. The fragment does not contain the re-arrangement, so appears identical in each 
MS/MS experiment. 
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Figure 2-9. (A) MS/MS spectra of THC. Product ion mass spectrum of (i) m/z 315 and (ii) m/z 313 are shown. Both 
spectra were obtained by direct infusion. Peaks with a star symbol denote a mass shift of 2 Da. (B) Proposed re-
arrangement of THC and structures of fragments present at m/z 259 and 257 and 193.  
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2.5 Derivatisation of cannabinoids 
 
Since the laser is an essential component in MALDI-MS, the only way to analyse THC 
and avoid the unwanted re-arrangement is to chemically modify THC before analysis. 
Derivatisation of analytes has previously been identified as a possible strategy to 
improve signal strength when analysing small molecules using MALDI [195], however 
this approach had not previously been investigated for cannabinoids.  
Whilst derivatisation of analytes is undesirable due the additional time and reagents 
needed, this approach can be highly advantageous. Derivatisation results in analyte 
peaks shifted to a higher mass region, and so by use of a suitable reagent, it is possible 
to avoid matrix peak interferences for the analyte signal.  
Moreover, derivatisation with a reagent that can provide a permanent charge is 
particularly useful for non-charged compounds, which may not be possible to analyse 
otherwise [195]. Another advantage of derivatisation is that the signal strength can be 
increased, because the derivatised compound may have different chemical and 
physical properties, which can provide beneficial changes in volatility and higher 
ionization efficiency.  
In this study, the target for the derivatisation was the hydroxyl group, since all 
cannabinoids of interest contain this functional group. After carefully reviewing the 
literature, the derivatisation method using 2-Fluoro-1-Methylpyridinium p-
tolunesulfonate (FMPTS) to form an N-methylpyridinium derivative (shown in Figure 2-
10), as reported by Quirke et al. for the detection of alcohols using electrospray 
ionisation mass spectrometry, was chosen [217]. FMPTS derivatisation has previously 
been reported to improve the detection of a range of compounds with alcohol 
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moieties, in various sample types including surfactants [218], oestrogens [219] and the 
narcotic analgesic buprenorphine [220], using LC-MS analysis, and  polyamides [221] 
and sterols [222] in MALDI profiling experiments.  
 
Figure 2-10. Expected FMTPS derivatisation scheme with A) generic cannabinoid and B) THC. 
 
This strategy was selected due to the simplicity of the nucleophilic substitution 
reaction which occurs readily at room temperature [223], the stability of the products 
formed [218,224] and also the addition of a permanent charge to the analytes. This is 
of particular importance as it allows all cannabinoids to be analysed in positive mode 
analysis (despite the non-derivatised THC-COOH being theoretically more suited to 
negative mode) [225]. 
 
Derivatisation was successful for all cannabinoids of interest, with all expected peaks 
being observed and in agreement with the expected monoisotopic m/z values (Table 2-
1). The derivatised species show an addition of 92 a.m.u. as first observed by Quirke et 
al. [217] and confirmed by others [219,222].  
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Table 2-1. Theoretical and experimental m/z ratios for derivatised and non-derivatised cannabinoid standards. 
After derivatisation the ions corresponding to non-derivatised cannabinoids were not 
observed, suggesting that reaction went to completion (or such that non-derivatised 
cannabinoids remained present at concentrations below the limit of detection). The 
expected derivatised THC peak at m/z 406.28 was the most abundant in the spectrum 
(Figure 2-11a). However, there was evidence that rearrangement still occurred as the 
peak at m/z 404.27 was observed, though it was present at only 6% of the intensity of 
the m/z 406.28 peak, as opposed to approximately 100% when analysed without 
derivatisation. This suggests that the derivatisation largely protects THC from the re-
arrangement, possibly due to steric hindrance, or increasing the required amount of 
laser energy to re-arrange the molecule.  
The peak at m/z 406.28 was also observed in the mass spectrum of the derivatised CBD 
molecule. This was anticipated as THC and CBD are isobaric species, however an 
additional peak at m/z 483.32 was also detected in the CBD spectrum (Figure 2-11b); 
CBD gains two N-methyl-pyridinium groups as it has two hydroxyl groups, rather than 
the one for THC. The peak at m/z 483.32 corresponds to the loss of a methyl group 
from the doubly-derivatised molecule expected to be observed at m/z 498.32. 
Cannabinoid  [M+H] 
Theoretical 
[M+H] 
Experimental  
Derivatised 
[M+92] 
Theoretical 
Derivatised 
[M+92] 
Experimental 
THC 315.23 315.23 406.27 406.28 
CBN  311.20 311.20 402.24 402.24 
CBD 315.23 315.23 406.27 406.28 
11-OH-THC 331.23 331.23 422.27 422.26 
THC-COOH 345.21 345.21 436.25 436.25 
THC-COO-gluc 521.24 521.25 612.28 612.28 
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CBN was detected at the expected mass of 402.24 (Figure 2-11c).  
Whilst theoretically there could be two additions of the N-methyl-pyridinium group to 
11-OH-THC only one addition was observed corresponding to a mass of 422.26 (Figure 
2-11d).  
THC-COOH was observed at the expected mass of 436.26. However, an additional peak 
at m/z 450.27 was observed in greater abundance (Figure 2-11e). This peak is not 
observed in the mass spectrum of the FMPTS derivatisation reagent with CHCA and so 
it is assumed that it is associated with the THC-COOH analyte. The mass does not 
correlate to a doubly derivatised THC-COOH molecule and so the structure of the 
compound correlating to this mass is unknown.  
The THC-COO-gluc molecule could have up to five N-methyl-pyridinium additions on 
molecule because of multiple hydroxyl groups being present, though only the 
corresponding m/z value for one addition, at m/z 612.28 was observed (Figure 2-11f). 
The peak at m/z 436.25 was more abundant, suggesting the glucuronide group readily 
fragments from the parent molecule during analysis resulting in the detection of THC-
COOH.  
 
 
 
Figure 2-11. Mass Spectra of derivatized cannabinoids a) THC b) CBD, c) CBN, d) 11-OH-THC,  e) THC-COOH and f) THC-COO-glucuronide standards derivatised with FMPTS.  
 
 
A further experiment increasing the laser power used for analysis showed that the 
ratio of the peak pertaining to THC-COO-gluc to the peak corresponding to THC-COOH 
decreased sharply from 10 to 20% with an overall decrease of 28% when the laser 
power was increased from 15 to 30%, suggesting laser energy is at least partially 
responsible for the fragmentation observed (Figure 2-12).  
 
Figure 2-12. The effect of laser power on fragmentation of THC-COO-gluc to THC-COOH (n=3). 
 
2.5.1 Profiling of derivatised analytes with a range of matrices 
 
Since derivatisation changes the structure and functional groups of the cannabinoids, 
matrix selection was re-investigated. The addition of aniline to the derivatised THC 
molecule no longer improved the signal intensity when using the matrix CHCA. This 
could be because the addition of 92 a.m.u. means that the THC peak is no longer 
supressed by a matrix peak, as was previously observed.  
Following the results from the underivatised THC compound with a range of matrices 
(Figure 2-1), CHCA, ATT and a binary THC-DHB matrix proposed by Laugesen and 
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Roepstorff to improve crystal inhomogeneity [226] were spotted with all derivatised 
cannabinoids and metabolite standards and  profiled.  
The ATT matrix gave low intensities of analytes or had large standard deviations and so 
was excluded from future experiments, as shown in Figure 2-13. CHCA gave the 
highest intensities for CBD, CBN, and THC-COOH. The CHCA-DHB combined matrix gave 
the highest intensity for THC and 11-OH-THC, with CHCA only slightly lower. Following 
these results, the CHCA matrix was selected for future experiments.  
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Figure 2-13. Absolute intensity of peaks pertaining to derivatised cannabinoids and metabolites with a range of 
different matrices. 
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2.6 On-hair derivatisation 
 
Following the development of a method for detection of the derivatised cannabinoid 
standards, this section will discuss application of the method to hair samples.  
 
2.6.1 Microscopy of derivatised hair samples 
 
The derivatisation of THC was performed on spiked hair samples by spotting 1 µL of 
derivatisation reagent on top of the hair, followed by 1 µL of the 5 mg/mL CHCA matrix. 
Without derivatisation, profiling experiments indicated that 5 mg/mL concentration of 
CHCA was found to be optimal (see Figures 2-1 and 2-3). However, there was very little 
instrumental response for any m/z value on the derivatised hair sample.  
Microscopy of the hair showed that at a CHCA concentration of 5 mg/mL there was 
very little matrix crystallisation (Figure 2-14), explaining the absence of instrumental 
response. Further investigations were conducted in order to ascertain the optimum 
matrix concentration and volume placed directly onto the hair are presented in Figure 
2-14. 
Using 5 mg/mL CHCA there were very few matrix crystals on the hair sample, whilst 
increasing the concentration of CHCA to 15 and 20 mg/mL led to the formation of 
crystals. Usefully it was seen that the addition of the derivatisation reagent appeared 
to help the CHCA matrix adhere to the hair sample (Figure 2-15). 
 
 
 
Figure 2-14. Microscope images of derivatised hair samples with different concentration and volumes of matrix applied 
 
 
 
Figure 2-15. Derivatised and underivatised hair with 20 mg/mL CHCA matrix spotted on top.  
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2.7 Profiling and imaging of cannabinoids in hair samples  
 
Following the evaluation of the matrix application under the microscope, CHCA (2 µL, 
20 mg/mL) was used as the matrix to analyse hair spiked with THC. Unlike with 
previous experiments where CHCA (1 µL, 5 mg/mL) was used, the analyte could now 
be detected during profiling experiments.   
Following the evaluation of microscopy and profiling experiments, 15 mg/mL and 20 
mg/mL concentrations of CHCA were selected and a MALDI-MSI experiment was 
performed. Samples were prepared as described in Section 2.2.5. A schematic of the 
experiment can be seen in Figure 2-16 and the mass spectrometry image can be seen 
in Figure 2-17. 
At all concentrations and volumes of CHCA the THC compound had been delocalised 
from the hair and into the surrounding matrix. This can be seen most prominently in 
the first hair sample with 15 mg/mL CHCA where signal intensities directly on top of 
the hair are lower than those in the surrounding area.  However, signal intensities for 
THC were also highest at the 1 µL volume 15 mg/mL CHCA concentration. 
Delocalisation of the THC compound could be due to THC being soluble in the 
derivatisation reagent and so it spreads out as far as the spot of the derivatisation 
solution.  
The delocalisation of analytes is undesirable as it may lead to interpretational 
difficulties. For example, the analyte may delocalise into a region of the hair that 
originally did not contain the analyte. This could lead to misleading results when trying 
to estimate a timeline of usage.  
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Figure 2-16. Schematic of imaging experiment. 
 
Figure 2-17. MALDI image of peak 406.2 corresponding to derivatised THC. 
 
2.7.1 Spraying of derivatisation reagent  
 
It was hypothesised that the delocalisation of the analyte could be due to the relatively 
large volume of derivatisation reagent being spotted. To test this hypothesis a hand 
sprayer (see Section 2.2.6) was used to supply a fine mist of the derivatisation reagent 
before spraying the sample with CHCA matrix using an automated sprayer (see Section 
2.2.7). A hand sprayer was chosen due to hazards associated with the trimethylamine 
component of the derivatisation reagent, as it was easily used in a fume hood. The 
result of using a spray for the derivatisation reagent can be seen in Figure 2-18. Since 
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previously the delocalisation was equal in all directions (see Figure 2-17) it is 
reasonable to assume that delocalisation is not occurring along the hair sample, 
although this cannot be ruled out.  
Once the derivatisation and spraying of analytes was optimised blank and cannabinoid 
spiked hairs were imaged to verify efficiency of the derivatisation method for imaging 
purposes and were compared to hairs which had not gone through the derivatisation 
step, the results of which can be found in Figure 2-18. 
 
Figure 2-18. Comparison between derivatised and non-derivatised hairs. Hair A soaked in methanol and 
derivatised. Hair B soaked in THC standard then derivatised. Hair C soaked in THC-COOH standard and 
derivatised. Hair D soaked in a 1:1 mixture of THC standard and THC-COOH standard and derivatised. Hair E 
soaked in methanol and not derivatised. Hair F soaked in THC standard and not derivatised. Hair G soaked in THC-
COOH standard and not derivatised. Hair H soaked in a mixture of THC and THC-COOH and not derivatised.   
 
Unless dramatic modifications are made to contrast and brightness, underivatised hairs 
soaked in THC standard could not be visualised in the 2D molecular map as the ion 
signals of the underivatised THC were of extremely low intensity. Interestingly THC-
COOH could be visualised in the 2D molecular ion map (Cyan colour) in hairs G and H 
which were soaked in THC-COOH standard and a mixture of THC and THC-COOH 
standard respectively, however this was also at relatively low intensity. The peak at m/z 
406.2 corresponding to derivatised THC is clearly seen in the hair that was spiked with 
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THC and subsequently derivatised (red in colour). Similarly, the expected ion at m/z 
436.2 was observed in the hair spiked with THC-COOH and subsequently derivatised 
(green colour); the hair which was spiked with a mixture of THC and THC-COOH and 
then derivatised appears yellow in colour as both THC and THC-COOH ions are present 
(a mixture of red and green gives yellow).  
Since it was established that derivatisation enhances both the THC and THC-COOH 
signal in imaging experiments (as shown in Figure 2-18), a second mapping experiment 
with the other cannabinoids shown in was carried out (Figure 2-19). The peak at m/z 
406.2 corresponding to derivatised THC is clearly seen in the hair which was spiked 
with THC and then derivatised (red m/z map), the peak at m/z 483.2 was observed in 
the hair spiked with CBD and derivatised (yellow m/z map), the peak at m/z 402.2 was 
corresponding to the derivatised CBN was observed in the hair which was spiked with 
CBN and derivatised (blue m/z map), the peak at m/z 436.2 corresponding to the 
derivatised THC-COOH was observed in the hair which was spiked with THC-COOH and 
derivatised (green m/z map) and finally the peak at m/z 422.2 corresponding to the 
derivatised 11-OH-THC was observed in the hair which was spiked with 11-OH-THC and 
derivatised (magenta m/z map). As with the profiling experiments, THC-COO-gluc 
fragmented to give THC-COOH at a m/z of 436.2 (green m/z map) and its image 
intensity reflect a 5X lower concentration compared to the other standards due to the 
concentration in which it is supplied.    
 
1 cm 
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Figure 2-19. Simultaneous imaging of several cannabinoids of interest. Hair A soaked in Methanol. Hair B soaked 
in THC. Hair C soaked in THC. Hair D hair soaked in CBD. Hair E soaked in THC-COOH. Hair F soaked in 11-OH-THC. 
Hair G soaked in THC-COO-gluc. All hairs were derivatised with FMTPS prior to analysis.  
 
Once verified the efficiency of the derivatisation method coupled with the MALDI MSI 
analyses, users' hair was investigated employing this optimised method. MALDI MS/MS 
images were obtained of hairs collected from a volunteer who self-reported to use 
cannabis once a week and the transition m/z 406.2 derivatised THC parent ion 
compound to m/z 110.0 was monitored (Figure 2-20). The product ion at m/z 110.0 
corresponds to the hydrated methylpyridinium fragment which is common to all 
FTMPS derivatives and have previously been used for confirmation [218]. 
 
 
1 cm 
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Figure 2-20. MS/MS image of user hairs. 6A shows derivatised THC parent ion at m/z 406.2 6B shows the map of 
the fragment ion at m/z 110. 
 
2.8 MALDI Imaging to detect hair exposure to cannabis smoke  
 
Since THC is present in the smoke produced when the plant material is combusted, the 
presence of THC in hair can be due to exposure to smoke, and not necessarily direct or 
intentional usage. The exact mechanism of smoke contamination is not yet fully 
understood. Mapping the THC compound and its location in the hair sample after 
exposure to cannabis smoke could therefore offer new insights into the mechanism of 
contamination and the most appropriate procedure to remove external 
contamination. In this section preliminary results of hairs exposed to cannabis smoke 
and subsequently analysed using MALDI-MSP and the MALDI-MSI methods developed 
in Section 2.7 will be presented.  
2.8.1 Methods and Materials  
 
Methods for the matrix preparation, deposition of matrix, spiking of samples hair 
samples, and derivatisation were performed as previously described in Section 2.2. The 
1 cm 
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instrumentation was also used as described in Section 2.3. Additional methods and 
materials unique to this section can be found below.  
 Spraying of derivatisation reagent 
 
For imaging experiments in this section the derivatisation reagent was sprayed using a 
Bruker ImagePrep (Bruker Daltonics, Bremen, Germany). 
    Preparation of plant extracts  
 
The plant extract was prepared according to De Backer et al. [227]. The plant material 
(purchased from a coffee shop in Maastricht, The Netherlands) shown in Figure 2-21A 
was dried for 24 h in a 35 °C forced ventilation oven. The sample was then ground to a 
fine powder. 200 mg of powder (shown in Figure 2-21C) was extracted with a mixture 
of 20 mL mixture methanol/chloroform (v/v: 9/1) by agitation for 30 minutes. The 
extract was then filtered (shown in Figure 2-21D) and used for subsequent analysis.  
In addition to the "fresh" plant extract a 3-year-old plant extract which had been 
stored at 5°C was also analysed. The origin of the plant and process of extraction for 
this sample is unknown.  
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Figure 2-21. A-Cannabis plant material as bought from a coffee shop. B-Cannabis plant material after grinding. C-
Cannabis plant material after drying at 30 °C for 24hr and grinding with pestle and mortar. D-Cannabis plant 
material filtrate.  
 
 Preparation of cannabis cigarettes 
 
Cannabis cigarettes were prepared by a regular user, who was asked to make 
cigarettes as they normally would. Briefly, the plant material shown in Figure 2-21A 
was ground using a herb grinder to separate the cannabis bud from small stems which 
were still attached. This resulted in a consistency that is more amenable to rolling into 
a cigarette (Figure 2-21B).  Each cannabis cigarette contained approximately 130 mg of 
plant material and 700 mg of Lucky Strike tobacco and was rolled using Rizla green 
regular rolling paper.  
 
 Smoke exposure conditions 
 
A hair sample (approximately 5 g) from an individual who reported that they did not 
use cannabis was placed inside a desiccator. Hairs were approximately 12 cm in length. 
The cannabis cigarette was placed inside the tap of the desiccator as shown in Figure 
2-22. The contents were then placed under vacuum and the cigarette was then lit. The 
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tap was turned on and off at regular intervals to mimic inhalation and keep the 
cigarette alight. After 15 minutes in the desiccator under smoke conditions the hair 
was removed and stored in foil at room temperature before analysis.  
 
Figure 2-22. Experimental set up of cannabis smoke exposure experiments. 
 
2.8.2 Instrumentation 
 
Profiling and high-speed imaging was performed on a Bruker RapifleX MALDI 
TissuetyperTM system (Bruker Daltonik GmbH, Bremen, Germany). The instrument was 
operated in reflectron mode in positive ion mode in the mass range m/z 100-600. The 
instrument was calibrated prior to analysis using red phosphorus clusters. Images were 
acquired using a 50 × 50 µm raster (25 × 25 µm beam scan area). The images were 
generated using the FlexImaging 5.0 software (Bruker Daltonik GmbH) and were 
normalized to the total ion current (TIC). 
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2.8.3 Results 
 
 Profiling of plant extracts and hair samples 
 
In the three-year-old plant extract, peaks at m/z 406 and 402 were detected which 
correspond to FMTPS derivatised THC and CBN respectively (Figure 2-23A). The relative 
intensities of the peaks were high, being the largest two peaks in the spectrum. The 
peak corresponding to THC was also detected in the fresh plant extract; however, the 
peak corresponding to CBN was not (Figure 2-23B). This could be due to the fact the 
THC is known to degrade to CBN [228–230], or that the two extracts were of different 
plant strains (discussed in detail in Section 1.1.2). The three-year-old plant extract 
mass spectrum also contained an additional peak at m/z 438 which was not detected 
in the fresh plant extract and is of unknown origin. It does not correspond to 
theoretical values of FMTPS derivatised cannabis plant constituents reported in the 
study from which the extraction procedure was reproduced [227]. 
The profile of a hair exposed to THC smoke also contained m/z 406 in the mass 
spectrum. Interestingly, the peak corresponding to CBN is also detected (denoted with 
an arrow on Figure 2-23C) but at a much lower abundance than in the aged plant 
extract. This suggests that the degradation of THC to CBN is accelerated due to 
exposure to high temperature when burned in the cigarette.  
The peak at m/z 438 is detected in the hair sample exposed to cannabis smoke and the 
aged plant extract, but not in the fresh plant extract, suggesting it also may be a 
degradation product of the plant material induced by pyrolysis.   
A peak was observed at m/z 420 in the hair sample that was exposed to cannabis 
smoke but was not detected in either the plant material extracts or the blank hair 
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sample. It is hypothesised that this corresponds to a compound in the tobacco or the 
rolling paper used to make the cannabis cigarette.  
Peaks corresponding THC, CBD and CBN were not detected in the blank hair sample 
from the non-user (Figure 2-23D). The peak corresponding to the doubly-derivatised 
CBD (m/z 483) was not detected in any sample.
 
 
 
Figure 2-23. MALDI-MSP mass spectrum of A) 3-year-old plant extract. B) Freshly prepared plant extract. C) cannabis smoke contaminated hair sample. D) hair sample not exposed to cannabis 
smoke  
 
 
 Imaging of smoke contaminated hairs  
 
In addition to a smoke contaminated hair prepared as described in the previous 
section, a blank hair from the non-user and a hair spiked with fresh plant extract as 
described in Section 2.2.5 were subsequently imaged using MALDI-MSI. During spray 
optimisation experiments the peak at m/z 324 was found to be a suitable marker for 
the derivatisation reagent due to high signal intensity, and was used to deduce 
whether the derivatisation reagent was sprayed heterogeneously on the sample. The 
results from Figure 2-24A suggests a good coverage of the derivatisation reagent on 
the hairs; however, there are some regions where the mass correlating to the 
derivatisation reagent has a lower intensity due to inhomogeneity in the spraying of 
the derivatisation reagent. This is reflected in lower abundance of analytes in the 
regions where the derivatisation is at a lower intensity as seen in Figure 2-24B and 2-
24C.  
As with the profiling experiments, m/z 406 corresponding to THC was observed in both 
the plant extract spiked hair and the hair exposed to cannabis smoke.  m/z 420 was 
only detected in the smoke contaminated hair. As before, the hair not exposed to 
cannabis smoke (control) did not have m/z 406 or m/z 420 detected. 
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Figure 22-24. MALDI-MSI  A) map of derivatisation reagent (m/z 324). B) map of THC (m/z 406). C) map of m/z 
420.   
 
2.9 Further work   
 
2.9.1 Optimisation of FMTPS spray  
 
At present, the spray method can cause inhomogeneities in the volume of 
derivatisation reagent across the hair sample. Therefore, additional optimisation of the 
FMTPS spray method should be conducted. A homogeneous spray is needed to reliably 
identify relative intensities within the sample so that any assignment of high or low 
intensities of cannabinoid peaks are in fact due to the relative abundance of 
compounds in that area, and not due to inhomogeneity of the derivatisation reagent.  
If homogenous spraying of the derivatisation reagent is not achieved, investigations 
into normalising any image to a peak associated with the derivatisation reagent should 
be investigated.  
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2.9.2 Longitudinal sectioning of hair samples  
 
The methods developed in this study have been applied to intact hairs, however there 
are limitations associated with this type of analysis. As drugs are considered to be 
entrapped inside the keratin matrix of the hair (described in detail in Section 1.3.5), it is 
difficult to know whether a) the drug is completely extracted out of the hair by the 
MALDI matrix solution or b) if the detected drug originates from external 
contamination or metabolic incorporation [231]. 
To be able to make a distinction between external contamination and intake, 
examination of drug distribution inside the hair itself is required and so should be 
investigated in future work. Whilst methods for the preparation of longitudinal sections 
of hair samples have previously been described [189,191,193,231,232] analysis of 
cannabinoids in sliced hair samples has not yet been reported.  
In relation to smoke contamination, an assessment of whether the cannabinoids found 
in cannabis smoke remain on the cuticle of the hair (indicating external contamination) 
or are found inside the cortex (indicating usage) should be a priority along with an 
assessment of the effectiveness of current decontamination procedures.  
 
2.9.3 Quantification of cannabinoids in hair samples  
 
Quantification of analytes was not attempted in this study and is a logical next step for 
future work. This may be achieved by utilising a method developed in collaboration 
with Flinders et al.  during the course of this study to determine the amount of cocaine 
detected in hair samples [233]. The full text of this article can be found in Appendix II.  
 
2.9.4 Use of realistic smoke contamination procedures  
 
Realistic smoke contamination conditions should be used in future studies, with 
additional investigations into whether the method is sensitive enough to detect 
cannabinoids under these conditions. 
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One such exemplar method was conducted by Röhrich et al. to investigate the levels of 
cannabinoids in urine and blood after exposure to cannabis smoke.  The exposure to 
cannabis smoke by non-users took place in a coffee shop in Maastricht in the 
Netherlands. Coffee shops in the Netherlands are pubs where cannabis can be 
consumed legally. The coffee shop in which exposure took place had no windows but 
relatively efficient ventilation and, therefore, was not very smoky during the exposure.  
This type of experiment would create a more realistic method of contaminating hair 
samples than the one used currently used in this PhD study. Findings form a realistic 
experiment would be more applicable to interpretation of cannabinoid findings in 
authentic hair samples.  
2.9.5 Analysis of different hair types  
 
The hair cuticle is the region affected by stress caused by the external environmental 
and physical factors. Undamaged hair has a smooth cuticle and outer layer, while 
damaged hair has a dull and dry cuticle with a rough outer layer [234]. Morphological 
characteristics such as roughness, pores, pits, and cracks, holes, or overall severe 
peeling (desquamation) occur in the cuticle layers and can be observed and classified 
using scanning electron microscopy (SEM) [235].   
In relation to cannabinoid detection in hair samples, future work should focus on 
establishing whether there is a link between hair damage and cannabinoid 
concentrations found in hair samples after exposure to cannabis smoke by analysing 
samples using both SEM and MALDI-Imaging.  
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2.9.6 Further Analysis of user hairs  
 
Finally, prior to integration into a toxicology workflow a much larger sample of user 
hairs, from different levels of users and with different hair types should be analysed 
and the relative levels of each metabolite reported. Initially these analyses should be 
carried out in parallel with well-established techniques such as GC-MS/MS to assess 
whether the techniques are comparable.  
 
2.10 MALDI-MS optimisation discussion and Conclusions  
 
In this study several approaches to detecting cannabinoids using MALDI Mass 
spectrometry were investigated. A range of different matrices and matrix compositions 
were evaluated, and it was shown that CHCA yielded the greatest signal intensity for 
the THC molecule at a concentration of 5 mg/mL in a solution of 70:30 ACN:0.2% 
aqueous TFA.  It was also shown that the neither the addition of cetrimonium bromide 
nor lithium salts improved the detection of THC. In contrast, the addition of the ionic 
liquid aniline did improve the relative intensity of the THC peak significantly.  
During the development of this method an interesting, laser induced, THC 
rearrangement was detected and reported. This resulted in two peaks which 
corresponded to the THC molecule (m/z 131 and m/z 315) and hence lower ability to 
detect the molecule without derivatisation.   
The derivatisation of several cannabinoids and metabolites of interest with the 
addition of N-methylpyridium was found to be successful.  
The novel in situ derivatisation, completed in minutes at room temperature using 
FMPTS, showed a greatly increased signal intensity over the non-derivatised analytes, 
enhancing the ability to detect THC, CBD, CBN and THC metabolites.  The ability to 
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detect the metabolites of THC only formed in vivo THC-COOH, 11-OH-THC and THC-
COO-gluc will enhance the ability of the analyst to distinguish between use and 
exposure. During analysis the THC-COO-gluc fragments to form THC-COOH, with the 
consequence that if the m/z 436.2 is detected it cannot be determined which of the 
analytes was present. The m/z 612 is however unique to the THC-COO-gluc. This is an 
advantage over traditional GC-MS methods where the glucuronide is not generally 
detected as a parent compound due to the common practice of hydrolysis or digestion 
of the hair sample which converts it into the THC-COOH [236].  
Due to the processing in this method the limits of detection for the analysis are not 
reported. The main limitation of the study the inability to assess LODs due to the 
spiking procedure as it is not possible to ascertain how much of the spiking solution the 
hair has taken up. 
The method reports a sample preparation workflow, notwithstanding the derivatisation 
step, which is less complicated than the traditional GC-MS or LC-MS methods. This 
method also gives the opportunity to simultaneously detect THC and metabolites in a 
single workup and analysis. Application to a single user hair has shown applicability to 
real life samples. The traditional method of segmenting the sample into 1 cm pieces 
means a one-month history can be obtained, using MALDI-IMS experiments the 
resolution will be much smaller than that, allowing possibly isolating use on a single 
day.  
 
2.11 Smoke contamination discussion and conclusion  
 
The preliminary findings in this study suggest that MALDI-MS could be a useful tool to 
differentiate between the THC and CBN content in plant extracts which can be an 
indicator of degradation. This could be an advantage over commonly used techniques 
such as LC-MS due to the rapid nature of MALDI-MSP analysis.  
 
114 
 
THC was detected on hair contaminated with cannabis smoke using MALDI-MSP and 
MALDI-MSI. This is an important finding as MALDI-MSI could also be used to 
distinguish whether a compound is in the cortex or cuticle of the hair, which is not 
possible in current analysis techniques as GC-MS and LC-MS. This may be beneficial as 
the major pitfall of hair analysis is the presence of external contamination, making 
interpretation of analytical findings problematic.  
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Chapter 3. Development of Gas Chromatography-Mass 
Spectrometry to detect cannabinoids in hair samples 
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This chapter includes a discussion of current GC-MS methodologies used to analyse 
hair for cannabis use. The novel work in this chapter introduces a sample preparation 
technique optimised for the simultaneous detection and quantification of THC, CBD, 
CBN, 11-OH-THC and THC-COOH using GC-MS in hair samples.   Additionally, the use of 
atmospheric pressure chemical ionisation (APCI) for detection and quantification of 
cannabinoids in hair samples will be investigated for the first time.   
 
3.1 Introduction 
 
GC-MS was first used to detect cannabinoids in hair samples in the 1990s, specifically 
THC and THC-COOH were initially targeted [237]. A comprehensive review of sample 
preparation methods from literature published between 2000 to 2014 was conducted 
by Vogliardi et al. [161] and is summarised in Table 3-1.  Ideally a method would 
simultaneously detect THC, CBD and metabolites. This review revealed that only 12% 
of studies analysed both the parent compound THC and the metabolite THC-COOH. 
Without the analysis of metabolites cannabis consumption cannot be confirmed due to 
potential contamination issues which are outlined in Section 1.3.7. Similarly, only a 
third of studies detected both THC and CBD. The detection and quantification of CBD is 
becoming increasingly relevant due to possible clinical applications of CBD (see Section 
1.1.4) and changes in the potency of cannabis plants.  
There are no published methods included in the review article which analyse the 
metabolite 11-OH-THC, or simultaneously analyse THC, CBD and THC-COOH. This 
amounts to a distinct lack of scope in current methodology, possibly limiting the 
amount of information gained before the difficult process of interpretation of 
analytical findings can take place.  
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This lack of coverage of analytes is also reflected in more recent literature [238]. The 
previously reported limits of detection and quantitation of several instrumental 
methods can be seen in Table 1-2 of Chapter 1.  
Compound(s) Analysed Number of studies References  
THC  3 [239–241] 
THC, CBD and CBN 8 [108,109,113,115–
117,119,242] 
THC and THC-COOH 3 [121,165,243] 
THC-COOH  12 [122–127,160,244–248] 
11-OH-THC 0  
Total 26  
Table 3-1. Total number of published methods for each combination of cannabinoids and/or metabolites taken 
from the years 2000-2014. 
Due to low incorporation rates of THC metabolites [45], highly sensitive 
instrumentation is needed for successful analysis.  Many GC methods utilise EI 
ionisation, however this this considered to be a “hard” ionisation technique which is 
prone to fragmentation of analytes. This can result in sub-optimal amounts of the 
intact compound reaching the detector, making the method less sensitive.  
In contrast, APCI is considered a low energy “soft” ionisation technique. This promotes 
ionisation with very little fragmentation, resulting in the formation of M+H+ or M+ ions 
as the base peaks of the mass spectrum (see Section 1.4.2. for more information). The 
reduced fragmentation observed by using this relatively new source can have a 
significant impact on target analysis at trace levels. In recent years the usefulness of 
the interface has been demonstrated in several fields including environmental analysis 
[249,250], food safety [251–253], and metabolic profiling [254]. However, it has not 
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been applied to the detection of cannabinoids in any sample type. It has also not been 
evaluated for the detection of any compounds in hair samples.  
 
3.2 Sample preparation  
 
There are several sample preparation steps that are required before a hair sample can 
be analysed using GC-MS. Briefly, this includes: 
 washing of the hair to remove external contamination (see Section 1.3.8 for 
more information) 
 digestion of hair to liquify the sample or soaking the hair to extract the drugs  
 clean up and extraction of analytes from the digest (see Section 3.2.6) 
 derivatisation to make the analytes more amenable to GC (see Section 3.2.3) 
 
3.2.1 Decontamination of hair samples  
 
The wash protocol chosen for decontamination of hair samples was taken from a 
recent study conducted by Duvier et al. [255].  After extensive testing of both single 
and sequential decontamination protocols, the authors concluded that three 
sequential wash protocols were found to perform equally well regarding the removal 
of external cannabis contamination originating from smoke or indirect contact. In 
addition, these methods did not remove incorporated THC. These steps were: (1) 
methanol, SDS; (2) methanol, SDS, methanol and (3) methanol, methanol. Due to 
reagent availability and the additional preparation time needed for a 3-step 
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decontamination procedure, the methanol-methanol decontamination step reported 
by Duvier et al. was chosen for future experiments in this PhD project.  
Hair samples were washed with MeOH (5 mL) before drying at room temperature and 
washing with a further 5 mL. After vortexing (10 s) and ensuring that all the hairs were 
in the solvent, the test tubes were shaken (15 min at 100 rpm). The hair samples were 
then removed from the test tube using tweezers and placed on paper to dry in a fume 
hood.  
It is, however, important to note that the main limitation of the above study is that 
only THC was analysed. 
3.2.2 Digestion of hair samples  
 
For substances that are stable in alkaline conditions, a useful method for extraction of 
analytes from the hair matrix consists of digestion in an aqueous solution of NaOH. 
Under these conditions, there is complete dissolution of the hair. Whilst the hydrolysis 
of morphine, heroin and cocaine occurs in alkaline conditions, cannabinoids have been 
found to be stable [161]. Since this is a well-established method it was chosen for use 
without alteration.  
 
 
 
 
 Figure 3-1. 20 mg of hair a) before and b) after 30 minutes at 70°C with NaOH (1 mL, 1 M). 
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3.2.3 Derivatisation  
 
Derivatisation of cannabinoids before GC analysis is necessary to increase their 
volatility. A recent literature review into plant cannabinoid derivatisation techniques 
by Monlár and Molnár-perl showed that alkylsilyation of cannabinoids was the most 
common technique, followed by acylation and/or esterification [256]. In this section a 
range of derivatisation reagents, taken from published methods or potentially of use 
for cannabinoids will be assessed to identify the most suitable for further experiments.  
Before derivatisation experiments analytical standards (10 ng/µL) were dried under a 
flow of nitrogen at 45°C and reconstituted in ethyl acetate (50 µL). Experiments were 
conducted without derivatisation by reconstituting analytical standards in ethyl 
acetate (50 µL).   
 Derivatisation methods  
 
The expected m/z of derivatised analytes using different derivatisation reagents can be 
found in Table 3-2. The ion of greatest abundance for each compound was used, 
where this is not the [M]+ ion, [M]+ ions were also monitored for confirmatory 
purposes. Illustrative examples of THC and THC-COOH derivatised with each regent 
used in this study can be found in Figure 3-2. 
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Derivatisation 
reagent 
THC THCOOH 
None  
 
 
BSTFA 
  
MTBSTFA 
 
 
BSTFA/MTBSTFA 
 
 
PFPOH/PFOH 
 
 
Figure 3-2. Representative structures of THC and THC-COOH after derivatisation with BSTFA, MTBSTFA, a mixture 
of BSTFA and MTBSTFA and a mixture of PFPOH and PFOH. 
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Table 3-2. m/z values monitored for each compound with different derivatisation reagents  
 BSTFA 
 
BSTFA derivatisation was performed as per Han et al. Extracts were reconstituted in 
BSTFA (50 µL) and heated at 70°C for 30 min. The sample was then dried under N2 and 
reconstituted in ethyl acetate (50 μL) [257].  
 MTBSTFA 
 
MTBSTFA derivatisation was performed according to Uhl and Sachs. Dried extracts 
were heated in MTBSTFA (75 μL) at 90°C for 1 hour. The sample was dried under N2  
and reconstituted in ethyl acetate (50 μL) [160]. 
 BSTFA/MTBSTFA mixture 
 
The BSTFA/MTBSTFA mixture was prepared according to Brewer et al. Dried extracts 
were reconstituted in equal parts of BSTFA:MTBSTFA:ACN (50 μL) at 90°C for 1 hour 
[258]. The sample was dried under N2 and reconstituted in ethyl acetate (50 μL) prior 
to analysis. 
 
 
 Ions monitored 
Compound No  
Reagent 
BSTFA MTBSTFA BSTFA/MTBSTFA 
mix 
PFPA/PFOH 
THC 299 371 371 371 377 
CBD 231 390 371 390 377 
CBN 295 367 424 367 295 
11-OH-THC 330 371 444 374 622 
THC-COOH 344 371 515 371 489 
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 PFPA/PFOH 
 
For derivatisation with PFPA/PFOH, dried extracts were heated in PFPA (50 μL) and 
PFPOH (25 μL) at 65°C for 30 min. The sample was dried under N2 and reconstituted in 
L ethyl acetate (50 µL) prior to analysis. This method was proposed by Baptista et al. 
[259].  
 
3.2.4 Instrumental parameters  
 
All analyses were conducted using the following method: 
A 1 µl sample was injected into a Hewlett Packard (HP) GC/MS system: HP 6890 series 
GC system (USA) with an Agilent Technologies DB-5MS column (crosslinked 5% phenyl 
methylsiloxane, 30 m x 250 µm x 0.25 µm film thickness) coupled to a Waters 
Micromass® Quattro MicroTM  GC tandem mass spectrometer (Manchester, UK) using 
an Agilent Technologies 7683B series autosampler (CA, USA) 
The inlet temperature was 220°C with a splitless injection. The carrier gas was helium 
(1.0 mL/min). The column oven temperature was programmed to rise from an initial 
temperature of 150°C, held for 1 minute, to 270°C, at 20°C per minute and then held 
for 5 min. To determine the retention times and characteristic mass fragments, the 
primary electron ionization (EI) mass spectra were recorded in full-scan mode (m/z 50–
650).  
 
 
 
 
124 
 
3.2.5 Results of derivatisation experiments 
 
Whist THC, CBD and CBN could be detected without derivatisation, the metabolites 11-
OH-THC and THC-COOH could not. Once derivatised THC and CBD showed increased 
peak areas, whilst 11-OH-THC and THC-COOH could be detected, with all reagents 
when compared to no derivatisation. CBD showed an increase in peak area with all 
derivatisation reagents compared to without, except PFPA/PFOH. BSTFA derivatisation 
gave the largest peak area for all cannabinoids, as shown in Table 3-3. BSTFA also gave 
the largest peak height for all analytes. As an illustrative example, an overlaid 
chromatogram of THC under all the investigated derivatisation conditions can be seen 
in Figure 3-3. 
Table 3-3. Summary of the peak area of analyte when injected underivatised and under different derivatisation 
methods (10 ng/µL) to three significant Figures (n=3). 
THC and CBD both have the same retention time and mass spectrum with PFPA/PFOH 
derivatisation, this also reported by Baptista et al.[259].  Andrews and Paterson also 
reported this phenomenon with HFIP/TFAA derivatisation [260]. This is thought to be 
due to conversion of CBD to THC under acidic conditions [260].  
The importance of measuring THC/CBD ratios to establish potency and due to possible 
clinical applications of CBD (described in detail in Section 1.1.8) means differentiation 
between the two compounds is highly desirable in any current method of analysis. In 
 Peak areas with varying derivatisation reagents 
Compound No Reagent BSTFA MTBSTFA BSTFA/MTBSTFA mix PFPA/PFOH 
THC 55600 761000 261000 97800 103000 
CBD 50100 1100000 304000 292000 45300 
CBN 517000 4850000 867000 184000 813000 
11-OH-THC ND 1390000 50800 219000 288000 
THC-COOH ND 590000 355000 359000 209000 
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addition, the conversion of CBD to THC raises the possibility of over-estimation of the 
true value of THC in a sample as the value obtained is in fact THC+CBD [259,261].  
For the above reasons, derivatisation with PFPA/PFOH and HFIP/TFAA reagents were 
excluded from further investigation in this study. 
 
Figure 3-3. Overlay of chromatograms obtained from the derivatisation of THC with a variety of reagents 
Based on peak shape, retention time and response BSTFA was chosen as the 
derivatisation reagent for future experiments.  
3.2.6 Extraction of analytes from hair 
 
The purpose of the extraction procedure is to selectively extract and concentrate the 
analytes of interest from the hair digest. This is necessary to reduce the presence of 
possible interference caused by organic compounds in high abundance from the hair 
matrix. This is generally carried out by liquid-liquid extraction (LLE) or solid phase 
extraction (SPE) [161].  
Initially the hair digest was extracted using SPE cartridges (Bond Elut Certify, Varian 
Inc., Palo Alto, CA, USA). The method was adapted from Sears [262] with the addition 
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of a conditioning step taken from Guthery et al. to buffer the sample to pH 7 before 
extraction [263]. THC, CBD, CBN and 11-OH-THC could be extracted using this protocol. 
However, THC-COOH was not detected after SPE extraction, despite the utilisation of 
separate elution steps as described by Sears [262]. 
Considering this, an LLE extraction protocol was then selected after careful review of 
the literature. The chosen method was developed by Han et al. [243] and allowed for 
the sequential extraction of neutral and acidic analytes. 
Briefly, hair digests were extracted with n-hexane:ethyl acetate (2 mL 9:1) for 10 
minutes by quick mechanical shaking (250 rpm) for the extraction of THC, CBD, CBN 
and 11-OH-THC. The organic layer was then transferred into a screw-cap tube. This 
procedure was performed twice.  
For the extraction of THC-COOH buffer (1 mL of 0.1M sodium acetate buffer, pH 4.5) 
and acetic acid (200 µL) were added. Hair digests were re-extracted with n- 
hexane:ethyl acetate (2 mL, 9:1) and the organic extract was transferred into the screw 
cap tube. Hair samples were extracted with n-hexane:ethyl acetate (2 mL, 9:1) one 
more time and the organic extract was transferred into the same screw-cap tube and 
evaporated to dryness at 45◦C under a gentle stream of nitrogen. 
This method of extraction allowed for the detection of all analytes of interest.  
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3.3 GC-EI-MS/MS method development 
 
In this section the optimisation of GC oven temperature and development of a 
selected reaction monitoring (SRM) method will be discussed.  
3.3.1 Oven temperature parameters.  
 
A review of literature revealed a range in GC oven temperature parameters for the 
separation of trimethylsilyl derivatives of cannabinoids [108,160,241,248]. Start 
temperatures ranged from 60 °C [160] to 120 °C [248] depending which cannabinoids 
were analysed. Final oven temperatures ranged from 250 °C [241] to 300 °C [108,160]. 
At the commencement of this work no studies had been conducted on simultaneous 
detection of THC, CBD, CBN, THC-COOH and 11-OH-THC in hair samples, and so oven 
temperature parameters were optimised for peak shape, peak separation and total run 
time.  
Figure 3-4 demonstrates the chromatographic separation of analytes at A) 300°C final 
temperature and B) 320°C final temperature. All analytes are well separated with both 
oven temperature parameters; however, at a 300°C end temperature the latest eluting 
peak THC-COOH (5) is broad.  This can be seen in Figure 3-4Aii. At a final temperature 
of 320°C peak 5 becomes narrower and is now much closer in peak height to analyte 
11-OH-THC (4). The narrowing of the peak also means that signal to noise increases, 
improving the limit of detection (LOD) of the analyte. This is imperative since 
metabolites are found in low concentrations in hair samples.  Increasing the starting 
temperature from 40°C to 150°C decreased the retention time of the latest eluting 
peak (THC-COOH) from 15.4 minutes to 9.7 minutes, reducing the overall time for each 
run,awhichaisaveryaadvantageousainaaahighathroughputalaboratory.  
 
 
 
Figure 3-4. GC oven programme starting A) 40°C start ending at 300°C at 20°C/min (B) 150°C start ending at 320°C degrees 20°C/min. 1- CBD 2-THC 3-CBN 4-11-OH-THC 5-THCCOOH i) full 
chromatogram ii) compounds 4 and 5.   
 
 
3.3.2 Tandem mass spectrometry analysis 
 
The use of tandem mass spectrometry (MS/MS) greatly increases selectivity and 
sensitivity, especially when analysing complex matrices such as hair. This then enables 
low limits of detection for the analytes (see Section 1.4.2 for more information). The 
precursor ion in tandem MS is ideally of relatively high mass and abundance to obtain 
a product ion mas spectrum of analytical significance. This allows for identification of 
the analyte and will help to achieve a good signal-to-noise ratio with low detection 
limits. 
The selected reaction monitoring (SRM) transitions for CBN, THC, and CBD previously 
reported by Lachenmeier et al. [264] were found to give a high response, as shown in 
Figure 3-5c, 3-5d and 3-5e respectively. Similarly, the SRM transition for THC-COOH, 
reported by Niedbala et al. gave a relatively high response (Figure 3-5a).  
No SRM transition for 11-OH-THC had been previously reported; however target ions 
of m/z 459 and m/z 371 had previously been described by Sears [262]. Based on the 
literature and the successful transition of 488 → 371 for the structurally similar THC-
COOH compound, for 11-OH-THC an SRM transition of 459 → 371 was chosen. 
However, it yielded a relatively low response (Figure 3-5b) and so required further 
optimisation.          
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Figure 3-5. SRM chromatograms of 10 ng/µL of a) THC-COOH, b) 11-OH-THC, c) CBN, d) THC, e) CBD. On each 
chromatogram the MS/MS transition (quadrupole 1 to quadrupole 3) m/z can be found. 
 
 Optimisation of selected reaction monitoring for 11-OH-THC 
 
Upon inspection of the full scan mass spectrum for 11-OH-THC, it was observed that 
the [M]+ ion at m/z 459 was in relatively low abundance (circled in Figure 3-5A). The 
ion of the greatest abundance in the mass spectrum was m/z 73, however, this ion has 
low specificity as it is also observed in septa bleed [265]. As 73 is a low m/z it is also 
doubtful that significant further fragmentation, or unique fragmentation, would occur. 
Consequently, the second most abundant peak in the spectrum at m/z 371 was 
selected to undergo a product ion scan, shown in Figure 3-5B. The most abundant ion 
in the product ion scan was at m/z 305, and so the chosen SRM transition was 371  
305, a chromatogram of which can be seen in Figure 3-6. 
 
131 
 
 
Figure 3-6. A) Full scan mass spectrum of 11-OH-THC, the M+. ion m/z 459 is circled. The second most abundant 
peak m/z 371 is indicated with an arrow. B) product ion scan of m/z 371. The most abundant peak m/z 305 is 
circled.   
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The optimised precursor and production ions selected for SRM along with retention 
times for each analyte, including isotopically standards, using the GC temperatures as 
optimised in Section 3.3.1 can be found in Table 3-4.  
Compound name  Precursor ion (m/z) Product ion (m/z) RT (min) 
THC 386 371 8.17 
CBD 390 301 7.57 
CBN 387 310 8.54 
11-OH-THC 371 304 9.15 
THC-COOH 488 371 9.69 
THC-d3 389 374 8.16 
CBD-d3 393 304 7.55 
CBN-d3 340 313 8.52 
11-OH-THC-d3 374 308 9.13 
THC-COOH-d3 491 374 9.67 
Table 3-4. Precursor and product ions chosen for SRM and retention times for all analytes 
 
Figure 3-7. Comparison of 11-OH-THC chromatograms of SRM a) the original transition 459371 and b) the 
optimised transition 371305 
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3.3.3 GC-EI-MS/MS Calibration of spiked hair extracts 
 
A matrix-matched calibration was constructed using hair samples from a self-reporting 
non-user. Samples (20 mg) were washed, digested, and extracted as described (Section 
3.2). The extracts were then spiked with THC, CBD and CBN at 0.02, 0.05, 1, 2.5, 5, 7.5 
and 10 ng/mg. In addition, samples were spiked with the metabolites 11-OH-THC and 
THC-COOH at 0.1, 0.2, 0.5, 1, 2, 5 and 10 pg/mg. Deuterated internal standards were 
added to each sample, one per analyte. THC-d3, CBD-d3, CBN-d3 were added at a 
concentration of 2.5 ng/mg per sample whilst 11-OH-THC-d3 and THC-COOH-d3 were 
added at 2 pg/mg.  
The calibration ranges were based on reported concentrations of cannabinoids the hair 
of cannabis users (see Table 1-3) and also to be in line with cut-off concentrations 
recommended by the SoHT [145].  
After spiking with analytes and deuterated standards, hair extracts were derivatised 
with BSTFA as described in Section 3.2.3. 
Calibration curves were constructed for each analyte by plotting concentration against 
response ratio. The response ratio was calculated as the peak area of the analyte 
divided by the peak area of deuterated standard.  
 Results of GC-EI-MS/MS calibration of spiked hair extracts 
 
The exact limit of detection for THC, CBD and CBN was not determined, as the lowest 
calibrant (0.02 ng/mg) had a signal to noise ratio greater than three. This is below the 
SoHT recommended cut-off of 0.05 ng/mg and so was deemed adequate for the 
application of hair testing. However, when calculated, the linear range (within 15%) did 
not include the lowest two calibrants. Whilst 11-OH-THC and THC-COOH were both 
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detected at the SoHT suggested limit of 0.2 pg/mg neither analyte gave a linear 
response at any three points in the calibration range (r2=0.566 and 0.724 respectively).  
Without the hair matrix 11-OH-THC gave a linear response between 0.16 and 10 pg/µL 
(r2 0.998), THC-COOH gave a linear response between 0.31 and 10 pg/µL (r2 0.996). It is 
likely that this is due a phenomenon known as the matrix effect.  
Matrix effects and selectivity issues have long been associated with bioanalytical 
techniques. The matrix effect is a change in MS signal of an analyte due to co-eluting 
matrix [266]. The analyte signal can be enhanced or suppressed resulting in inaccurate 
performance characteristics of the method. Matrix effect is a parameter of concern 
during method development and/or validation as it can lead to over or 
underestimation of the analyte concentration.  
It is suggested that the ion interface can also affect matrix effect as physiochemical 
processes of ion formation vary depending on the ionization technique [266]. 
However, a comparison of matrix effect with different ionisation modes has not been 
reported for the analysis of cannabinoids in hair samples.  
Table 3-5. Linear range and coefficient of correlation for THC, CBD and CBN in spiked hair samples 
 
 
Analyte  Linear range (ng/mg) Coefficient of correlation (r2) 
THC 1-10 0.980 
CBD 1-7.5 0.984 
CBN 1-10 0.956 
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3.4 GC-APCI-MS/MS methods 
 
3.4.1 Sample preparation  
 
Sample preparation was as in Section 3.3.3. Hair samples (20 mg) of a self-reporting 
non-user were washed, digested and extracted before spiking with analytes and 
deuterated standards.   
3.4.2 Instrumentation   
 
Sample analysis was performed using a Xevo TQ-XS equipped with an atmospheric 
pressure ionization source coupled to a triple quadrupole mass spectrometer (Waters 
Corporation, Wilmslow, England), an Agilent 7890A gas chromatograph and 7693 
autosampler (Agilent Technologies, Santa Clara, CA), and a Restek Rxi-5Sil (30m x 
0.25mm x 0.25µm, Restek UK LTD Buckinghamshire, UK) column was used for the 
analysis. Samples were injected with a volume of 1 µL. The GC oven parameters were 
as follows: initial temperature of 150 °C increasing at 20 °C/min to a final temperature 
of 320 °C. The Xevo TQ-XS triple quadrupole mass spectrometer was operated under 
dry conditions to promote charge transfer ionisation. Nitrogen was supplied by an 
INMATEC PN6000 (Inmatec GaseTechnologie, Germany) nitrogen generator and was 
used as the auxiliary gas, maintained at a flow rate of 200 L/hr. Argon was used as the 
collision gas and maintained at 0.23 mL/min. Cone gas flow was initially set at 290 L/h. 
Corona voltage was set at 2.0 μA. The cone voltage was maintained at 10 V for all 
compounds with a source offset at 30 V. The APGC source was kept at 150°C.  
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3.4.3 GC-APCI-MS/MS analysis of analytes  
 
The applicability of the “soft” ionisation method of the APCI source was tested using 
TMS derivatised cannabinoid standards. As an illustrative example, a comparison of 
the full mass spectrum of THC in EI and APCI ionisation modes can be seen in Figure 3-
8. Unlike with EI, the molecular ion peak of THC (m/z 386) is the most abundant in the 
spectrum when APCI is utilised. This was also the case for all other analytes. A 
comparison of optimised SRM transitions for EI and APCI and their theoretical 
derivatised mass can be found in Table 3-6.  
 
Figure 3-8. A) EI full scan spectrum of THC standard B) APCI full scan spectrum of THC standard 
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Cannabinoid  Theoretical 
Derivatised mass (m/z) 
EI transition 
(m/z) 
APCI transition 
(m/z) 
THC 386.1 386.1 → 371.1 386.1 → 371.1 
CBD 458.3 390.1 → 301.1 458.2 → 390.1 
CBN 382.2 367.1 → 310.1 382.1 → 367.1 
11-OH-THC 474.3 371.1 → 305.1 474.2 → 371.1 
THC-COOH 488.2 488.2 → 371.1 488.2 → 371.1 
Table 3-6. Theoretical m/z for each alanyte with optimised EI and APCI SRM transitions. 
3.4.4 GC-APCI-MS/MS Cannabinoid Standard Calibrations 
 
A calibration rage from 100 ag/µL to 50 pg/µL of all analytes was prepared to assess 
the LOD, LOQ and linear range of the APCI method. Deuterated standards of each 
analyte were added to each calibrant at a concentration of 1 pg/µL. 
Calibration curves were constructed for each analyte by plotting concentration against 
response ratio. The response ratio was calculated as peak area of analyte/peak area of 
d3 standard.  
As can be seen in Table 3-7, all analytes had a LOD ≤ 10 fg/μL, with THC and CBN 
having LODs of 1 fg/μL. All analytes also had a wide linear range across several orders 
of magnitude; the widest being 25-25000 fg/μL for CBD and the narrowest being 5-
1000 fg/μL for THC-COOH and 11-OH-THC. An example of calibration points, standard 
deviation and % error for THC can be found in Table 3-8, all points being less than 
±10%. Figure 3-9 is an example chromatogram of blank BSTFA (a), the derivatised THC 
standard at 1 fg/μL (b) and 1pg/μL (c).    
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Analyte  Limit of detection 
(fg/µL) 
Linear range 
 (fg/µL) 
Coefficient of 
correlation  
THC 1 25-10000 0.998 
CBD 10 25-25000 0.997 
CBN 1 25-1000 0.996 
11-OH-THC 5 
 
5-1000 0.999 
 
THC-COOH 2.5 5-1000 0.998 
 
Table 3-7. Limits of detection, linear range and coefficient of correlation for THC, CBD, CBN,11-OH-THC and THC-
COOH 
Analyte Concentration fg/μL SD % Bias 
THC 25 0.0006 6.3 
 
50 0.0006 1.2 
 
250 0.0029 2.8 
 
500 0.0076 8.2 
 
2500 0.0157 0.27 
 
5000 0.0686 0.13 
 
10000 0.3400 0.47 
Table 3-8. Example of THC standard calibration (n=3) 
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Figure 3-9. Chromatogram SRM transition 378.9→374.2 of a) BSTFA blank (ND) b) 1fg/µL (S:N 8.39), c) 10pg/µL 
(S:N 20341). Retention time and S/N shown above the peak on each Figure. 
 
3.4.5 Spiked hair calibration with GC-APCI-MS/MS 
 
Washed and dried hair extracts of a self-reporting non-user were spiked to prepare the 
following concentrations:  
THC, CBD, CBN - 50, 100, 250, 500, 2500, 10000 fg/µL 
11-OH-THC and THC-COOH - 5, 10, 25, 50, 250, 1000 fg/µL  
All d3 analogues were added at a concentration of 1000 fg /µL 
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 Results of spiked hair calibration with GC-APCI-MS/MS 
 
In contrast to the standard calibrations in section 3.5.2, the deuterated analogues of 
the cannabinoids in a matrix-matched calibration did not give a consistent response at 
1 pg/μL, sometimes being undetectable. The THC d3 analogue was not detectable in 
any of the samples, making quantitation unreliable.  
One approach proposed to minimise matrix effects is to dilute the final extract to be 
injected onto the analytical column. In some instances this method has been reported 
to be effective for reducing signal suppression, while achieving acceptable sensitivity 
during electrospray ionisation of wastewater [267,268].  
In this study diluting the sample from 20 μL to 100 μL improved the signal to noise of 
all analytes, as can be seen in Table 3-8. However, the values were still much lower 
than the standards without the hair matrix. As an illustrative example, chromatograms 
of the d3 analogue without hair matrix (A) in 20mg of hair (B) and diluted 1 in 5 (C) are 
shown in Figure 3-10. 
The hair matrix also affected the retention time of analytes, the most affected being 
CBD with a shift of 0.06 minutes and the least affected being THC-COOH with a shift of 
0.01 minutes.  
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Figure 3-10. A) 1pg/µL THC-d3 standard. B) 20 mg hair extract spiked with 1pg/µL THC-d3 standard. C) sample B 
diluted 1 in 5. Retention times and signal to noise is shown above each peak.    
 
Analyte Without hair Spiked hair sample  Spiked hair sample 
after 1 in 5 dilution 
THC-d3 815 ND 279 
CBD-d3 560 13 45 
CBN-d3 1440 19 228 
11-OH-THC-d3 6869 81 467 
THC-COOH-d3 4188 42 127 
Table 3-9. Signal to noise ratio (1 pg/µL) cannabinoids without hair, in 20mg hair extract, and after 1 in 5 dilution.  
 
Due to these findings a new six-point calibration was made by spiking 20 mg hair 
extracts from a self-reporting non-user to the following: 
THC, CBD, CBN - 50, 100, 250, 500, 2500, 10000 fg/μL  
THC-COOH and 11-OH-THC 25, 50, 100, 500, 5000, 25000 fg/μL  
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All d3 analogues were added at a concentration of 10000 fg/µL  
The final volume of all samples was 100µL. The conversion from fg/µL to pg/mg was 
calculated using the equations below: 
ܥ݋݊ܿ݁݊ݐݎܽݐ݅݋݊ (݂݃/݉݃) =
ܥ݋݊ܿ݁݊ݐݎܽݐ݅݋݊ (݂݃/ߤܮ) × ݏܽ݉݌݈݁ ݒ݋݈ݑ݉݁ (µܮ)
݉ܽݏݏ ݋݂ ℎܽ݅ݎ ݏܽ݉݌݈݁ (݉݃)
 
ܥ݋݊ܿ݁݊ݐݎܽݐ݅݋݊ (݌݃/݉݃) =
ܥ݋݊ܿ݁݊ݐݎܽݐ݅݋݊ (݂݃/݉݃)
1000
 
CBD no longer gave a linear response when in the matrix-matched calibration. This 
suggests that CBD suffers from matrix-related irreproducibility. In addition, repeat 
injections of the same CBD calibrant gave a high standard deviation. All other analytes 
(THC, CBN, THC-COOH and 11-OH-THC) gave a linear response as shown in Table 3-10.  
THC had a limit of detection of 0.5 pg/mg which is lower than the SoHT cut-off of 50 
pg/mg. The upper limit of quantification in this method is 50 pg/mg and so user 
samples may need diluting into the linear range, as THC concentrations in the order of 
ng/mg have been reported previously (see Table 1-3).  
The exact limit of detection for CBD, CBN was not determined, as the lowest calibrant 
(0.25 pg/mg) had a signal to noise ratio greater than 3. This is well below previously 
reported limits of detection (see Table 1-3). Similarly, the lowest calibrant (0.125 
pg/mg) for metabolites THC-COOH and 11-OH-THC also had a signal to noise ratio 
greater than 3. This is higher than some previously reported limits of detection but was 
deemed acceptable as is lower than the SoHT cut-off of 0.2 pg/mg.  
As shown in Table 3-10, the analytes CBN and 11-OH-THC were linear across the whole 
calibration range however, THC and THC-COOH were only linear within the highest 3 
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calibrants. An example of standard deviation and % error for a THC calibration curve is 
given in Table 3-11. 
Analyte  Linear range (pg/mg) Coefficient of correlation (r2) 
THC 2.5 -50 0.999 
CBD N/A 0.869 
CBN 0.25-50 0.999 
11-OH-THC 0.125-125 0.998 
THC-COOH 2.5-125 0.992 
Table 3-10. Linear ranges and coefficient of correlation of THC, CBD, CBN, 11-OH-THC and THC-COOH in spiked 
hair samples  
 
Concentration (pg/mg) SD % Bias 
2.5 0.002 5.9 
12.5 0.005 0.26 
50 0.016 1.17 
Table 3-11. Example of calibration for THC in spiked hair sample (n=3) 
 
3.4.6 Further work 
 
 Investigation and reduction of matrix effect 
 
One area for future investigation is the occurrence of matrix effects and whether these 
vary substantially between different hair donors. The closeness of a match between 
the matrix to be used for calibration and the samples to be investigated is of great 
importance in achieving reliable and accurate results [266]. Matuszewski et al. 
demonstrated a high variability of matrix effect among different lots of plasma and 
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highlighted the need to investigate the relative matrix effect which can reveal 
differences in response among various lots of the same matrix [269]. It is reasonable to 
assume that hair, which is a complex matrix, may also result in variability of matrix 
effects between different hair types (ethnic groups, colour, damage, heat and chemical 
treatment) and should be thoroughly investigated before this technique is 
incorporated into casework.  
Another strategy to reduce matrix effects is to ensure that the maximum amount of 
analyte is extracted from the digest with minimal matrix. This may be achieved by 
using a more specific extraction method such as molecularly imprinted solid phase 
extraction (MISPE). A method for the extraction of THC, CBD, CBN and THC-COOH from 
oral fluid and urine using MIPSE has recently been reported by Cela-Perez et al. [270]. 
In addition, Gonzalez et al. have also recently utilised MIPSE to extract THC,CBD,CBN, 
THC-COOH and 11-OH-THC from plasma and urine [271]. The use of MIPs as SPE 
sorbent allows a rapid, simple, and effective and selective extraction compared to 
traditional SPE since they are materials prepared in the presence of a target analyte or 
closely related species that serves as a mold for the formation of complementary 
binding sites. Both studies reported increased sensitivity when using MISPE.  
Matrix effects may also be reduced by utilising two-dimensional (GCxGC) gas 
chromatography. Comprehensive GC×GC allows the whole chromatogram to be 
transferred onto a secondary column. It has been recognised as a technique capable of 
providing improved resolution of complex matrices compared to conventional single 
dimensional GC (1D-GC) [272]. This was demonstrated for a variety of drugs (including 
CBN) in hair samples in a study conducted by Guthery et al. In the study, endogenous 
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compounds, long chain fatty acids, and amides were detected with much greater signal 
intensities than the drug and metabolite compounds. However, drug compounds were 
clearly resolved from the interfering matrix compounds when compared to 1D-GC 
[263].  
Prior to introduction into a toxicology workstream there are several steps that need to 
be taken for the method to be fully validated. These include the determination of 
inter-day and intra-day accuracy and precision and the use of using quality control (QC) 
samples. A full review of the steps needed for method validation has been conducted 
by Peters et al.[273]. 
3.4.7 Discussion and conclusions  
 
The use of APCI has been evaluated as an alternative source for GC-MS/MS analysis of 
cannabinoids in hair samples. In contrast to EI ionisation, molecular ions were the most 
abundant in the mass spectrum. The molecular ions are highly favourable as a 
precursor ion in MS-MS and in this study improved sensitivity compared to GC-EI-
MS/MS. Instrumental LODs of between 1 and 10 fg/µL were achieved for all analytes. 
The response was repeatable and linear (<15% error) over several orders of 
magnitude.  
The hair matrix was found to affect detection for all analytes, causing suppression of 
signals and a retention time shift. Signal suppression of up to a factor of 85 was 
observed in certain cases. After dilution, LODs of 0.125 pg/mg could be achieved in 
matrix-matched samples for some analytes. All analytes were detected at 
concentrations well below SoHT requirements (50 pg/mg and 0.2 pg/mg for THC and 
THC-COOH, respectively) and therefore this study demonstrates the advantages and 
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applicability of APCI as new source for GC-MS/MS detection of cannabinoids in hair 
sampels. The main limitation of the technique was the fact that CBD could not be 
quantified due to matrix-related irreproducibility. Reducing matrix effects should 
therefore be a priority in future investigations.  
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Chapter 4. Application of atmospheric pressure chemical 
ionisation gas chromatography mass spectrometry to detect 
cannabinoids in hair samples  
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4.1 Introduction  
 
In this section the GC-APCI-MS/MS method developed in Chapter 3 will be applied to 
participant-derived hair samples. These samples were collected in the context of a 
study into the age of onset of cannabis use and executive function. The researcher 
sought to use hair samples to confirm participant answers from lifestyle questionnaires 
on recent cannabis use. 
Recent studies to detect cannabis use in hair samples exclusively analyse THC, CBD, 
CBN or the metabolite THC-COOH, possibly limiting the amount of information gained 
before the difficult process of interpretation of analytical findings can begin.  
Due to difficulties in simultaneous detection of THC and metabolites several studies 
have solely analysed THC-COOH [122–125] and so the presence of THC in addition to 
THC-COOH has not been considered in interpretation of  analytical findings.  
In this study all the previously detected analytes and an additional THC metabolite (11-
OH-THC) are simultaneously analysed and reported for the first time in real user hairs. 
There is currently no consensus in the scientific community about what constitutes a 
positive result for the detection of cannabis use.  Therefore, this study will include an 
evaluation into the different strategies proposed in literature: 
 Detection of metabolites 
 The use of cut-offs 
 Wash residue analysis 
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4.2 Methods and Materials  
 
Methods for decontamination of hair, extraction of analytes and derivatisation prior to 
analysis were performed as previously described in chapter 3. The instrumentation 
was also used as described in Chapter 3. Additional methods and materials unique to 
this chapter can be found below.  
 
4.2.1 Hair Samples 
 
Hair samples were obtained from individuals in the context of a study into the age of 
onset of cannabis use and executive function. The hair sample collection was approved 
by the Sheffield Hallam University Research Ethics committee (SHU ethics number 13-
2011). Written and informed consent was obtained from all participants. All results 
were anonymised.  
Some participants had self-reported cannabis use, some had not and were included in 
the studies' control group. In the interest of preventing bias, self-report data was not 
available until after GC-APCI-MS/MS analysis.  
Hair was stored at room temperature in foil to prevent UV damage for approximately 5 
years before analysis. 10-20 mg of hair was analysed, due to a lack of samples weighing 
20 mg or more.  
Of the 70 samples submitted for analysis, 63% (44) were excluded as sample weighed 
less than 10 mg which is presumed to be insufficient for analysis [274].  
Based on self-report data, samples were divided into three categories for 
interpretation. Non-user, infrequent user (fewer than 10 lifetime cannabis cigarettes) 
and frequent users (greater than 10 lifetime cannabis cigarettes, with a mean of 1000).  
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4.2.2 Preparation of wash residue  
 
The wash residues obtained from the decontamination procedure as described in 
Section 1.3.8.3 were transferred into a new vial and dried under nitrogen at 45°C 
before derivatisation with BSTFA as described in Section 4.2.4 prior to analysis.  
 
4.3 Results of hair analysis and concordance with self-report data 
 
Of the 70 participants originally recruited, 26 had hair samples above 10 mg and were 
included in the analysis. Over one third (43%) of the samples (n=11) were non-users of 
cannabis, 38% (n=10) were infrequent users and 19 (n=5) were frequent users. Full 
details of the concentrations of THC, CBD, CBN, 11-OH-THC and THC-COOH in each 
usage grouping can be found in Appendix I.   
The results of the GC-APCI-MS/MS analysis are summarised in Table 4-1. 
Concentrations of THC and CBN were substantially lower than had been reported 
previously (in the pg/mg rather than ng/mg range as shown in Table 1-2). The 
concentration of THC-COOH was also lower than previously reported, with none of the 
detected concentrations being above 0.5 pg/mg. 
It is not possible to compare 11-OH-THC concentration with literature values since this 
compound is rarely reported in literature. Moreover, where 11-OH-THC has previously 
been detected in hair samples, the limit of detection was 1 pg/mg of hair [155] which 
is greater than the concentrations detected in this study. In other studies, the limit of 
detection was not reported [156]. 
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Table 4-1. Concentration ranges and mean concentrations of THC, CBD, CBN, 11-OH-THC and THC-COOH detected 
in participant hair samples analysed with GC-APCI-MS/MS.  
Out of a total of 26 samples, only three did not have any of the analytes detected. Of 
these, two were from self-reported non-cannabis users and one was from a self-
reported frequent user (an average of 2 joints a day); CBD, CBN and THC-COOH was 
detected in the wash residue of this sample.   
Conversely, only one sample had all analytes detected. This individual had self-
reported to use an average of one joint a day and had reported 2-3 days between last 
use.    
In 10 samples THC was detected, however metabolites were not, suggesting external 
contamination or infrequent usage of cannabis. Of these 30% fell into the frequent 
cannabis user category, 40% in the infrequent user category and 30% in the non-user 
category. This suggests that THC detection alone is not a reliable usage discriminator. 
No samples had metabolites detected without also having THC detected. However, in 
three out of the seven samples in this group THC was only detected in trace amounts 
(below the LOQ). This poses an interesting interpretational dilemma, if the metabolites 
are only generated in-vivo should the detection of these metabolites indicate usage, 
Analyte Detected 
samples 
Samples below 
LLOQ 
Concentration 
ranges 
(pg/mg hair) 
Mean 
Concentration 
(pg/mg hair) 
THC 18 9 1.28-31.40 9.20 
CBN 23 1 1.30-18.19 3.56 
11-OH-THC 3 0 0.21-0.32 0.27 
THC-COOH 5 0 0.16-0.42 0.32 
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even if the parent compound is detected only at trace levels? It is worth noting that 
two out of three of these samples were from self-report non-users.  
CBD was detected in six samples, due to non-linearity of response with hair samples 
(see Section 3.4.5) quantitation of CBD was not possible. In all cases where CBD was 
detected, CBN and THC were also detected. Four of these samples were from self-
declaring frequent users, however two of these samples were from self-reporting non-
users of cannabis. 
The metabolite 11-OH-THC was detected in three samples. All samples in this category 
came from declared cannabis users. In only one of the three samples where the 
metabolite 11-OH-THC was detected, THC-COOH was also. This would result in a false 
negative by interpretational methods which only use the results of THC-COOH analysis.  
CBN was detected in all but three samples. Whilst CBN is known to be a degradation 
product of THC in resin [228,229] and plant material [230] it was surprising to detect 
CBN on 82% of hair samples provided by individuals who self-report never to have 
used cannabis.  
Carryover of CBN was excluded due to the lack of signal in blank samples which were 
put into the run after every four participant samples. In addition, 12% of samples (n=3) 
did not have CBN detected, which suggests that the reagents used were not the cause 
of the signal. Chromatographic separation with additional MS-MS data is thought to be 
gold standard in compound identification and so further investigations whether the 
source of CBN is a commonly encountered interference or exposed hairs should be 
conducted.  
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There is a lack of research articles on the degradation of THC in hair samples. Skopp et 
al. conducted a study where hair samples were exposed to sunlight for 10 weeks. 
Contrasting to studies in plant and resin material, the authors found that 
concentrations of THC, CBD and CBN decreased over the course of the study and 
hypothesised that CBN was further degraded to other compounds.   
There are no studies on the stability of cannabinoids in hair samples stored for 5 years 
or stored in darkness. In the absence of this literature, it may be reasonable to assume 
that: 
a) the original concentrations of THC in the hair samples decrease over time 
b) THC degrades to other products in addition to CBN, therefore the THC and CBN 
concentration in degraded material will not equal the original THC 
concentration of the fresh sample   
In addition to CBN being a degradation product of THC, several other studies of have 
reported a higher concentrations of CBN than THC or CBD [108,113,242], possibly due 
to hair being exposed to sunlight before sample collection.  
In two studies which had control groups CBN was not detected, however limits of 
detection were much higher than the GC-APCI-MS/MS  (LODS of 0.025 ng/mg [117] 
and 0.15 ng/mg [108] compared to 0.00025ng/mg with GC-APCI-MS/MS).  
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4.4 Discussion of published reporting criteria  
 
4.4.1 Recommended cut-offs.  What is their value?  
 
Cut-off levels are essential in any toxicological analysis. The cut-off is the point at 
which a result is either reported to be positive or negative. This value should optimise 
drug detection but minimise the number of false positives. It is important to note that 
a sample which is reported to be negative does not have to be drug-free but it may 
have the drug detected at a concentration below the defined cut-off.  
The society of hair testing recommend a THC-COOH cut off of 0.2 pg/mg [145], the FDA 
recommends a cut off of 0.1 pg/mg [275] whilst SAMSHA recommend a cut off of 0.05 
pg/mg  for the detection of THC-COOH [276].  
The SoHT also recommend cut off of 50 pg/mg for THC. There are no reported 
guidelines for CBN, CBD or 11-OH-THC but since CBN and CBD are also found in plant 
materials and cannabis smoke it is reasonable to assume the cut-off for these analytes 
would be 50 pg/mg. Similarly, there are no guidelines for the cut-off value of 11-OH-
THC. It is assumed the cut off would be 0.2 pg/mg of hair as with the metabolite THC-
COOH.   
In this study four samples had a THC-COOH concentration greater than 0.2 pg/mg of 
hair; two of these samples belonged to regular users and two belonged to self-
reporting non-users.  
Two additional samples had a concentration of 11-OH-THC greater than the assumed 
0.2 pg/mg of hair cut off, both samples belonged to self-reporting regular cannabis 
users.  
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No samples in this study had a THC, CBD or CBN concentration greater than the 
recommended cut off for THC, possibly due to the age of the hair samples.  
In the case of hair samples, the origin of recommended cut-offs is questionable. The 
SoHT guidelines state that the cuts offs are: 
"Based on previous guidelines and the available literature on drug concentrations in 
hair from drug users"- Cooper, G.A., Kronstrand, R. and Kintz, P., 2012. Society of Hair 
Testing guidelines for drug testing in hair. Forensic Science International, 218(1-3), pp.20-24. 
 
It is important to note that these guidelines were published in 2012 and have not been 
updated since. It is unclear exactly which literature the guidelines were based on, 
however given the available literature at the time it can be assumed that there was a 
relatively small number of studies, each with differing wash, extraction, derivatisation, 
and analytical techniques. Moreover, studies are often based on results of individuals 
who are suspected to be drug users, and so are not necessarily reflective of the 
general population. It also appears that the cut-offs are heavily influenced by the 
sensitivity of instrumental methods at the time of writing, rather than based on 
scientific evidence as can be seen from the following quote: 
"The higher sensitivity of the instrument method enables us to lower the cut off of THC 
from 0.1 to 0.05 ng" - Nadulski, T. and Pragst, F., 2007. Simple and sensitive determination of 
Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in hair by combined silylation, headspace 
solid phase microextraction and gas chromatography–mass spectrometry. Journal of 
Chromatography B, 846(1-2), pp.78-85. 
 
Since the GC-APCI-MS/MS method reported in this study allows detection of 
cannabinoids at concentrations much lower than the recommended cut-offs it begs 
the question, should the recommended cut-offs be amended? Is it possible for an 
instrument to be too sensitive when it comes to analysing cannabinoids in hair, given 
the compounds low incorporation rate [45]? It also asks the question what does it 
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mean to detect such a low level of cannabinoids (usage, association with, or the 
amount that can be expected in the general population)?  
 
4.4.2 Wash residue analysis 
 
Tsanaclis and Wicks proposed using the wash residue obtained from the 
decontamination procedure as a strategy to differentiate between external 
contamination and usage of cannabis when metabolites are not detected [162]. In the 
study, the concentration of THC in the wash residue was compared to the 
concentration of THC in the hair after the completion of washing procedures. It was 
claimed that wash ratios of zero (i.e. no drug found in the wash procedure) suggested 
drug use was likely, while ratios greater than 0.1 and less than 0.5 indicated drug use 
was 'possible' and ratios greater than 0.5 meant that drug use was 'questionable' 
(Table 4-2).  
 
Table 4-2. Guidelines for the interpretation of results of the analysis of hair samples and wash residues based on 
the authors’ laboratory results in cases when parent drug is present and the relevant metabolite is not Taken 
from Tsanaclis and Wicks [162]. 
 
The method as proposed by Tsanaclis and Wicks was used to analyse samples in this 
study and findings are reported below: 
 THC wash residue analysis  
 
Of the eligible samples (n=4) where THC was quantifiable in both wash and hair, three 
samples had a wash to hair ratio greater that 0.5 therefore have "questionable" drug 
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use and so the interpretation should be "Not sure of drug use; indicates association 
with drugs". All the samples in this category were from frequent cannabis users.   
One sample had a wash to hair ratio of 0.26 which puts the sample in the "possible" 
drug use category. The interpretation should be "might have used drug; indicates 
association with drug". This sample was the only sample to have all 5 analytes detected 
and was from a frequent cannabis user.  
 CBN Wash residue analysis  
 
Whilst the method in the Tsanaclis and Wicks study was only applied to THC 
concentrations, in this study the method is also applied to CBN. Since the samples were 
stored a long time prior to analysis it is possible that THC present in the hair at the time 
of collection has degraded to CBN (see Section 4.3.2).  
CBN was detected in the wash and hair of 23 of the 26 samples. The majority (16) had 
a hair to wash ratio greater than 0.5 and so were in the "questionable; not sure of drug 
use” category. These samples belonged to participants in all three groupings of usage. 
Four samples had a ratio between 0.1 and 0.5 and so were in the "possible" drug use 
category, both samples were from frequent users.  
Three samples had a CBN wash to hair ratio <0.1 and so are in the "drug use likely" 
category. Two out of three of these samples were from non-users and one was from an 
infrequent user, suggesting the wash ratio of CBN for aged samples is not an accurate 
indicator of usage.  
  Metabolite wash residue analysis 
 
Whist THC-COOH was detected in some hair samples, 11-OH-THC was detected in 
more wash samples, as shown in Figure 4-1. 11-OH-THC was detected in both the wash 
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residue and hair of some samples whereas THC-COOH was exclusively detected in the 
hair or the wash residue.  
Two cannabis users had metabolites present in the wash residue, but not in the 
corresponding hair sample. On the other hand, three non-users had metabolites in 
wash residue. Therefore, assuming self-report is correct, wash residue analysis of 
metabolites is not an accurate indicator of usage.  
In this study there was a greater concentration of metabolites found in wash residues 
than in hair samples as shown in Figure 4-2. Since metabolites are not produced in the 
cannabis smoke it could be suggested that the detection of metabolites in wash 
residue is also indicative of cannabis usage, however further investigations with a 
larger sample size is needed to test this hypothesis.  
 
Figure 4-1. Number of samples where THC-COOH and 11-OH-THC are detected in the wash residue, hair sample, 
and in both hair and wash. 
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Figure 4-2. Mean concentrations detected of (left) 11-OH-THC in har samples (n=3) and washes (n=6) and (right) 
THC-COOH hair (n=6) and washes (n=4)  
 
4.5 Determination of positive samples  
 
There are many different methods of interpretation which can make assigning a hair 
sample as positive or negative for cannabis use problematic. These methods include 
the detection of metabolites, the use of cut-offs, and the analysis of wash residue. In 
this study each method of interpretation has been applied to the participants of the 
psychology study and compared with the self-report data using methods described 
above. A summary of the evaluations can be seen in Table 4-3.  
Of note is detection of metabolites in relation to the number of "positive" samples. 
Whilst the detection of any metabolite in hair or wash residue yields 12 positive 
samples, only one of these samples remains positive if both THC-COOH and 11-OH-THC 
are both detected in the hair sample. This sample belongs to a frequent cannabis user.  
On the other hand, five non-users would be reported as having a positive sample if 
either metabolite was detected in wash or hair, however none of these samples would 
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remain positive criteria was that both THC-COOH and 11-OH-THC had to be detected in 
the hair sample.  
There is also a discrepancy between the number of positive samples depending on 
which metabolite cut off is applied. Given the potentially life changing consequences 
for a positive sample, a consensus based on scientific investigation should be reached.  
The THC hair/wash residue analysis technique did not identify any participants and 
being likely to use drugs. This may in part be due to the time elapsed between sample 
collection and analysis (5 years).  
Table 4-3. Comparison of self-report data with different methods of interpretation for frequent cannabis users 
(n=10), infrequent users (n=5) non-users (n=11) 
 
 
Interpretation method Total No. 
of positive 
samples  
Total No. 
of positive 
(frequent 
users) 
Total No. of 
positive 
(infrequent 
users) 
Total No. of 
positive 
(non-users)  
Any Cannabinoid or metabolite detected 23 9 5 9 
Any metabolite detected hair or wash  12 6 1 5 
Any metabolite detected in hair  7 5 0 2 
THC-COOH only detected hair 4 2 0 2 
11-OH-THC only detected hair 2 2 0 0 
THC-COOH and 11-OH-THC detected in hair  1 1 0 0 
Metabolites above SoHT cut-off  6 4 0 2 
Metabolites above FDA cut-off  7 5 0 2 
Metabolites above SAMHSA cut off  7 5 0 2 
THC, CBD and CBN detected in hair  6 4 0 2 
THC, CBD, CBN above SoHT cut-off  0 0 0 0 
THC Wash ratio >0.1 and <0.5 (possible 
dug use) 
1 1 0 0 
THC Wash ratio 0 and <0.1 (likely drug use)  0 0 0 0 
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4.5.1 Further work 
 
One area for further research is to investigate whether certain wash protocols remove 
metabolites from hair, rather than just removing externally bound smoke 
contamination. As yet there are no specific guidelines on wash protocols for the 
detection of cannabis use in hair, and the few studies that have been conducted in this 
area have exclusively investigated THC and not metabolites.   
Given the lack of current literature, another avenue for future investigation is to study 
whether cannabinoids in hair samples are in fact stable, and if so, for how long.  
Finally, an additional biomarker of cannabis use (such as urine testing) would be useful 
in this type of investigation to confirm or refute self-report data as it is known that it 
can be unreliable.  
4.5.2 Conclusions 
 
The GC-APCI-MS/MS method previously optimised in Chapter 3 was successfully 
applied to authentic user hair samples for the first time. No single analysis method 
could identify all 10 self-declared users. According to self-report data, 11-OH-THC was 
the only indicator of cannabis use without also incurring false positives, on the other 
hand there were many false negatives using this interpretation method (n=7). THC-
COOH was detected in 18% (n=2) of the self-reporting non-cannabis users.  
Evaluation of the reporting criteria for cannabinoids in hair samples showed that a 
different number of samples would be considered to be positive for cannabis use 
depending on which interpretation method was used.  
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Chapter 5. Overall Conclusions 
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5.1 Background to investigations 
 
Hair differs from other human materials used for toxicological analysis such as blood or 
urine because of its substantially longer detection window (months to years) enabling 
retrospective investigations of drug consumption. Due to its solid and durable nature, 
hair analysis can be performed even centuries after growth. Other advantages of hair 
analysis include the non-invasive nature of collection, which is of particular importance 
in infant/child investigations, and also the ease of sample storage.  
Although hair analysis offers the potential to reveal information which is not possible 
with other biological matrices, it also suffers from some unique limitations that can 
make interpretation of findings challenging. These are largely due to exposure of hair 
to the environment before analysis takes place.  
Existing analytical techniques allow detection and quantification of cannabinoids in 
hair samples. These techniques include GC-MS/MS and LC-MS/MS. Recent studies 
exclusively analyse THC, CBD, CBN or the metabolite THC-COOH, limiting the amount 
of information gained before the difficult process of interpretation of analytical 
findings.  
Recently, MALDI-MS analysis of hair samples has been suggested as an alternative 
technique to traditional methods such as GC-MS. This is due to reduced sample 
preparation, the ability to detect a narrower time frame of drug use and a reduction in 
sample amount required for analysis. In addition, MALDI-MS offers the unique 
opportunity of being able to analyse a longitudinally sliced hair to detect xenobiotics 
inside the hair itself, possibly eliminating the interpretational issues associated with 
exposure to the environment.  
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However, despite cannabis being the most commonly used illicit drug worldwide, a 
MALDI-MS method for the detection of cannabinoids in a single hair had not been 
reported. At the commencement of this research MALDI-MS had only been applied to 
the analysis of cocaine, methamphetamine, ketamine and nicotine in relation to hair 
testing. These compounds are both more readily incorporated into hair [45] and more 
easily ionisable using MALDI than cannabinoids [277];  posing a difficult challenge in 
the development of a technique to detect cannabinoids using MALDI-MS.   
 
5.2 MALDI-MS and MALDI-MSI method optimisation  
 
5.2.1 CHCA was the optimal matrix for the detection of THC 
 
An in depth literature review revealed that MALDI matrix is the "key to success" [175], 
however finding the right matrix for analytes is unfortunately a trial and error process 
[195]. During this study the matrix selection and the use of additives were investigated 
to develop a suitable method for detection of cannabinoids in hair samples using 
MALDI-MS. It was found that CHCA with the additive aniline gave the highest signal 
intensities for THC, however ionisation efficiencies for underivatised cannabinoids 
were poor, as also described by Groeneveld et al. [197].  This led to an investigation 
into in situ derivatisation. 
 
5.2.2 THC underwent a laser induced in-source re-arrangement  
 
THC underwent an in-source re-arrangement producing another species which was 
detected at approximately the same intensity as the analyte. This would theoretically 
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have the effect of impairing detection. To investigate this phenomenon further, LC-
MS/MS analysis of the THC standard was performed. A single peak in the 
chromatogram confirmed the purity of the THC standard and MS/MS analysis support 
the hypothesis that the THC molecule loses two hydrogens as free radicals during an 
in-source re-arrangement as a result of the energy from the laser source. To further 
investigate the influence of the laser on the molecule an experiment was carried out 
with increasing laser power. As the laser power increased the ratio of m/z 313 
(corresponding to the re-arranged THC molecule) to 315 (corresponding to THC) signal 
intensity increased.  
 
5.2.3 Derivatisation of THC improved signal intensity  
 
Derivatisation had been identified as a possible strategy to improve signal strength and 
decrease matrix interference [142]. Despite the derivatisation of cannabinoids being 
commonplace for GC-MS analysis, a review of the literature revealed that this 
approached had not been tried for MALDI-MS.   
The target for the derivatization was the hydroxyl group since all cannabinoids of 
interest contain this functional group. After carefully reviewing the literature, 
derivatization using 2-Fluoro-1-Methylpyridinium p-tolunesulfonate (FMPTS) to form 
N-methylpyridinium derivatives was chosen. Derivatisation was successful and 
improved signal intensities of peaks corresponding to the analytes. CBD has two 
hydroxyl groups whereas THC has only one, so the detection of a peak at m/z 483.32 
(related to CBD with the addition of two derivatisation groups) in the CBD spectrum 
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allowed for differentiation between THC and CBD, which would not be possible 
without derivatisation.  
 
5.2.4 Spaying of derivatisation reagent allowed in situ derivatisation and 
MALDI-MS-imaging  
 
During initial MALDI-MSI experiments the THC compound had been delocalised from 
the hair and into the surrounding matrix. It was hypothesised that the delocalisation of 
the analyte could be due to too large a volume of derivatisation reagent being spotted 
on top of the hair sample. To test this hypothesis a hand sprayer was used to supply a 
fine mist of the derivatisation reagent before spraying the sample with CHCA matrix 
using an automated sprayer. Following this method of derivatisation, delocalisation of 
the analyte did not occur. Hairs spiked with THC, CBD, CBN, 11-OH-THC, THC-COOH 
and THC-COO-gluc were successfully derivatised and imaged for the first time.  
 
 THC can be detected on single hairs exposed to cannabis smoke using 
MALDI-MSP and MALDI-MSI  
 
In both MALDI-MSP and MALDI-MSI experiments, m/z 406 corresponding to THC was 
observed on hair exposed to cannabis smoke.  No m/z 406 was detected on blank 
unexposed hair. Whilst these are preliminary findings in unrealistic smoking 
conditions, the result suggests that MALDI could be used to investigate how exposure 
to cannabis smoke affects the levels of cannabinoids found in hair samples. In 
particular, analysing longitudinal slices of hair exposed to cannabis smoke could give 
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insight into whether or cannabinoids penetrate the hair cortex, and which 
decontamination procedures are most effective.  
 
5.2.5 MALDI-MS and MALDI-MSI Further work  
 Matrix selection and application  
 
Whilst several different approaches including matrix selection and the use of additives 
were investigated in this study to develop a suitable method to detect cannabinoids in 
hair samples using MALDI-MS, many more remain untried. Of particular interest could 
be halogen-substituted CHCA [278,279] and other liquid ionic matrices [280]. 
Investigation into a more suitable matrix could yield greater signal intensities, which 
could in turn lower the limit of detection.  
There are also many matrix application techniques that have not been assessed in this 
body of work. These include sublimation and acoustic matrix deposition. In future 
experiments these application techniques should be trailed alongside the automated 
spraying method described in this work to determine the optimum technique in terms 
of matrix homogeneity and signal intensity of analytes, whilst avoiding delocalisation 
of analytes.   
 
 Derivatisation 
 
Further work includes optimisation of the derivatisation method to assess whether it is 
possible to completely derivatise CBD. In this current study CBD is detected as both a 
singularly and doubly derivatised compound. The singular derivatisation m/z is 
 
168 
 
identical to singularly derivatised THC, and so complete derivatisation of CBD is 
necessary for differentiation of the two analytes. Experiments could include 
investigating the effect of different time points and reaction temperatures in solution.  
 
 Quantitation 
 
In the MALDI aspect of this study quantitation of cannabinoids was not attempted. 
MALDI-MSP and MALDI-MSI both have limitations in terms of quantitation. These 
include the inability to control for tissue-specific ion suppression and the 
irreproducibility of ion signals from scan to scan [281]. These limitations can be caused 
by numerous factors including tissue heterogeneity, matrix crystal heterogeneity and 
laser power fluctuations.  
In recent years the use of internal standards has facilitated the quantitation of a 
variety of analytes in a range of tissue types [193,282–293] and so quantitation of 
cannabinoids in hair samples using MALDI-MSI could be possible future line of 
investigation. 
 Direct comparison with established techniques  
 
Prior to integration into a toxicology workflow a larger sample of user hairs, from 
different levels of users and with different hair types should be tested and the relative 
levels of each metabolite reported. Initially these should run in parallel with well-
established techniques such as GC-MS/MS or LC-MS/MS to validate the MALSI-MSI 
method.   
 
 
 
169 
 
 Smoke and plant material contamination experiments 
 
Preliminary studies suggest that contamination with cannabis smoke can be detected 
using MALDI-MS and MALDI-MSI. Further investigations using more realistic smoking 
conditions such as those proposed by Röhrich et al. [132] should be conducted. These 
investigations could lead to the detection of new markers of smoke exposure.  
 
 Application of technique to other sample types  
 
Further work includes the application of the derivatisation method proposed in this 
thesis to other compounds and tissue types.  
Since derivatisation occurs with phenol moieties, this technique could be extended to 
other biologically relevant analytes such as oestrogen, or xenobiotics including 
synthetic cannabinoids.    
In addition, the method developed in this study could be used on tissues other than 
hair. For example, preliminary studies on finger marks suggest that the derivatisation 
technique enhances the signal from THC that was on the finger, whilst keeping ridge 
detail intact. Furthermore, finger marks were also shown to contain THC after handling 
of plant material (data not shown).  
 
5.3 GC-MS/MS method optimisation  
 
Since MALDI-MS is not yet a quantitative method of analysis of cannabinoids in hair 
samples, the well-established technique of GC-MS/MS was optimised and used to 
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investigate cannabinoids in hair samples collected for a psychology study. The use of 
GC-MS/MS also allowed for comparisons with previously reported values.  
 
5.3.1 BSTFA was the optimal derivatisation reagent 
 
Whist THC, CBD and CBN could be detected without derivatisation 11-OH-THC and 
THC-COOH could not. THC, CBD, 11-OH-THC and THC-COOH showed an increased peak 
area with all derivatisation techniques compared to no derivatisation. CBN showed an 
increase in peak area with all derivatisation reagents apart from with PFPA/PFOH. 
BSTFA derivatisation gave the largest peak area and peak height for all cannabinoids. 
Based on peak shape, retention time and response BSTFA was chosen as the 
derivatisation reagent for future experiments.  
 
5.3.2 GC-APCI-MS/MS improved limits of detection and quantitation 
compared to GC-EI-MS/MS  
 
During GC-EI-MS/MS investigations, the limit of detection for THC, CBD and CBN was 
below the SoHT recommended cut off. However, the linear range was narrow. Whilst 
11-OH-THC and THC-COOH were both detected at the SoHT limit of 0.2 pg/mg, neither 
analyte gave a linear response using any three points in the calibration range and so 
quantitation using this method was not possible.  
Without the hair matrix 11-OH-THC gave a linear response between 0.16 and 10 pg/µL 
THC-COOH gave a linear response between 0.31 and 10 pg/µL. This suggests that 
matrix effects are larger at lower analyte concentrations, and that the higher 
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concentrations of THC, CBD and CBN mean matrix effects has less of an effect on 
overall analysis.  
During GC-APCI-MS/MS experiments all analytes and were detected and quantifiable 
in the fg/µL range, with linear ranges spreading several orders of magnitude. However, 
in spiked hair calibrants matrix effects were apparent as concentrations that could be 
detected using standards (1 pg/µL) were undetectable when the matrix was added. 
Matrix effects were in part lessened by the dilution of hair samples. Limits of detection 
and quantitation were below the suggested SoHT cut off.  
 
5.3.3 THC, CBD, CBN THC-COOH and 11-OH-THC were simultaneously 
detected in authentic hair samples    
 
Hair samples were collected in the context of a study into the age of onset of cannabis 
use and executive function.  
Out of 26 samples, three did not have any analytes detected. Only one sample had all 
analytes detected. Concentrations of THC, CBD and CBN were substantially lower than 
had been reported previously (in the pg/mg rather than ng/mg range). The 
concentration of THC-COOH was similar to previously published articles with two 
sample concentrations being above 0.2 pg/mg, the cut off recommended by the 
society of hair testing. 
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 Concordance with self-report   
 
Out of a total of 10 samples in the self-report "cannabis user" group, THC-COOH was 
detected in just 20%. The metabolite 11-OH-THC was detected in a different 20% of 
samples whilst 10% of samples had both THC-COOH and 11-OH-THC detected.  
Therefore, 50% of the samples in the cannabis user group were identified by the 
presence of THC metabolites in the hair. Analysis of the washes to determine the ratio 
of cannabinoids in wash residue compared to that detected in the hair samples, 
proposed as an additional way of identifying positive samples, failed to identify any 
additional positive samples in this group.  
Metabolites were not detected in any of the infrequent cannabis users (n=5) and as 
above, the wash ratio analysis did not identify any samples as positive.   
Surprisingly, metabolites were detected in 2 of the 11 samples provided by individuals 
who self-reported not to have used cannabis in their lifetimes.  
If the self-report data is accurate, this reveals a worrying number of both false 
positives and false negatives in the various interpretation methods to detect cannabis 
use. A limitation of this study is that the time since last use was not known beyond one 
week prior to collection.  
 
5.3.4 Further work for GC-MS/MS analysis 
 
Further work includes an in-depth analysis of matrix effects in hair samples and 
strategies to reduce them. For example, a lower initial amount of hair may help to 
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overcome matrix effects, as well as having the practical advantages associated with 
smaller sample size. 
There is a distinct lack of research published relating to how the physical condition of 
the hair could affect matrix effects. Other aspects such as dyeing, bleaching, heat 
damage and ethnicity of hair should also be assessed in future work.    
Further work may also include investigations into whether two-dimensional-GC could 
separate hair matrix interferences away from analytes and allow for more efficient 
ionisation, which is less prone to matrix effects. This was suggested as a potential 
analytical technique for use in hair samples by Guthery et al. [294], however its 
application to cannabinoids in authentic hair samples has not yet been explored.  
Finally, with current technologies allowing for lower limits of detection and 
quantitation of cannabinoids in hair samples, experiments need to be conducted into 
assessing scientifically derived cut-offs, rather than instrumental ones.  
 
5.4 Concluding remarks 
 
The scientific findings in this thesis have contributed novel research and furthered 
knowledge in the fields of matrix-assisted laser desorption mass spectrometry and in 
the analysis of cannabinoids in hair samples. In addition, the PhD project has raised 
questions around the reporting criterion for positive hair samples and highlighted new 
avenues for future study.  
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Publications, presentations and posters  
Peer review publications  
Full copies of these publications can be found in Appendix II 
Beasley, E., Frances, S. and Bassindale, T., 2016. Detection and mapping of 
cannabinoids in single hair samples through rapid derivatization and matrix-assisted 
laser desorption ionisation mass spectrometry. Analytical chemistry, 88(20), pp.10328-
10334. 
Flinders, B., Beasley, E., Verlaan, R.M., Cuypers, E., Francese, S., Bassindale, T., Clench, 
M.R. and Heeren, R.M., 2017. Optimization of sample preparation and instrumental 
parameters for the rapid analysis of drugs of abuse in hair samples by MALDI-MS/MS 
imaging. Journal of the American Society for Mass Spectrometry, 28(11), pp.2462-2468. 
Oral presentations  
Rapid derivatisation for the detection of cannabinoids in hair samples using MALDI-
Imaging Mass Spectrometry presented at the British Mass Spectrometry Society 
Special Interest Group meeting for Imaging Mass Spectrometry, Sheffield, UK 
5.5 Poster Presentations 
Beasley, E., Frances, S. and Bassindale, T. Detection and Mapping of Cannabinoids in 
Single Hairs Through Rapid derivatisation MALDI-Imaging Mass Spectrometry 
presented at the International Association of Legal Medicine, Venice, Italy, 2016. 
Beasley, E. Morgan G., Bassindale, T. Development of Offline and Fully Automated 
Sample Preparation Methods for Analysis of Cannabinoids in Hair Samples. Presented 
at the 65th American Society for Mass Spectrometry, IdIndianapolis, USA.
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Appendix I
 
 
 
 Sample THC 
(H) 
CBD 
(H) 
CBN 
(H) 
11-OH 
(H) 
COOH 
(H) 
THC 
(W) 
CBD (W) CBN (W) 11-OH 
(W) 
COOH 
(W) 
Time since last use Est lifetime use  
(cannabis 
cigarettes) 
A 27.84 + 18.19 0.21 ND 22.57 59.31 229.86 1.90 ND 2-3 days 1350 
B 13.65 + 9.25 0.27 ND 6.98 115.66 246.38 6.68 ND 2-3 days 1800 
C <LOQ ND 1.4 ND 0.16 ND 6.59 1.08 ND ND >1 week 10 
D 31.39 + 15.45 0.32 0.32 8.24 ND 6.85 ND ND 2-3 days 2214 
E 2.12 + 3.12 ND 0.38 ND 268.43 3.27 <LOQ ND >1 week 126 
F ND ND ND ND ND ND 9.60 0.37 ND 0.05 >1 week 3280 
G ND ND 1.72 ND ND ND 10.46 0.28 ND ND 4-5 days 1440 
H 1.30 ND 1.70 ND ND ND ND 1.02 ND ND >1 week 216 
I 1.94 ND 4.07 ND ND ND ND 43.36 ND ND 4-5 days 264 
J 1.56 ND 4.87 ND ND 2.47 14.05 12.43 ND ND >1 week 168 
Table A-1 cannabinoid concentrations (pg/mg) in hair (H) and wash (W) of self-report frequent cannabis users. ND not detected, + shows that CBD was detected, <LOQ shows that the 
concentration was above the limit of detection and lower than the limit of quantification. 
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 Sample THC 
(H) 
CBD (H) CBN 
(H) 
11-OH 
(H) 
COOH 
(H) 
THC 
(W) 
CBD (W) CBN (W) 11-OH 
(W) 
COOH 
(W) 
Time since last use Est lifetime use 
(cannabis 
cigarettes) 
k <LOQ ND 1.70 ND ND ND 124.28 1.99 ND ND  n/a 2 
l <LOQ ND 2.15 ND ND ND 923.34 35.14 ND ND >1 week 4 
m ND ND 1.53 ND ND ND 11.65 0.13 ND ND >1 week 3 
n <LOQ ND 1.62 ND ND ND 41.42 2.55 0.09 ND  n/a 3 
o <LOQ ND 1.56 ND ND ND 1144.70 5.14 ND ND  n/a 2 
Table A-2  cannabinoid concentrations (pg/mg) in hair (H) and wash (W) of self-report infrequent cannabis users. ND not detected, + shows that CBD was detected, <LOQ shows that the 
concentration was above the limit of detection and lower than the limit of quantification. 
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Table A-3 cannabinoid concentrations (pg/mg) in hair (H) and wash (W) of self-reporting non-cannabis users. ND not detected, + shows that CBD was detected, <LOQ shows that the concentration 
was above the limit of detection and lower than the limit of quantification. 
 Sample THC 
(H) 
CBD 
(H) 
CBN 
(H) 
11-OH 
(H) 
COOH 
(H) 
THC 
(W) 
CBD (W) CBN (W) 11-OH 
(W) 
COOH 
Wash (W) 
Time since last use Est. lifetime use 
(cannabis 
cigarettes) 
p ND ND 1.512 ND ND ND ND 17.03 ND ND n/a 0 
q ND ND 2.578 ND ND ND 30.904 0.20 ND ND n/a 0 
r ND ND <LOQ ND ND ND ND 0.10 ND ND n/a 0 
s ND ND 1.902 ND ND ND 29.620 0.12 ND 0.10 n/a 0 
t <LOQ ND 1.578 ND ND ND ND 13.17 ND ND n/a 0 
u <LOQ + 1.297 ND 0.423 ND ND 0.44 ND ND n/a 0 
v <LOQ ND 1.536 ND 0.304 ND 76.903 2.63 ND ND n/a 0 
w ND ND ND ND ND ND 75.285 0.99 ND ND n/a 0 
x <LOQ ND <LOQ ND ND ND ND 3.91 ND ND n/a 0 
y 1.567 + 2.09 ND ND ND 15.941 7.07 0.53 2.11 n/a 0 
z ND ND ND ND ND 22.57 211.415 23.26 8.80 5.84 n/a 0 
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Detection and Mapping of Cannabinoids in Single Hair Samples
through Rapid Derivatization and Matrix-Assisted Laser Desorption
Ionization Mass Spectrometry
Emma Beasley, Simona Francese, and Tom Bassindale*
Centre for Mass Spectrometry Imaging, Biomolecular Research Centre, Sheﬃeld Hallam University, Howard Street, S1 1WB
Sheﬃeld, United Kingdom
ABSTRACT: The sample preparation method reported in this work has permitted
for the ﬁrst time the application of matrix-assisted laser desorption ionization mass
spectrometry (MALDI-MS) proﬁling and imaging for the detection and mapping of
cannabinoids in a single hair sample. MALDI-MS imaging analysis of hair samples
has recently been suggested as an alternative technique to traditional methods of
GC/MS and LC/MS due to simpler sample preparation, the ability to detect a
narrower time frame of drug use, and a reduction in sample amount required.
However, despite cannabis being the most commonly used illicit drug worldwide, a
MALDI-MS method for the detection and mapping of cannabinoids in a single hair
has not been reported. This is probably due to the poor ionization eﬃciency of the
drug and its metabolites and low concentration incorporated into hair. This research
showed that in situ derivatization of cannabinoids through addition of an N-
methylpyridium group resulted in improved ionization eﬃciency, permitting both
detection and mapping of Δ9-tetrahydrocannabinol (THC), cannabinol (CBN),
cannabidiol (CBD), and the metabolites 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH), 11-hydroxy-Δ9-
tetrahydrocannabinol (11-OH-THC), and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol glucuronide (THC-COO-glu). Addition-
ally, for the ﬁrst time an in-source rearrangement of THC was observed and characterized in this paper, thus contributing to new
and accurate knowledge in the analysis of this drug by MALDI-MS.
The use of hair as an alternative biological sample intoxicological analysis is well documented. This is due to
the fact that hair oﬀers a longer time frame to detect drug use
than the more traditional blood or urine. By measuring the
length of the hair and approximating the rate of hair growth (1
cm/month on average),1 it is possible to estimate when speciﬁc
drug intake occurred, over a time period as long as the length of
the hair allows (weeks, months, or even years).2 This is in stark
contrast to blood and urine analysis, where most drugs cannot
be detected beyond a few hours to days after intake.3 Some
important applications of hair samples for retrospective
detection of drug intake include investigating drug-facilitated
crime, workplace testing, child protection cases, and therapeutic
monitoring.
Hair analysis is often used to identify cannabis consumption.
Cannabis continues to be the most widely used illicit drug in
England and Wales, with an estimated 6.7% of adults having
used cannabis in the last year,4 a higher percentage than the
European average of 5.7%.5 Δ9-Tetrahydrocannabinol (THC)
is the main psychoactive constituent of cannabis. THC
undergoes a complex hepatic metabolism based on oxidation
and subsequent glucuronidation.6 Since this enzymatic pathway
is present only in vivo, metabolite detection has been suggested
as a solution to external contamination problems associated
with solely analyzing THC content in hair samples.1 The main
oxidative metabolites of THC are 11-hydroxy-Δ9-tetrahydro-
cannabinol (11-OH-THC) and 11-nor-9-carboxy-Δ9-tetrahy-
drocannbinol (THC-COOH). This molecule then undergoes
glucuronidation (phase II metabolism) to form 11-nor-9-
carboxy-Δ9-tetrahydrocannabinol glucuronide (THC-COO-
glu)7 as shown in Figure 1. Other cannabinoids routinely
analyzed in hair samples include the Cannabis sativa plant
degradation products cannabinol (CBN) and cannabidiol
(CBD).8−13
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Figure 1. Degradation (ex vivo) and metabolic (in vivo) pathways of
THC.
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THC and associated cannabinoids and metabolites can
already be detected in hair samples by standard analytical
techniques such as gas chromatography (GC)/mass spectrom-
etry (MS)12,14−18 and liquid chromatography (LC)/MS.19−23
However, GC/MS requires multiple laborious and time-
consuming steps before chromatographic analysis can take
place, including digestion, extraction, sample cleanup, and
derivatization.
LC/MS has gained in popularity over recent years, as the
aforementioned derivatization step is often not needed for
successful analysis. However, both methods require a large
amount of hair sample (10−50 mg). GC/MS and LC/MS
analyses typically give a time of intake accuracy of 1 month due
to the common practice of segmenting the hair into 1 cm pieces
before analysis.
More recently, direct analysis in real time (DART) has been
proposed as a method for the analysis of cannabinoids and
cocaine in hair samples;2,24 however, this method is not able to
distinguish between the two isobaric species of THC and CBD,
despite tandem mass spectrometric (MS/MS) analysis, because
both compounds result in the same product ions. In addition to
this, a large sample size is required, and currently the method is
applicable only to high levels of THC associated with chronic
users because the detection limit is approximately 5 ng/mg of
hair. The authors stated that DART “should only be considered
as a rapid pre-screening method”; however, this could result in
false negative results for lower-level users.
Matrix-assisted laser desorption ionization mass spectrometry
(MALDI-MS) has been highlighted as a potential hair analysis
method due to several advantages over current techniques,
including improved chronological information,25 simpler
sample preparation, and ability to detect drugs on one single
hair. Several drugs have already been analyzed in hair samples
by MALDI-MS, including methamphetamine26 and ana-
logues,27 cocaine,28−31 ketamine,32 Zolpidem,33 and nicotine34
by utilizing an α-cyano-4-hydroxycinnamic acid (CHCA)
matrix without the need for analyte derivatization. Cannabis
products were determined in the work of Musshof et al.,29 but
they were unable to determine the diﬀerence between the
isobaric THC and CBD and did not look for any in vivo
metabolites.
In this study, initial experiments suggested the occurrence of
an in-source rearrangement of the THC molecule; in addition
to low analyte ionization eﬃciency, this highlighted the low
probability of success in mapping cannabinoids in hair samples
by MALDI-MS imaging. However, the ﬁnal method developed
included the novel use of 2-ﬂuoro-1-Methylpyridinium p-
tolunesolfonate (FMTPS) derivatization of hair samples in situ
and showed greatly improved detection of cannabinoids and
metabolites, allowing these species to be mapped by MALDI-
MS imaging.
■ EXPERIMENTAL SECTION
Materials and Reagents. α-Cyano-4-hydroxycinnamic
acid (CHCA), triﬂuoroacetic acid (TFA), 2-ﬂuoro-1-methyl-
pyridinium p-toluenesulfonate (FMPTS), and triethylamine
(TEA) were purchased from Sigma−Aldrich. Cannabinol
(CBN), cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC),
11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH), 11-
hydroxy-Δ9-tetrahydrocannabinol (11-OH-THC), Δ9-tetrahy-
drocannabinolic acid A (THCA-A), and 11-nor-9-carboxy-Δ9-
tetrahydrocannabinol glucuronide (THC-COO-glu) were
purchased as analytical references from Cerilliant (Sigma−
Aldrich). Acetonitrile (ACN) and methanol were purchased
from Fisher Scientiﬁc.
Sample Preparation. CHCA was prepared at 5 mg/mL
with the solvent composition being 70:30 ACN/0.2% aqueous
TFA. Cannabinoid standards were mixed 1:1 with the matrix
solution and deposited in triplicate on the MALDI target. The
spots were left to dry at ambient temperature before analysis.
Cannabinoid concentrations were 100 μg/mL.
Derivatization of Standards for MALDI Proﬁling
Analysis. Derivatization was carried out according to Thieme
et al.35 Brieﬂy, 40 μL of FMPTS (10 mg/mL in acetonitrile)
and 10 μL of triethylamine were mixed by vortexing. This
caused the colorless solution to turn canary yellow as previously
reported.35,36 A 20 μL aliquot of each cannabinoid standard
(100 μg/mL) was then added, and the solutions were left at
room temperature for 5 min. A sample (1 μL) of each solution
was then spotted onto a target plate.
Spiking of Hair. Hair samples from an individual who
reported not using any illicit drugs were collected by cutting
and washed with methanol and water by vortexing. The
samples were then cut into 5 cm sections and placed into the
bottom of a well in a 24-well cell culture plate in order to keep
the spiking solution volume to a minimum while still
submerging the hairs. The limitation of 5 cm is due to the
size of a MALDI target plate. Spiked samples were prepared by
soaking in 300 μL of 0.5 μg/mL cannabinoid standard solution.
Blank hair samples were prepared by soaking in 300 μL of
methanol. The plate was sealed with tape to avoid evaporation
of the standards. All hairs were soaked for 2 h, removed, and
allowed to dry for 1 h at room temperature.
User Hair Sample. The hair sample collection was
approved by the Sheﬃeld Hallam University Research Ethics
committee (SHU ethics number 13-2011). The hair sample was
provided from a male volunteer who self-reported smoking
cannabis once a week. The hairs were less than 5 cm in length.
To wash, the hairs were placed in a clean test tube with
methanol (5 mL) and brieﬂy vortexed before being removed.
This was repeated twice and the hairs were then left for 2 h at
room temperature to dry.
In Situ Derivatization of Cannabinoids. The hair was
placed on a glass slide by use of double-sided Sellotape Super
Clear tape. Derivatization reagent (2.5 mL) was then sprayed
by use of a Neo for Iwata airbrush at a pressure of 30 psi onto
an area of 9 cm2, with the sample in the center of the area. This
step was carried out in a fume hood due to hazards associated
with use of the triethylamine catalyst.
Deposition of Matrix for Imaging. The hairs were coated
in CHCA at 5 mg/mL, with the solvent composition being
70:30 ACN/0.2% aqueous TFA, by use of the SunCollect
autospraying system (SunChrom GmbH, Friedrichsdorf,
Germany). Fifteen layers were sprayed at a ﬂow rate of 2
μL/min.
■ INSTRUMENTATION
MALDI Instrumentation and Analytical Conditions. All
data were acquired in positive-ion mode on an Applied
Biosystems/MDS Sciex hybrid quadrupole time-of-ﬂight mass
spectrometer (Q-Star Pulsar-i) with an orthogonal MALDI ion
source (Applied Biosystems, Foster City, CA) and a neo-
dymium-doped yttrium aluminum garnet (Nd:YAG) laser (355
nm, 1 kHz). The laser power was 30% (1000 Hz, 3.2 μJ), with
an elliptical spot size of 100 × 150 μm.37 Image acquisition was
performed in raster image mode.38 Declustering potential 2 was
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set at 15 arbitrary units and the focusing potential at 20
arbitrary units, with an accumulation time of 0.999 s. The
MALDI-MS/MS images were obtained with argon as the
collision gas; the declustering potential 2 was set at 15 and the
focusing potential at 20, and the collision energy and collision
gas pressure were set at 20 and 5 arbitrary units, respectively.
Images were acquired with oMALDI Server 5.1 software
supplied by MDS Sciex (Concord, Ontario, Canada) and
processed with Biomap 3.7.5 software (www.maldi-msi.org) to
generate black and white images for each m/z ratio of interest.
Further image analysis and processing was performed with the
public domain software ImageJ (NIH; http://rsb.info.nih.gov/
ij), where the previous black and white images were assigned
diﬀerent colors and overlaid to create one ﬁnal image.
LC/MS Instrumentation and Analytical Conditions. All
experiments were performed on a Thermo Finnigan LCQ
classic quadrupole ion-trap liquid chromatography mass
spectrometer with electrospray ionization (ESI) interfaced to
a liquid chromatography system. The system used also
consisted of an autosampler and autoinjector. The column
used was a Phemonex Lunar C18 (150 mm × 1 mm, 5 μm)
with a corresponding guard column. LC/MS/MS chromato-
graphic separation was realized by gradient elution according to
a previously published method by Roth et al.39 Brieﬂy, 0.1%
HCOOH in water was used as mobile phase A, and ACN +
0.1% HCOOH was used as mobile phase B. Mobile phase A
was gradually reduced over time while mobile phase B was
increased from 20% to 95%. The total run time was 15 min,
with the THC molecule eluting at 4 min.
■ RESULTS AND DISCUSSION
Proﬁling of THC. In preliminary MALDI-MS proﬁling
experiments, analyses were carried out on the cannabinoid
standard THC as purchased from the supplier. We immediately
observed a detection issue due to interference from a matrix ion
peak (m/z 315.10 as seen in Figure 2A, which is more apparent
at concentrations lower than 100 μg/mL) in addition to a
general low ionization yield in MALDI, as previously
reported.40 For this reason, diﬀerent matrix systems were
tried, including type and amount of matrix [2,5-dihydrox-
ybenzoic acid (DHB), 6-aza-2-thiothymine (ATT), 3-hydrox-
ycoumarin (3-HC), and 2′,4′,6′-trihydroxyacetophenone
monohydrate (THAP)], diﬀerent solvent compositions, diﬀer-
ent amounts of triﬂuoroacetic acid (TFA), and the addition of
additives [cetrimonium bromide (CTAB), lithium salts, and
aniline]. In addition, negative mode analysis was conducted
with 9-aminoacridine (9-AA) matrix. None of these experi-
ments improved the detection of THC beyond that achieved
with CHCA, and they will not be discussed further in this
paper. Another observation from these MALDI proﬁling
spectra was the presence of m/z peaks at 313.22 and 315.23
(Figure 2A). While the peak at 315.23 ﬁtted the expected
monoisotopic m/z of THC, the peak at 313.22 was
unexplained. However, the absence of a peak at m/z 313.22
in the matrix blanks suggests that it is in fact associated with the
THC molecule.
In order to investigate this phenomenon further, LC/MS/
MS analysis of the THC standard (100 ug/mL) was carried
out. A single peak in the chromatogram conﬁrmed the purity of
the THC standard. Interestingly, the peak at m/z 313.22 had
3% of the intensity of the m/z 315.23 peak (seen on MALDI at
approximately 110%; Figure 2A), and the isotopic peak at m/z
314.23 was no longer detected. In addition, since this LC/MS
system utilizes electrospray ionization, it is reasonable to
assume that the additional peak at m/z 313.22 is speciﬁc to the
MALDI ionization process, and we hypothesized that it could
be dependent on the laser energy. In fact, experimentally it was
observed that increasing laser power causes the ratio of m/z
313.22 to 315.23 signal intensity to increase (Figure 2B).
One possible explanation for this observation is a laser-
induced rearrangement of the THC molecule. The loss of
hydrogens as free radicals would increase the conjugation of the
THC molecule, making it more stable and so the rearrange-
ment would be more favorable. MS/MS spectra of m/z peaks
313.1 and 315.1 obtained by direct infusion of the THC
standard also support this theory; the MS/MS spectrum of the
parent ion at m/z 315.1 is shown in Figure 3A(i), and that of
the rearranged parent ion at m/z 313.1 is shown in Figure
3A(ii). The spectra are very similar to many fragments formed
from common mass losses (peaks labeled with stars),
demonstrating that these peaks refer to the same (THC)
species. Both the parent ions and many of the product ions
have a mass shift of −2 Th, suggesting the loss of two
hydrogens from the THC parent ion.
Bijlsma et al.41 reported the fragmentation pathway of THC-
COOH, including fragments at m/z 193 and 257, based on
MSE accurate mass data. These fragments would be identical for
THC-COOH and THC due to loss of the COOH group from
the molecule. In this analysis the m/z 259 and 193 ions were
observed in the MS/MS spectrum of the 315.1 parent ion,
while we also observed a shift to m/z 257 in the MS/MS
spectrum of the 313.1 parent ion. The 193 fragment was
Figure 2. (A) m/z region 311−317 of THC standard with CHCA
matrix. (B) Ratio of signal intensity of peaks m/z 313.22 to 315.25 at
increasing laser energies.
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present in both MS/MS spectra, indicating this fragment does
not contain the proposed site of the rearrangement (see Figure
3B).
Derivatization of Cannabinoids. Once the nature of the
peak at m/z 313.22 was elucidated, in order to avoid
rearrangement due to the laser energy, a chemical modiﬁcation
of THC was carried out. Derivatization has previously been
identiﬁed as a possible strategy to improve signal intensity and
decrease matrix interference.42,43
The target for derivatization was the hydroxyl group, since all
cannabinoids of interest contain this functional group. After
careful review of the literature, the derivatization method using
2-ﬂuoro-1-methylpyridinium p-tolunesolfonate (FMPTS) to
form an N-methylpyridinium derivative, as reported by Quirke
et al.36 for the detection of alcohols by ESI-MS, was chosen.
FMPTS derivatization has previously been reported to improve
the detection of a range of compounds with alcohol moieties in
various sample types including surfactants,44 estrogens,45 and
the narcotic analgesic burprenorphine,35 by LC/MS analysis,
and polyamides42 and sterols46 in MALDI proﬁling experi-
ments.
This strategy was also selected due to the simplicity of the
nucleophilic substitution reaction (which occurs readily at
room temperature),47 the stability of the products forme-
d,44,48and also the addition of a permanent charge to the
analytes. This is of particular importance, as it allows all
cannabinoids to be analyzed in positive-ion mode (despite the
nonderivatized THC-COOH being theoretically more suited to
negative mode).
Derivatization was successful for all cannabinoids of interest,
with all peaks being observed and in agreement with the
expected monoisotopic m/z values (Table 1). The derivatized
species show an addition of 92 amu, as ﬁrst reported by Quirke
et al.36 and conﬁrmed by others.45,46
After derivatization, the ions corresponding to nonderivat-
ized cannabinoids were not observed, suggesting that reaction
went to completion (or such that nonderivatized cannabinoids
remained present at concentrations below the limit of
detection). The expected derivatized THC peak at m/z
406.28 was the most abundant in the spectrum. However,
there was evidence that rearrangement still occurred, as a peak
at m/z 404.27 was observed, though it was present at only 6%
of the intensity of the m/z 406.28 peak, as opposed to
approximately 100% when run without derivatization. This
suggests that the derivatization largely protects THC from
rearrangement, possibly due to steric hindrance or increasing
the required amount of laser energy to rearrange the molecule.
The peak at m/z 406.28 was also observed in the mass
spectrum of the derivatized CBD molecule. This was
anticipated as THC and CBD are isobaric species; however,
an additional peak at m/z 483.32 was also detected in the CBD
spectrum; CBD gains two N-methylpyridinium groups, as it has
one more hydroxyl group than THC. The peak at m/z 483.32
corresponds to the loss of a methyl group from the doubly
derivatized molecule expected to be observed at m/z 498.32.
Theoretically there could be two additions of the derivatization
group to 11-OH-THC and THC-COOH and up to ﬁve
additions on the THC-COO-glu molecule as a result of
multiple hydroxyl groups being present, though corresponding
m/z values were not observed. THC-COO-glu was detected at
m/z 612.28 in the mass spectrum, corresponding to a single
addition, though the peak at m/z 436.25 was much more
abundant, suggesting that the glucuronide group readily
fragments from the parent molecule during analysis, resulting
in detection of THC-COOH. A further experiment in which
the laser power used for analysis was increased showed that the
ratio of THC-COO-glu to THC-COOH decreased with
increasing laser power (data not shown). Another potential
interferent in the assay was THCA-A, the biogenic prescursor
to THC. This was analyzed by the same method and showed
no trace of ions relating to THC or derivatized THC (data not
presented).
It was also noted that for all derivatized samples there was
almost complete suppression of CHCA matrix-related peaks, as
previously observed by Murgasova et al.42
Imaging of Cannabinoids in Hair Samples. Once the
detection of cannabinoids through derivatization was opti-
mized, this sample preparation method was adapted to permit
mapping of these species in single hair samples by MALDI-MS
imaging. Preliminarily, blank and cannabinoid spiked hairs were
imaged to verify eﬃciency of the derivatization method for
Figure 3. (A) MS/MS spectra of THC. Product ion mass spectra of
(i) m/z 315 and (ii) m/z 313 are shown. Both spectra were obtained
through direct infusion on an LCQ instrument. Peaks with a star
symbol denote a mass shift of 2 Th. (B) Proposed rearrangement of
THC and structures of fragments present at m/z 259, 257, and 193
(257 and 193 structures as proposed by Bijlsma et al.41).
Table 1. Theoretical and Experimental m/z Ratios for
Derivatized and Nonderivatized Cannabinoid Standards
[M + H] derivatized [M + 92]
cannabinoid theor exptl theor exptl
THC 315.23 315.23 406.27 406.28
CBN 311.20 311.20 402.24 402.24
CBD 315.23 315.23 406.27 406.28
11-OH-THC 331.23 331.23 422.27 422.26
THC-COOH 345.21 345.21 436.25 436.25
THC-COO-glu 521.24 521.25 612.28 612.28
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imaging purposes and were compared to hairs that had not
gone through the derivatization step (Figure 4).
Unless dramatic modiﬁcations are made to contrast and
brightness, underivatized hairs soaked in THC standard could
not be visualized in the two-dimensional (2D) molecular map,
as the ion signals of underivatized THC were of extremely low
intensity. Interestingly, THC-COOH could be visualized in the
2D molecular ion map (cyan) in hairs G and H, which were
soaked in THC-COOH standard and a mixture of THC and
THC-COOH standards, respectively; however, this was also at
relatively low intensity (Figure 4). The peak at m/z 406.2,
corresponding to derivatized THC, is clearly seen in hair B,
which was spiked with THC and subsequently derivatized
(red). Similarly, the expected ion at m/z 436.2 was observed in
hair C, which was spiked with THC-COOH and subsequently
derivatized (green). Hair D, which was spiked with a mixture of
THC and THC-COOH and then derivatized, appears yellow in
color as both THC and THC-COOH ions are present (a
mixture of red and green appears yellow).
Since it was established that derivatization enhances both
THC and THC-COOH signals in imaging experiments (as
shown in Figure 4), a second mapping experiment with the
other cannabinoids was carried out (Figure 5). The peak at m/z
406.2, corresponding to derivatized THC, is clearly seen in hair
B, which was spiked with THC and then derivatized (red); the
peak at m/z 483.2 was observed in hair C, which was spiked
with CBD and derivatized (yellow), the peak at m/z 402.2,
corresponding to derivatized CBN, was observed in hair D,
which was spiked with CBN and derivatized (blue); the peak at
m/z 436.2, corresponding to derivatized THC-COOH, was
observed in hair E, which was spiked with THC-COOH and
derivatized (green); and ﬁnally, the peak at m/z 422.2,
corresponding to derivatized 11-OH-THC, was observed in
hair F, which was spiked with 11-OH-THC and derivatized
(magenta). As with the proﬁling experiments, THC-COO-glu
fragmented to give THC-COOH at m/z 436.2 (green), and its
image intensity reﬂect a 5× lower concentration compared to
the other standards due to the concentration in which it is
supplied.
Users’ hairs were investigated by the derivatization method
coupled with MALDI-MS imaging, employing this optimized
method. In particular, MALDI-MS/MS images were obtained
of hairs collected from a volunteer who self-reported using
cannabis once a week, and the transition from m/z 406.2
derivatized THC parent ion to m/z 110.0 fragment ion was
monitored (Figure 6). The product ion at m/z 110.0
corresponds to the hydrated methylpyridinium fragment,
which is common to all FTMPS derivatives and has previously
been used for conﬁrmation.44
■ CONCLUSIONS
The use of MALDI imaging and proﬁling to detect
cannabinoids in hair samples following in situ derivatization is
presented. The method shows, for the ﬁrst time, potential to
detect cannabinoids from a single hair.
During the development of this method, an interesting, laser-
induced THC rearrangement was observed. This caused
increased fragmentation of THC and hence low ability to
detect the molecule without derivatization. The novel in situ
derivatization, completed in minutes at room temperature with
FMPTS, showed a greatly increased limit of detection over the
nonderivatized analytes and THC, CBD, CBN, and THC
metabolites. The ability to detect the metabolites of THC only
formed in vivo (THC-COOH, 11-OH-THC, and THC-COO-
glu) will enhance the ability of the analyst to distinguish
between use and unintentional exposure. During analysis, the
THC-COO-glu fragments form THC-COOH, with the
consequence that if m/z 436.2 is detected, it cannot be
determined which of the analytes was originally present. The
m/z 612 peak, however, is unique to THC-COO-glu. This is an
Figure 4. Comparsion between (A−D) derivatized and (E−H)
nonderivatized hairs: (A) soaked in methanol and derivatized, (B)
soaked in THC standard and derivatized, (C) soaked in THC-COOH
standard and derivatized, (D) soaked in a 1:1 mixture of THC and
THC-COOH standards and derivatized, (E) soaked in methanol and
not derivatized, (F) soaked in THC standard and not derivatized, (G)
soaked in THC-COOH standard and not derivatized, and (H) soaked
in a mixture of THC and THC-COOH standards and not derivatized.
Figure 5. Simultaneous imaging of several cannabinoids of interest:
hairs were soaked in (A) methanol, (B) THC, (C) CBD, (D) CBN,
(E) THC-COOH, (F) 11-OH-THC, and (G) THC-COO-glu. All
hairs were derivatized with FMTPS prior to analysis.
Figure 6. MS/MS image of user hairs: (A) Derivatized THC parent
ion at m/z 406.2. (B) Map of fragment ion at m/z 110.
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advantage over traditional GC/MS methods, where the
glucuronide is not generally detected due to the common
practice of hydrolysis or digestion of the hair sample, which
converts it into THC-COOH.49
Prior to integration into a toxicology workﬂow, a large
sample of user hairs should be tested, from diﬀerent levels of
users and with diﬀerent hair types. The comparison of levels of
metabolites detected by traditional methods with the results
from MALDI analysis will determine the limit of detection for
hair samples and applicability to lower-level users, as well as the
possibility of using the method quantitatively in the future. This
will allow an assessment of the suitability of the method for
users or whether it will be a screen for external contamination.
The user hair tested here, from a regular but low-level user,
provides proof that the THC at least can be detected.
The method reported has a sample preparation workﬂow,
notwithstanding the derivatization step, that is less time-
consuming, due to the lack of extraction step, than traditional
GC or LC methods. This method also gives the potential to
simultaneously detect THC and metabolites in a single workup
and analysis. An additional advantage is the potential of
MALDI-MS imaging resolution, allowing increased sensitivity
to the time period of use, better than the traditional month-by-
month history, although such an approach will require further
validation. Analysis of hairs from a known cannabis user has
shown applicability of the method to detect THC in real-life
samples.
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Abstract. Matrix-assisted laser desorption/ionization-mass spectrometry imaging
(MALDI-MSI) has been employed to rapidly screen longitudinally sectioned drug user
hair samples for cocaine and its metabolites using continuous raster imaging. Opti-
mization of the spatial resolution and raster speed were performed on intact cocaine
contaminated hair samples. The optimized settings (100 × 150 μm at 0.24 mm/s)
were subsequently used to examine longitudinally sectioned drug user hair samples.
The MALDI-MS/MS images showed the distribution of the most abundant cocaine
product ion atm/z 182. Using the optimized settings, multiple hair samples obtained
from two users were analyzed in approximately 3 h: six times faster than the standard
spot-to-spot acquisition method. Quantitation was achieved using longitudinally sec-
tioned control hair samples sprayed with a cocaine dilution series. A multiple reaction monitoring (MRM)
experiment was also performed using the ‘dynamic pixel’ imaging method to screen for cocaine and a range of
its metabolites, in order to differentiate between contaminated hairs and drug users. Cocaine, benzoylecgonine,
and cocaethylene were detectable, in agreement with analyses carried out using the standard LC-MS/MS
method.
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Introduction
H air testing is a powerful tool routinely used for thedetection of drugs of abuse in toxicology and forensic
applications [1–3]. The analysis of hair is highly advantageous
as it can provide prolonged detection and chronological infor-
mation about drug intake or chemical exposure in contrast to
the analysis of biological fluids [4]. However, current method-
ology routinely involves complex and time-consuming
homogenization, derivatization, sample-clean up, and extrac-
tion techniques followed by gas or liquid chromatography
coupled with mass spectrometry (GC-MS or LC-MS). Also
these techniques require large amounts of hair sample (10–100
mg) and can only provide the chronological information per
month (based on the average growth rate of 1 cm/mo).
Matrix-assisted laser desorption/ionization-mass spectrom-
etry imaging (MALDI-MSI) is well established for the detec-
tion and imaging of drugs and pharmaceuticals in tissues.
However, it is increasingly being used for the analysis of drugs
of abuse in hair, as it offers several advantages over the cur-
rently established techniques, such as requiring fewer hair
samples, simpler and faster sample preparation, and providing
more accurate and visual chronological information in hours or
days.
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1007/s13361-017-1766-0) contains supplementary material, which is available
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MALDI-MSI has been used to monitor the distribution of a
wide range of compounds, including drugs of abuse, pharma-
ceuticals, and other compounds in single hair samples, such as
cocaine [5], methamphetamine [6, 7], ketamine [8], cannabi-
noids [9], tilidine [10], zolpidem [11, 12], and nicotine [13].
New techniques have also been introduced into the field, such
as infrared-matrix-assisted laser desorption electrospray
ionization-mass spectrometry imaging (IR-MALDESI-MSI),
which has been used to monitor the distribution of the antire-
troviral efavirenz in hair samples from HIV infected patients
[14]. Recently, mass spectrometry imaging techniques have
been used to address some of the current issues with forensic
hair testing, such as the process/rate of drug incorporation [15],
the effects of cosmetic treatment [16], and the consequences of
different washing procedures [17].
Whilst these examples show it is possible to monitor the
distribution of a wide range of compounds in single hair
samples, multiple hairs need to be analyzed in order to account
for the different growth phases of hair. As a result, depending
on the length and number of the hair samples or the spatial
resolution, it can take several hours to a few days to acquire
images with the conventional spot-to-spot acquisition method.
One way to overcome this and improve the speed of analysis is
to use Braster imaging^ mode. This method of data acquisition
is achieved by continuously firing the laser in rows across a
sample. The generated data is placed into a bin at selected
intervals during the raster, which is based upon the selected
spatial resolution and sampling speed [18, 19]. Another issue is
the extraction efficiency of the embedded drugs by the matrix
solution. As the drugs are considered to be bound to melanin
inside the core of the hair, it remains difficult to know whether
the drug is completely extracted from the hair by the MALDI
matrix, especially through the impermeable outer surface; this
can be overcome by longitudinally sectioning the hair samples
prior to analysis.
In the work reported here, instrumental and experimental
parameters were optimized to rapidly generate high quality
images of longitudinally sectioned drug user hair samples using
continuous raster imaging. In order to quantify the detected
drug, a novel method for preparing a calibration line on longi-
tudinally sectioned hair was developed. To further confirm if
the detected drugs and metabolites are indicative of actual
ingestion, a multiple reaction monitoring (MRM) method was
developed to screen for unique metabolites.
Experimental
Materials
Alpha-cyano-4-hydroxycinnamic acid (CHCA), cocaine
(COC), benzoylecgonine (BZE), norcocaine (NCOC),
cocaethylene (CE), ecgonine methyl ester (EME),
anhydroecgonine methyl ester (AEME), and dichloromethane
(DCM) were purchased from Sigma Aldrich (Schnelldorf,
Germany). Acetonitrile (ACN), methanol (MeOH), and
trifluroacetic acid (TFA) were purchased from Biosolve
(Valkenswaard, The Netherlands).
Sample Preparation
Hair samples were collected from volunteer drug users and hair
samples of non-users were collected from volunteers and ana-
lyzed as negative controls. Hair samples were decontaminated
using two 10 mL dichloromethane washes for 1 min by shak-
ing. After washing, the hair samples were left dry at room
temperature [20, 21]. Longitudinal sections of hair samples
were prepared using the previously reported method [22].
Briefly, the hair sample was affixed onto a metal plate that
contains grooves ranging from 20 to 80 μm.Whilst holding the
other end of the hair sample with a gloved finger, a holder with
a blade fixed at a 20° angle was run along the length of the hair.
After visual inspection using a Leica DM RX light microscope
(Leica, Wetzlar, Germany) equipped with a Nikon DM100
digital camera (Nikon, Tokyo, Japan), the hair samples were
mounted onto a glass slide using double-sided tape. Control
hair samples were placed into a 1 mg/mL solution of cocaine
(50:50 acetonitrile:water) before mounting onto a glass slide
using double sided tape.
Preparation of Standards for Quantitation
Cocaine standards were prepared from a 1 mg/mL stock solu-
tion to give the following standards: 0.1, 0.2, 0.5, 1, 2, 5, and 10
ng/μL in 70% acetonitrile. In order to achieve a homogenous
and uniform deposition, the cocaine standards were sprayed
onto longitudinal sectioned control hair samples using the
Suncollect automated pneumatic sprayer (Sunchrom,
Friedrichsdorf, Germany) with the aid of stencils made from
polylactic acid. The stencils (containing square holes that are 2
mm2) were made using a Ultimaker Original 3D printer
(Ultimaker, Geldermalsen, The Netherlands). The standards
were sprayed in a series of 30 layers. The initial layer was
sprayed at 10 μL/min, then stepped up from 20 μL/min to 30
μL/min, and subsequent layers were sprayed at 40 μL/min. The
hair samples were mounted onto a glass slide using double
sided tape.
Matrix Application
The samples were coated with 7 mg/mL CHCA in 50:50
acetonitrile:water with 0.2% TFA using a Bruker ImagePrep
(Bruker Daltonics, Bremen, Germany).
Instrumentation
All data were acquired in positive ion mode on an Applied
Biosystems/MDS Sciex hybrid quadrupole time-of-flight mass
spectrometer (Q-Star Pulsar-i) with an orthogonal MALDI ion
source (Applied Biosystems, Foster City, CA, USA) and a
neodymium-doped yttrium aluminium garnet (Nd:YAG) laser
(355 nm, 1 KHz). The laser power was 30 (1000 Hz, 3.2 μJ)
and the laser beam had an elliptical spot size of 100 × 150 μm.
Image acquisition was performed using the Braster image^
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mode [18, 23]. Images were generated using the freely avail-
able Novartis Biomap 3.8.0.4 software (www.maldi-msi.org).
MALDI-MS spectra were obtained in positive ion mode in the
mass range between m/z 50 and 1000. Declustering potential 2
was set at 15 arbitrary units and the focus potential at 10
arbitrary units, with an accumulation time of 0.999 s. The
MALDI-MS/MS spectra were obtained using argon as the
collision gas; the declustering potential 2 was set at 15 and
the focusing potential at 20, and the collision energy and
collision gas pressure were set at 20 and 5 arbitrary units,
respectively.
Dynamic pixel imaging was employed to perform MRM
imaging experiments. The method was optimized using stan-
dards of cocaine and its metabolites (100 ng/μL in 70% meth-
anol), and the most abundant product ions were selected for
imaging. The laser power was 80% (1000 Hz, 8 μJ), the
instrument parameters were accumulation time of 0.4 s,
seconds/spot 2.4 s, and the mass range was ±2 u for each
product ion. Images were generated using the oMALDI server
5.1 software (MDS Sciex, Concord, ON, Canada).
Data Processing
For presentation purposes, mass spectra from the Analyst QS
1.1 software were exported in the form of text files and
imported into mMass software, an open-source mass spectrom-
etry software used for mass spectral processing [24].
Results and Discussion
In the initial phase of the study, the optimization of instrumen-
tal parameters was carried out:
Optimization of Spatial Resolution and Raster Speed
for MALDI-MS/MS Imaging
To determine the optimal spatial resolution and raster speed
intact cocaine contaminated hair samples were analyzed in
triplicate, and these results were plotted as a function of the
average intensity and time, respectively. The results from these
experiments are shown in Figure 1.
The average intensity of the product ion of cocaine at m/z
182 for each of the spiked hair samples analyzed (n = 3) was
determined using the region of interest (ROI) tool in the
Biomap 3.8.0.4 imaging software. The results shown in Fig-
ure 1 show that analysis of samples at a high spatial resolution
results in a decreased sample throughput and sensitivity. This is
due to the increased number of rasters and extensive
oversampling. Conversely, analysis of samples at a lower spa-
tial resolution results in an increased sample throughput and
sensitivity, because of the reduced number of rasters and a fresh
area being consistently sampled.
However, it should be noted that when performing the
analysis of hair samples at a lower spatial resolution, the results
from individual hairs begin to merge. This is observed in the
MALDI-MS/MS images (Figure 1c), therefore when preparing
hair samples the spacing between the hair samples needs to be
taken into account. Whilst high spatial resolution imaging is
possible, it may not be necessary, especially across the width of
the hair, as the chronological information is obtained longitu-
dinally along the length of the hair. In addition, the incorpora-
tion rate and keratinization of drug into the hair can take several
days.
Based on the findings of this study, the optimal spatial
resolution was determined to be 100 × 150 μm and the optimal
raster speed was 0.24 mm/s (416 shots/pixel). Whilst it may
appear that imaging the hair samples at 150 × 150 μm, 0.17
mm/s is optimal, the corresponding image shows the hairs
begin to merge into one; in addition, there is not much gain
in intensity. As the spatial resolution along the length of the
hair is 150 μm, each pixel is equivalent to around 12 h of
growth. This allows for a much narrower time frame of detec-
tion than the standard GC-MS and LC-MSmethods, which can
only provide information about drug use averaged over a 1 mo
period.
Determination of Optimal Sample Orientation
In order to determine if the orientation of the hair samples in
relation to the movement of the laser affects the results, six
cocaine contaminated hair samples were analyzed in different
orientations using the optimized settings. TheMALDI-MS/MS
images of the cocaine contaminated hair samples are shown in
Figure 2.
The MALDI-MS/MS images show cocaine contaminated
hair samples analyzed in both the horizontal (Figure 2a) and
vertical (Figure 2b and c) orientations. The images show that
using the optimized settings clearly differentiates between in-
dividual hairs.
The MALDI-MS/MS image shown in Figure 2a shows hair
samples analyzed in the horizontal orientation, and the insert
shows each hair consists of around to 3–4 pixels. Whereas the
image in Figure 2b shows hair samples analyzed in the vertical
orientation, the insert shows that each hair consists of 2–3
pixels. The MALDI-MS/MS image in Figure 2c shows better
separation, which could be due to the elliptical laser spot size
(100 × 150 μm). This is also observed in the insert that shows
an expanded view of a single hair prior to smoothing, which
consists of around to 2–3 pixels per hair. This experiment
shows that hair samples can be analyzed in either orientation;
however, the spatial resolution needs to be adjusted according-
ly. For subsequent experiments, the hair samples were analyzed
in the horizontal orientation with the laser running parallel (150
× 100 μm).
MALDI-MS/MS Imaging of Longitudinal Sectioned
Drug User Hair Samples
Once the spatial resolution and raster speed was optimized to
produce the best quality image in the shortest time, the method
was applied to monitor the distribution of cocaine in a number
of longitudinally sectioned hair samples from cocaine users. In
order to quantify the amount of cocaine present in the hair
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Figure 1. Graphs to determine the optimal spatial resolution and raster speed for imaging the distribution of cocaine in hair samples
by MALDI-MS/MS imaging. The graphs show (a) the average intensity of the cocaine product ion at m/z 182 at each spatial
resolution tested at different raster speeds, and (b) the time taken for each spatial resolution tested at different raster speeds. (c)
MALDI-MS/MS images of cocaine contaminated hair samples analyzed used to determine the optimal parameters showing the
distribution of the product ion atm/z 182. The highlighted image and areas indicated by the red arrows show the determined optimal
parameters
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Figure 2. MALDI-MS/MS images of cocaine contaminated hair samples analyzed in different orientations, showing the distribution
of the product ion at m/z 182. (a) Horizontal direction (150 × 100 μm), (b) vertical direction (150 × 100 μm), and (c) vertical direction
(100 × 150 μm). The inserts show the number of pixels per hair
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samples, control hair samples sprayed with a cocaine dilution
series were also analyzed. The MALDI-MS/MS images of the
cocaine user hair samples and cocaine standard hair samples
are shown in Figure 3.
The MALDI-MS/MS image (Figure 3a) shows the distribu-
tion of the most abundant cocaine product ion at m/z 182,
which is formed by the neutral loss of benzoic acid from the
intact molecule and was detected in both user hair samples. In
contrast, it was not detected in the longitudinal sectioned con-
trol hair sample; due to the number of hair samples available
from the second user, only three hairs were analyzed. The
length of the analyzed hair samples was 4 cm; given the
average growth rate of human hair is approximately 1 cm per
month, this corresponds to a growth period of 4 mo [25]. Since
the spatial resolution along the hair is 150 μm, each pixel is
equivalent to around 12 h of growth. The analysis of the
longitudinally sectioned user hair samples took 3 h and
22 min (136 s per raster). This is around six times faster in
comparison to the standard spot-to-spot acquisition method at
this spatial resolution, which takes around 18 h. Analysis with
the current methodology takes around 1 h; however, the sample
preparation takes approximately 1 d. In contrast, the sample
preparation for MALDI-MSI takes around 1 h; along with the
optimized settings it takes approximately 4 h to perform the
entire experiment. This is six times faster than the currently
established method. The insert shows a close-up view of a
longitudinally sectioned hair sample, prepared using the previ-
ously published method [22]. The image clearly shows mini-
mal damage to the hair with the medulla in the center
surrounded by the cortex and the cuticle on the edge of the hair.
In order to quantify the amount of cocaine in the longitudinally
sectioned user hair samples, a cocaine dilution series was pre-
pared.Thiswas initially spottedonto theglass slidenext to thehair
samples; however, this resulted in an uncontrollable deposition
due to spreading. Therefore, to overcome this issue, the cocaine
dilution series was sprayed onto longitudinally sectioned control
hair samples using the describedmethod, in order to reproducibly
produce uniform and homogenous standards as shown in Fig-
ure 3b. The obtained image does suggest that this method of
standard deposition has resulted in homogenous and uniform
deposition. A decreasing response with respect to the concentra-
tion is clearly observable with good reproducibility for each hair
sample (see Supplementary Figure S1). The concentration per
standard was reported in ng/mm2, which was calculated from the
parametersused tospray thecocainestandards.Theanalysisof the
quantitation hair standards took1h and10min. It should be noted
that thecontrolhair samplesusedfor thecalibrationcurvewerenot
the same color as those from the drugusers, andother information
suchas race andgenderwasnot available. Ideally thehair samples
used for quantitation should bematched based on hair color, race,
and gender.
Using the ROI tool of the Biomap 3.8.0.4 software, the
average intensity of the calibration standards (Supplementary
Figure S1) and the four segments from both of the user hairs
(Supplementary Figure S2) were determined. The calibration
curve was linear over two orders of magnitude (R2 = 0.9908).
Using the calibration curve the concentration of cocaine per
segment for the first user was determined to be 0.437, 0.389,
0.340, and 0.305 ng/mm2 (1–4), whereas the concentration of
cocaine per segment for the second user was determined to be
0.151, 0.154, 0.1720, and 0.186 ng/mm2 (1–4). These results
indicate both users have a prolonged history of cocaine use and
that the first user is a heavier user in contrast to the second user;
this is also apparent in in the MALDI-MS/MS image.
MALDI-MS/MS Imaging of Cocaine Metabolites
in Drug User Hair Samples
Oneway todetermine if adetecteddrug is present due to ingestion
rather than environmental contamination is to monitor the
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Figure 3. MALDI-MS/MS images of (a) longitudinally sectioned drug user hair samples (insert shows optical image of longitudinally
sectioned hair), and (b) longitudinally sectioned control hair samples sprayed with a cocaine dilution series. The MALDI-MS/MS
image shows the distribution of the product ion at m/z 182, derived from the precursor ion of cocaine at m/z 304
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presence of unique metabolites [20, 26]. In the case of cocaine,
cocaethylene (ametabolite formedby the simultaneousconsump-
tion of cocaine and ethanol), norcocaine (an in-vivometabolite of
cocaine), and anhydroecgonine methyl ester (a pyrolysis product
formedwhencrackcocaine issmoked).Othermetabolites, suchas
benzoylecgonine, the main metabolite of cocaine, can also be
formed by environmental degradation [27]. In order to screen
the drug user hair samples for cocaine and its metabolites, a
MRM imaging method using dynamic pixel imaging was devel-
oped.Dynamic pixel imaging is a technique that enablesmultiple
experiments tobeperformedconsecutively inasingleacquisition.
This is because the target plate ismovedaroundwithin eachpixel,
which enables longer acquisition time per pixel and thusmultiple
experiments to be performed [28]. The transitions for cocaine and
its metabolites were as follows: cocaine (m/z 304.15→182.12),
cocaethylene (m/z 318.17→196.15), norcocaine (m/z
290.13→136.09), benzoylecgonine (m/z 290.15→168.11),
ecgonine methyl ester (m/z 200.16→182.13), and
anhydroecgonine methyl ester (m/z 182.13→118.06). The
MALDI-MS/MSspectraof cocaine and itsmetabolites are shown
in Supplementary Figure S3.
Arequirementfor theuseof thedynamicpixel imagingmethod
is that thehairs needed tobe spacedas far apart as possible inorder
to distinguish individual hairs. This is due to the figure eight
movement of the sample stage during the acquisition, and as a
result the best spatial resolution that could be achievedwas 250 ×
250 μm. The MALDI-MS/MS images of cocaine and its metab-
olites in the longitudinal sectioned hair samples acquired in this
manner are shown in Figure 4.
The lengthof theanalyzedhair sampleswas3cm,andgiven the
average growth rate of human hair is around 1 cm per month, this
correspondstoagrowthperiodof3mo..Since thespatial resolution
along the hair is 250 μm, this corresponds to 18 h of growth.
Cocaine, themajormetabolitebenzoylecgonine,andthemetabolite
cocaethylene were detected in the drug user hair sample. This was
also confirmed using the routine LC-MS/MS analysis method.
Conclusions
The use of MALDI-MS/MS imaging for the rapid screening of
drugs of abuse in hair samples using continuous raster imaging
has been presented. Optimization of instrumental and experi-
mental parameters such as the spatial resolution, raster speed,
and sample orientations were performed in order to rapidly
analyze hair samples without compromising the quality of the
images. Whilst these settings are specific to this instrument,
they provide a starting point for the optimization of these
parameters on other instruments operating in raster imaging
mode. Using the optimized settings (100 × 150 μm at 0.24mm/
s), the analysis of the longitudinally sectioned hair samples of
two drug users took approximately 3 h, which is six times faster
in comparison with the standard spot-to-spot acquisition meth-
od at this spatial resolution, which takes around 18 h. In order
to quantify the amounts of cocaine in longitudinally sectioned
drug user hair samples, a novel method for the preparation of
standards was developed. In order to determine if the detected
drugs present are from actual abuse rather than external con-
tamination, a MRM imaging method utilizing ‘dynamic pixel’
imaging in combination with longitudinally sectioned hair was
developed. By screening for unique cocaine metabolites that
can only be formed in vivo, the confirmation of ingestion of
cocaine could be ascertained. Cocaine, benzoylecgonine, and
cocaethylene were present, which was consistent with the
standard LC-MS/MS method. The work presented here also
shows that if required, faster analysis is possible but the spatial
resolution and spacing between hair samples needs to be ad-
justed accordingly.
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